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Abstract 
The incidence of neoplasia at the gastroesophageal junction has increased 
markedly over the past 20 years, but the mutagen responsible for this remains 
unknown.  Human saliva contains substantial quantities of nitrite and is the main 
source of nitrite entering the stomach.  It is derived from the enterosalivary 
recirculation of dietary nitrate and its reduction by buccal bacteria.  Carcinogenic N-
nitrosocompounds may be formed from the nitrite in swallowed saliva by bacterially-
catalysed nitrosation in the achlorhydric stomach or acid-catalysed nitrosation in the 
healthy acid secreting stomach.  Protection against luminal acid-catalysed nitrosation is 
provided by the ascorbic acid content of human gastric juice which reduces nitrite to 
nitric oxide (NO).  A high luminal concentration of NO generated from salivary nitrite 
has been shown at the gastroesophageal junction. 
 
A bench top model has been developed to explore the chemistry occurring in an 
aqueous phase, representing the lumen at the gastroesophageal junction, after the 
addition of nitrite.  Within this model an adjacent lipid phase has been created.  The 
lipid phase represents the adjacent mucosa to the lumen or the dietary fat shown to sit 
within the fundus of the stomach.  In this two-phase model, addition of physiological 
concentrations of nitrite to an acidic aqueous phase in the absence of ascorbic acid 
generated nitrosative stress within the aqueous phase.  The addition of physiological 
concentrations of ascorbic acid to the aqueous phase prevents nitrosative stress within 
the aqueous phase but in so doing generates nitrosative stress within the lipid phase.  
This can be explained by the ascorbic acid converting the salivary nitrite to NO which 
vii 
 
diffuses into the lipid phase and there reacts with O2 to form the nitrosating species 
N2O3. 
The bench top model has been developed further to include the lipid 
antioxidants, α-tocopherol, β-carotene and BHT.  All three of these antioxidants are 
effective in inhibiting nitrosative stress within the lipid phase.  The concentration of α-
tocopherol required to inhibit nitrosation is less than would be expected from the 
reaction equation.  A possible explanation for this is that ascorbic acid recycles the 
active antioxidant α-tocopherol from its reduced form.  Further studies to support 
recycling of α-tocopherol by ascorbic acid are presented within this thesis. 
 
The design of a model used in vivo to assess for nitrosative stress is discussed.  
The model consisted of a hydrophobic silastic tubing containing a secondary amine at 
a neutral pH.  The hydrophobic membrane that the tubing is composed of allowed the 
passage of gaseous NO.  Human studies in healthy volunteers were performed using 
the silastic tubing.  The data presented shows that after a nitrate rich drink there is 
significantly more nitrosative stress within the upper gastrointestinal tract and this is 
particularly the case in the first part of the stomach where salivary nitrite meets acidic 
gastric juice containing ascorbic acid. 
 
Finally, the studies explore directly measuring nitrosative stress in biopsy 
samples from humans and rats.  As nitrite has been shown previously to be a marker of 
nitrosative stress in bench top models biopsy samples were assessed for nitrite and 
nitrate concentrations.  Methods for assessing nitrite and nitrate concentrations within 
viii 
 
biopsy samples from the upper gastrointestinal tract are discussed, as nitrite and nitrate 
have not been analysed from this region previously.  Thereafter, upper gastrointestinal 
biopsy samples from healthy human subjects were analysed after a control drink and a 
drink rich in nitrate.  The studies presented show that biopsy nitrate and nitrite was 
higher in samples taken from the proximal stomach as compared to the oesophagus and 
distal stomach.  This suggests that there is more nitrosative stress in the biopsies from 
the same area as where NO is generated after a nitrate meal. 
 
Together the data presented supports a novel mechanism for N-nitrosation in 
the upper gastrointestinal tract of a healthy subject.  The N-nitrosation is maximal 
where swallowed salivary nitrite from dietary nitrate meets acidic gastric juice 
containing the aqueous antioxidant ascorbic acid. 
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Chapter 1 – Introduction 
 
1.1 Overview of adenocarcinoma of the gastroesophageal junction and cardia 
of the stomach 
 
The first report of an oesophageal adenocarcinoma was over a century ago and 
is credited
 
to White in 1898. A review of the literature in 1900 revealed
 
only six 
cases (1).  Initially it was thought that this cancer was an extension of gastric 
tumours into the lower oesophagus.  It was not until the 1950s that the existence of a 
primary adenocarcinoma of the oesophagus was established.  While once an 
uncommon tumour, it is now one of the cancers with the fastest increasing incidence 
in the developing world.  In the US, the rate of increase in adenocarcinoma of the 
gastroesophageal junction and cardia of the stomach has overtaken the next closest 
cancer, melanoma, by nearly three times (2-4). Using the European computer 
database Eurocim, it was found that, when the period 1968-95 was examined, there 
was an increase in incidence of adenocarcinoma of the oesophagus and gastric cardia 
throughout most of Europe (5). The interest in cancer of the oesophagus and gastric 
cardia is such that the recent fourth meeting in the series of international ‘From Gene 
to Cure’ congress in 2002 was dedicated to the topic.  Scotland, in particular, has a 
high and increasing incidence of adenocarcinoma at and around the 
gastroesophageal junction.  The incidence here has increased two to three fold in the 
last three decades.  The incidence of cancer in Scotland, from all anatomical sites 
combined, has not changed much over the time period 1975-99.  However, when 
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broken down into regions of the body, there are some striking differences.  Areas of 
the body which are exposed to high luminal nitrite have shown significant increases 
in the incidence of cancer between the years 1975-99.  These areas include the oral 
cavity (+151%), oesophageal adenocarcinoma (+195%), oesophageal squamous 
carcinoma (+60%) and the cardia region of the stomach which has the highest 
increase in incidence over this time period with a percentage increase of 230% (6).   
 
In contrast to the increasing incidence of cardia gastric cancer, there is a 
progressive fall in incidence of distal gastric cancer (7).  These opposing trends 
would suggest that there is a different aetiology behind these cancers.  In keeping 
with this, non cardia cancer is associated with Helicobacter pylori induced atrophic 
gastritis and hypochlohydria (8,9), whereas, gastric cardia and gastroesophageal 
junction cancers occur in individuals with healthy acid secreting stomachs, and are 
not associated with Helicobacter pylori (8,10).   The decreasing incidence of non 
cardia gastric cancer may be explained by the decreasing incidence of Helicobacter 
pylori and associated atrophic gastritis.  However, the cause of the increasing 
incidence of gastroesophageal junction and gastric cardia adenocarcinoma remains 
unclear. Patients diagnosed with oesophageal cancer have a poor prognosis, with 5 
year survival ranging between 5% and 20% in patients amenable to surgery.  An 
understanding of the causes of this cancer and its progression is therefore important, 
to try and decrease the incidence of this disease and also to help direct therapeutic 
interventions. 
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1.2 Epidemiology of Gastroesophageal Junction Adenocarcinoma 
 
The incidence of oesophageal adenocarcinoma is usually higher in men than 
women and increases over the age of 35 years, although the rate of rise differs 
markedly between different regions, probably in association with differences in risk 
factor patterns.  Long-standing gastroesophageal reflux, Caucasian race and obesity 
are well recognised associations with this cancer.  While tobacco smoke has been 
shown in some studies to be a risk factor the evidence of this is not universal and 
some studies have shown no risk.  This is in contrast to non cardia gastric cancer 
where there is a strong association with cigarette smoking.  Long-standing 
gastroesophageal reflux disease may induce Barrett’s oesophagus, which is a pre-
malignant condition where the squamous cells of the lower oesophagus are replaced 
by columnar epithelial metaplasia. The rate of conversion from Barrett’s oesophagus 
to oesophageal adenocarcinoma is 0.5-1% per year.  There may be a protective 
effect from infection of the stomach with Helicobacter pylori and it is known that 
Helicobacter pylori is itself associated with achlorhydria.  There was a nested case 
control study from Norway based on over one hundred thousand individuals where it 
was shown that Helicobacter pylori was associated with a 5 fold reduction in risk of 
cardia cancer and a five fold increase in risk of non cardia cancer (11,12).  Similar, 
although less dramatic, results have been shown elsewhere
 
(13) and meta-analysis of 
this data shows a negative association between Helicobacter pylori infection and 
cardia gastric cancer (14). 
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The pattern of increase would make it unlikely that the increasing incidence in 
oesophageal adenocarcinoma is related to genetic factors and there does not seem to 
be any link with heredity.  This would therefore suggest that acquired factors are 
more likely to be involved. The demonstration of a ‘birth cohort effect’, with higher 
incidence in younger cohorts, would support the idea that exposure to environmental 
factors in early life is an important determinant of risk (15). A potential source of the 
acquired risk factors would be gastroesophageal reflux disease.  Perhaps 
surprisingly, there is not reliable data to suggest a correlation between GORD and 
oesophageal adenocarcinoma. It is also of note that long term acid suppressive 
therapy does not remove the risk of malignant complications of the disease (16,17).  
Acid reflux exposure has however been shown to cause non-specific DNA damage 
(18-20). There has been one large case control study that has demonstrated a positive 
association between use of lower oesophageal sphincter relaxing medication and the 
risk of oesophageal adenocarcinoma (21).  It has been postulated that the increased 
abdominal pressure caused by central obesity, a sedentary position and wearing of 
tight belts may be a factor for gastro-oesophageal reflux (22).  The pattern of 
incidence of adenocarcinoma, the rapidity of its increase and the marked male 
preponderance are inconsistent with the increased body mass index seen in the 
western world being related to GORD and subsequent adenocarcinoma.   
 
As well as the epidemiology discussed above, there have also been some 
interesting epidemiological findings which could suggest a possible implication of 
dietary nitrate in the increasing incidence of upper gastrointestinal cancer.  After the 
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Second World War, until the mid 1980s, there was an exponential rise in nitrogen 
fertiliser usage in the UK.  This same picture was seen in the USA (23).  In the UK 
there has been a gradual decline in the nitrate rich fertilisers used in predominately 
arable farming.  Since 1984 there has been a fall of approximately 30% in nitrate 
fertiliser use (24).  It is known that, for many epidemiological factors implicated in 
cancer development there is a lag period between the cancerous insult and the 
resulting cancer, an example being cigarette smoking and bronchial carcinoma.  This 
is found in comparing the rise in adenocarcinoma at and around the 
gastroesophageal junction and nitrogen fertiliser usage. There have been surprisingly 
few studies looking at the epidemiology of fruit and vegetable intake and 
cardia/gastroesophageal junction adenocarcinoma.  Most of the studies that have 
been performed have classified upper gastrointestinal cancers into oesophageal and 
gastric cancers.  As we suspect that there may be at least two different mechanisms 
to gastric cancer, with one involving the healthy acid secreting subject, and the other 
the hypochlorhydric Helicobacter pylori colonised stomach, it is difficult to draw 
useful relevant epidemiological analysis from most of these studies looking at non 
cardia cancer.  There was, however, a study from the Karolinska Institute in Sweden 
in 2001, where they evaluated fruit and vegetable consumption in the prevention of 
oesophageal and cardia cancers.  Interestingly, in the authors’ conclusions from this 
paper, they showed a 40% lower risk of oesophageal squamous cell carcinoma but 
no risk reduction for gastric cardia adenocarcinoma, in individuals in the highest 
fruit and vegetable exposure quartile. They suggest that the lack of association with 
gastric adenocarcinoma may be due to etiological differences between these cancers 
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(25).  Looking closely at the data from this study shows that there was a trend 
toward those with higher fruit and vegetable intake having a higher incidence of 
adenocarcinoma of the gastric cardia, although this was not statistically significant 
(p=0.92)
 
(25).  This raises the possibility that, despite the increased antioxidant 
provided by fruit and vegetables, there is still a potentially harmful effect from 
dietary nitrate that will be present within these farmed products.   
 
The possibility, that a luminal, locally acting carcinogen is involved, is 
highlighted by a study in Iran, looking at the anatomical site of gastric 
adenocarcinoma (26).  This group found that within the Ardabil region of Iran, an 
area with a very high incidence of gastric cancer, the great majority of the cancers 
were arising in the right side of the cardia.  It has previously been shown that, on 
entering the stomach, non solid material proceeds down the lesser curvature, 
following the ‘Magenstrasse’ formed by the longitudinal mucosal folds.  The right 
side of the cardia will therefore have a particularly high exposure to carcinogens 
from the lumen.  The observation that, within an area where they have the highest 
incidence of gastric cancers in the world, there are a significant number of the 
tumours located in the same anatomical region where non solid material passes 
through the stomach, makes it highly likely there is a luminally acting carcinogen. 
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1.3 Dietary Nitrate and Nitrite 
 
The dominating dietary source of nitrate is the ingestion of vegetables (27) and 
this in part relates to the use of nitrogen rich fertilisers.  Green leafy vegetables such 
as spinach and lettuce, but also beetroot, cauliflower and celery, are especially rich 
in nitrate, as are strawberries, grapes, and a few other fruits (28).  Total intake of 
nitrate is subject to seasonal variations, fertiliser use and cooking procedures, and 
varies greatly between individuals and regions.  Drinking water also contains nitrate 
and nitrite but the concentrations of these are strictly regulated in Europe and the 
USA in part due to fears over N-nitrosocompounds and also the formation of 
methaemoglobin in infants.  Nitrite in the form sodium nitrite is used as a fixative 
and preservative during the processing of meat, cheese and fish (29).  It is widely 
used to preserve lunchmeat, ham, sausages, hot dogs and bacon (30).  The 
antimicrobial activity of sodium nitrite is important in controlling the bacterium that 
causes botulism (31).  It is thought that there are more in the way of nitrates in our 
diet than nitrites, in part due to farming methods and due to regulations that are in 
place regarding nitrite. 
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1.4 Barrett’s oesophagus 
 
Barrett’s oesophagus is the conversion of oesophageal squamous epithelium to 
columnar-lined epithelium as first described by Norman Barrett from St Marks 
hospital in London in the 1950s.  Due to concerns regarding the incidence of both 
Barrett’s oesophagus and oesophageal adenocarcinoma, The UK National Barrett’s 
Oesophagus Registry (UKBOR) was set up in 1996 (32,33).  Barrett’s oesophagus 
can be considered a pre-malignant condition.  Between 5-10% of patients with 
Barrett’s oesophagus will develop adenocarcinoma, the annual risk in surveillance 
programmes being 0.5%-1%, which is 30-125 times that of the general population 
(3,34,35).  Not everyone with Barrett’s oesophagus has a similar risk of developing 
adenocarcinoma and much work has been done to identify risk factors that increase 
the risk of adenocarcinoma conversion from Barrett’s oesophagus (Table 1.1).   
 
Overall it is known that injury to the squamous oesophagus by bile reflux or 
acid causes chronic inflammation, which results in the evolution of Barrett’s 
oesophagus. The step which causes chronic inflammation to progress to Barrett’s 
oesophagus is as yet unknown.  The transition from metaplasia to adenocarcinoma 
proceeds via low grade and high grade dysplasia with increasing aneuploidy (53).  
There are many cell signalling pathways that have strong evidence to suggest 
involvement in oesophageal carcinogenesis: c-myc, TNF, FasL, MAP kinase 
activation, p53 and p27 cell cycle check point control, cytokine signalling 
(COX/prostaglandins, NFκB) and gastrin, to name a few.  Cyclooxygenase (COX)-2 
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is reportedly involved in chronic inflammation and epithelial cell growth.  It appears 
to be constitutively expressed in the oesophagus and the level of COX-2 expression 
seems to increase with progression from Barrett’s oesophagus to oesophageal 
adenocarcinoma.  In a study performed by the Triadafilopoulos group they have 
shown that when Barrett’s oesophagus explants are exposed to acid or bile there is a 
significant increase in COX-2 expression and stimulated proliferation (54,55).   
 
In order for an individual to develop Barrett’s oesophagus, and in some cases 
adenocarcinoma, environmental exposures probably need to interact with genetically 
determined characteristics that define personal susceptibility (56).  It is unlikely that 
a single gene mutation is to blame, as most cases occur in the absence of a family 
history.  This, therefore, means that inherited genetic factors are likely to be normal 
variants or polymorphisms in multiple genes, such as has been seen in DNA repair 
mechanisms, cytokine responses and chemical detoxification (57-59). 
 
The metaplastic conversion to columnar-lined epithelium from oesophageal 
squamous epithelium could arise from two different categories of cell.   One 
possibility is transdifferentiation, where there is the direct conversion of 
differentiated cells in the absence of cell proliferation (60).  The other possibility is 
where metaplasia can develop from the conversion of a pluripotent cell to columnar 
epithelium, either tissue specific stem cells (61) or bone marrow derived stem cells 
(62), although there is no direct evidence of the latter in Barrett’s oesophagus as yet.  
There are likely to be many determinants of a cell’s fate.  The triggering 
10 
 
mechanisms whereby specific genes are activated or silenced, leading to the 
development of Barrett’s metaplasia are not yet understood.  Given that GORD is 
implicated in the pathogenesis of Barrett’s oesophagus, it is interesting to know how 
this may affect gene expression.  Reflux contents are a complex mixture of variable 
pH fluid, bile salts and dietary components. The combination of any or all of these 
may be important as regards genotoxicity.  It is with respect to this refluxate that 
parts of this thesis are related. 
 
The COX-2 enzyme has a role in inducing angiogenesis (63), as well as effects 
on immune surveillance, tissue growth and cell adhesion.  As already discussed, acid 
and bile have been shown to increase COX-2 expression (54,55).  Laboratory and 
epidemiological data suggest that aspirin and NSAIDs may be chemopreventive, 
through inhibitory effects on COX-2 (64-66).  It has been suggested, by a 
prospective study, that the incidence of oesophageal cancer and aneuploidy is 
significantly lower in those people who took aspirin or NSAIDs (67).  Based on this 
COX-2 evidence and evidence suggesting that acid reflux is important in Barrett’s 
oesophagus, the 10 year AspECT chemoprevention trial has been set up to look at 
the role of high-dose versus low dose esomeprazole, with low dose or no aspirin in 
affecting the overall mortality of patients with Barrett’s oesophagus.  Although 
lacking a placebo limb, this trial offers a look at the effect of anti-secretory therapy 
in relation to oesophageal adenocarcinoma in Phase III studies.  This high profile 
study highlights the expected importance of the luminal environment, as well as 
signalling at a cellular level, in Barrett’s oesophagus.  
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Table 1.1: Risk factors for developing adenocarcinoma from Barrett’s oesophagus 
 
Risk Factor Category Risk Factor 
Demographic Male preponderance (M:F 4:1)
 
(36) 
Obesity (37,38)
 
Pathophysiological Hiatus Hernia length (39,40)
 
Increased acid exposure (40)
 
Decreased lower oesophageal sphincter pressure (40)
 
Duodeno-gastric reflux (41)
 
Environmental Drugs (lowering lower oesophageal sphincter pressure) 
(38,42)
 
Low fruit intake (37)
 
Dietary nitrate? (43,44,45)
 
Histopathological Length of Barrett’s >6cm (39,40,46)
 
Presence of dysplasia
  
(47,50)
 
Ulceration in high grade dysplasia (48,47,49,50,51)
 
Molecular Genetics (52) Increased Proliferation Increased Invasive potential 
TGFα, EGF, TGFβ EGFR, C-erb B2, p27 
COX-2, TNFα, iNOS PKC 
Gastrin, Bile salts, Acid c-myc, β catenin 
Ras, Fos, Jun, c-myc CCK2, COX2, p38
MAPK
, p44
ERK
 
CyclinD1, E, B1,  p16 p21 
P53, Bcl-2  
APC, FGF1&2, E-cadherin  
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1.5 Correa Hypothesis for non cardia gastric cancer  
 
The Correa hypothesis was first proposed as early as 1975 (68).  This 
hypothesis postulated that intestinal type gastric cancer is the end result of a series of 
mutations and cell transformations begun in early life, possibly as early as the first 
decade.  Initially, it was believed that factors such as a high salt diet may be the 
trigger to superficial gastritis. There is then a change from superficial gastritis to 
atrophic gastritis.  More is known about some of these early steps in this model since 
the identification of Helicobacter pylori infection.  It is known that this infectious 
agent is associated with increased gastric pH and achlorhydria.  Once the pH of the 
stomach is above pH of 4 it can be colonised by denitrifying bacteria.  This, 
thereafter, allows the bacterial generation of N-nitrosocompounds, which are known 
to be carcinogenic by causing DNA damage.  Since 1994 the infectious agent 
Helicobacter pylori has been regarded as a class I human carcinogen by the IARC 
(69).  More recently polymorphisms, in both the microbial agent and host, have 
shown the influence of genetic susceptibility to the development of gastric cancer 
(70).    
 
However, this hypothesis only explains the potential stages of development in 
non cardia gastric cancer and this cancer has been shown to be both decreasing in 
incidence and related to individuals who are Helicobacter pylori infected.  The focus 
of interest in the upper gastrointestinal tract has now shifted to look at 
gastroesophageal junction adenocarcinoma and proximal gastric cardia tumours.  
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The Correa hypothesis still provides us with insights into the construction of a model 
for other cancers of the upper gastrointestinal tract, in particular, the potential of N-
nitrosocompounds to be implicated in upper gastrointestinal tract tumours.  The 
Correa hypothesis is still directly relevant to non cardia gastric tumours. 
 
1.6 N-nitrosocompounds 
 
1.6.1 Introduction 
 
N-nitrosation is one of the oldest organic chemical reactions known.  N-
nitrosamines were first described in the middle of the nineteenth century.  N-
nitrosation is the replacement of hydrogen, attached to nitrogen, by a nitrosogroup as 
shown in the following reaction (71).  
 
                                 Y                                                    Y 
     X  NO          +          N   H                          H-X   +          N  NO 
                                 Z                                                     Z 
 
 
There are groups known as nitrosating agents which form nitrosogroups.  The 
prime candidate for the formation of nitrosating agents in vivo, particularly in the 
acidic environment of the stomach, is nitrous acid (HONO = NHO2) (pKa 3.3).  
Nitrous acid is formed from the reaction of nitrite ion (NO2
-
) with protons (H
+
 or 
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H3O
+
).  This reaction has been considered to be the prime candidate for the 
formation of nitrosating agents in the acidic environment of the stomach for some 
time.  There are a number of potentially N-nitrosatable substrates in the diet (72) as 
well as in refluxate, particularly of bile contents.  Secondary amines and amides are 
compounds capable of being nitrosated.     
 
The first validated confirmation of the environmental occurrence of N-
nitrosamines was provided when traces of N-nitrosodimethylamine were found in 
nitrite preserved herring, in sheep fodder, following an outbreak of toxic hepatosis 
(73).  N-nitrosocompounds have been found to produce tumours in many animal 
species.  Studies from more than 130 N-nitrosocompounds, obtained from foodstuffs 
(74), from the environment (75), and from the interaction between drugs and nitrite 
(76), indicate that about 80% of them are carcinogenic in animals.  Although this 
suggests that N-nitrosocompounds may be carcinogenic in humans, there has yet to 
be an established causal relationship between exposure to N-nitrosocompounds and 
human cancer.  In the IARC list of agents causing cancer in humans, there are no N-
nitrosocompounds mentioned.  This is not to say that N-nitrosocompounds are not 
carcinogenic.  It can be difficult to demonstrate a direct cause effect relationship 
when there is no unexposed control group and when the available epidemiological 
instruments lack the sensitivity to show a relationship between low levels of N-
nitrosocompounds and individual cancers.  The IARC classifies N-
nitrosodimethylamine, N-nitrosodiethylamine, N-methyl-N-nitrosurea and N-ethyl-
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N-nitrosourea as probably carcinogenic in humans (Group 2A) and have listed 15 
other N-nitrosocompounds as being possibly carcinogenic in humans (Group 2B).   
 
Epidemiological studies across several countries have shown evidence relating 
elevated intake of environmental nitrate being associated with stomach cancer.  
Sander and Buerkle first demonstrated that the reaction between ingested secondary 
amine and nitrite could occur in vivo and could produce carcinogenic nitrosamines in 
laboratory animals (77).  An effective and simple method for demonstrating the 
endogenous formation of N-nitrosoproline (NPRO) in humans was later designed 
(78) and was widely used to assess for the importance of nitrosation in vivo.  In a 
typical example of this technique, sequential oral doses of nitrate and proline were 
administered to a subject and the resulting NPRO measured in a 24 hour urine 
collection.  This method is effective because NPRO is not metabolised, is not 
carcinogenic and can be quantitatively measured in urine (79).  Patients with an 
achlorhydric stomach have suitable conditions for the intragastric formation of 
nitrosamines because of the presence of denitrifying bacteria and subsequent 
nitrosation of amino precursors.  In a field study of Polish inhabitants, from areas of 
low (urban) versus high (rural) risk for gastric cancer, the urinary excretion of N-
nitrosamino acids and nitrate was significantly higher in inhabitants of high risk 
areas than in inhabitants of low risk (80).  A similar study was performed in Japan 
(81), where three different 24 hour samples of urine were collected, from each of the 
inhabitants of a high risk area (Akita) and a low risk area (Iwate).  NPRO 
concentrations were measured before and after the ingestion of the nitrosatable 
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amine proline.  After the intake of proline, the NPRO concentration increased 
significantly only in the subjects who were from the high risk area.  The increase 
over urinary background NPRO in high versus low risk areas was 4 versus 1.4 fold.   
In both the Japanese and Polish studies ascorbic acid intake inhibited the increase in 
urinary N-nitrosocompounds.  In a study in Costa Rica, in an area of high risk of 
gastric cancer, children have a significantly higher urinary NPRO level after proline 
intake compared with results for children in a low risk area
 
(82).  In a separate study 
in a high risk group for gastric cancer, the results, when taken as a whole, suggest 
that gastric carcinogenesis, in high risk areas, is more likely to be related to 
intragastric N-nitrosocompounds formed by acid-catalysed nitrosation, whereas, in 
low risk areas it is more likely to be related to intragastric N-nitrosocompounds 
formed by biologically catalysed intragastric nitrosation (83).   
 
Oesophageal cancer is a prevalent disease in northern China and earlier studies 
suggested that environmental factors such as N-nitrosocompounds and their 
precursors may be important (84).  After this time a study was performed to look at 
urinary NPRO concentrations before and after oral proline intake, comparing high 
and low risk populations for oesophageal cancer.  Ingestion of proline led to 
increased urinary NPRO in inhabitants from both areas but the concentrations were 
twice as high in the high risk area (85).  This suggests that endogenous nitrosation 
may occur to a larger extent when appropriate amine precursors are present from 
ingestion of foodstuffs and also that the nitrosation seems to occur more in those 
who are living in the high risk group.  There have been further studies in China 
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indicating that there was a significant mortality rate associated with urinary 
excretion of NPRO and N-nitrosoarcosine (86).  There are also results that implicate 
N-nitrosocompounds with colorectal cancer (87), brain tumours (88), 
nasopharyngeal (89), pancreatic (90) and bladder cancers (91). 
 
There has been considerable interest in the role of N-nitrosocompounds and 
upper gastro-intestinal cancer for many years, in part based on the Correa hypothesis 
for gastric cancer. The thought being that, at a pH greater than 4, there is the 
potential for denitrifying bacteria to colonise the stomach and therefore generate N-
nitrosocompounds.  There has also been interest in N-nitrosocompounds within the 
diet, where they would potentially exert a carcinogenic effect on the environment in 
which they are first situated for a prolonged period of time. Little work was done on 
the role of nitrosamines in the upper gastrointestinal tract after the identification of 
Helicobacter pylori and the recognition of the microbe’s role in gastric cancer.  
However, we now propose a model by which N-nitrosocompounds may still be 
implicated in cancer of the upper gastrointestinal tract at and around the 
gastroesophageal junction but in those who are Helicobacter pylori negative.  This 
mechanism is discussed in more length later in the introduction. 
 
1.6.2 N-nitrosamines  
 
N-nitrosamines are the N-nitrosocompounds formed by the nitrosation of 
amines.  Amines can be divided into primary, secondary and tertiary as shown 
below. 
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R’    NH2                               R1’    N     H                             R1’    N     R3’ 
 
 
Amines are nucleophiles in that the lone electron-pair on the nitrogen atom in 
amines makes the N-atom a nucleophilic centre and is therefore an electron-pair 
donor.  The kinetics of secondary amine nitrosation are such that the rate of 
formation of secondary amines is proportional to the stoichiometric concentration of 
the amine and the square of the nitrite concentration.  It is only the unprotonated 
form of the amine that reacts, as is shown by the fact that the overall rate of reaction 
is dependent on the pH. 
 
Nitrosamines have been known for a number of years to be carcinogenic and 
because of this were used for the specific purpose of generating animal models of 
certain cancers.  Barnes and Magee first showed, in 1954, the hepatotoxicity of 
nitrosamines in the rubber industry before going on to note that 
nitrosodimethylamine was a potent carcinogen in rodents (92).  It was not until 1967 
that the same two researchers suggested that if you choose a suitable nitrosamine 
and test animal, cancer could be induced at any site in the body (93).  At that time, 
there was great interest in the formation of nitrosamines as possible carcinogenic 
agents but, as research into this area was proving difficult, there was a shift away 
R2’  R2’ 
Secondary amine Tertiary amine Primary amine 
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from studying this important group of compounds.  It has only been more recently 
that there has been renewed interest in these carcinogenic compounds.   
 
N-Nitrosamines are carcinogenic in that they act on DNA as alkylating agents.  
N-nitrosamines, per se, are stable under physiological conditions and require 
metabolic activation by cytochrome P450-dependent hydroxylation, at the carbon 
adjacent to the N-nitroso group, to form an α-hydroxynitrosamine.  This can then 
form an alkyldiazohydroxide by spontaneous elimination of an aldehyde (R
-
CHO).    
From the alkyldiazohydroxide an electrophilic alkyl diazonium ion, a strong 
carcinogen, is produced, which can react at nucleophilic sites of various cellular 
constituents.  The alkylation of DNA is generally considered to be the critical 
cellular target for carcinogens in the initiation of cancer (73). Alkylation of DNA by 
dialkylnitrosamines results in a range of modified bases.  Not all base modifications 
are biologically important.  The most abundant modified base produced by 
dialkylnitrosamines is alkylation of the seventh position of guanine and this shows 
no correlation with carcinogenic activity.  A significant proportion of alkylated DNA 
products are repaired.  The formation and persistence of O
6
-alkylguanine (94) and 
O
4
-alkylthymine (95) are considered to be important base modifications that result in 
miscoding, in RNA or DNA synthesis. 
 
There are several inhibitors of nitrosation.  The most effective of these and the 
one most relevant to our understanding of adenocarcinoma of the gastroesophageal 
junction is the powerful reducing agent ascorbic acid.  Ascorbic acid is found in 
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gastric juice at high concentrations (96).  These high concentrations can be assumed 
to be required as a luminal antioxidant.  It has previously been shown that this will 
potentially prevent the luminal generation of N-nitrosocompounds.  In acting as a 
reducing agent ascorbic acid requires O2 and forms NO.  O2 has been shown to be 
rapidly consumed in the presence of NO generation from nitrite by ascorbic acid in 
an acidic environment.   Other inhibitors of nitrosation are phenols and in a number 
of in vitro systems biologically occurring thiols (cysteine and glutathione) inhibit 
nitrosamine synthesis (97).  Nitrosamine formation is catalysed by thiocyanate.  At 
acidic pH with nitrite present and in the presence of high thiocyanate concentrations, 
the intermediate product NOSCN is a powerful and the most important nitrosating 
agent (98,99).   
 
1.6.3 N-nitrosomorpholine, N-nitrosopiperidine and N-nitrosodimethylamine 
 
There have been three nitrosamines that have been looked at closely in this 
thesis, in in vitro experiments simulating the gastroesophageal junction.  The first of 
these is N-nitrosomorpholine (NMOR).  It is formed from the nitrosation of the 
secondary basic amine morpholine.  Morpholine’s (Tetrahydro-1,4-oxazine) 
structure is shown in figure 1.1.  It has a relatively low pKa, for an amine, of 8.3.  
Another secondary amine measured in the following experiments is piperidine (pKa 
11.1), which forms N-nitrosopiperidine (NPIP) when nitrosated.  The most 
commonly found nitrosamine in the body is the volatile nitrosamine N-
nitrosodimethylamine (NDMA) and this was also examined in the following studies.  
NDMA is formed by nitrosation of the secondary amine dimethylamine (pKa 10.3). 
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Figure 1.1: The chemical structures for the secondary amine morpholine (left) and 
the N-nitrosated version of morpholine, N-nitrosomorpholine (right) are 
shown.  
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1.7 NO 
 
1.7.1 Introduction to NO 
 
NO is a small chemically simple and highly toxic gas, which has attracted 
much interest over the past two decades.  In 1992, it was the Molecule of the Year.  
Nearly every cell is capable of synthesising it by one of three NO synthase isoforms.  
It is also formed without enzymatic function in the body such as in the cardia of the 
stomach and through interaction with drugs with nitrogen related compounds.  The 
effects of NO depend on the site where it is formed, the amount formed and the local 
environment in which it is present. 
 
It was shown, in the 1970s, by Tannenbaum et al that nitrate was formed in 
humans (100) and this was later confirmed to be the final product of NO metabolism 
(101).  As well as generation of NO from nitrite, as outlined above, in gastric juice, 
NO can be synthesised from L-arginine through the L-Arg-NO pathway by NO 
synthase with NADPH (102) and O2 (103) as cosubstrates. NO consists of seven 
electrons from the nitrogen atom and eight electrons from the O2 atom.  Therefore 
NO
 
has the paramagnetism of a molecule with one unpaired electron and is highly 
reactive in the gas phase with O2, to form nitrosating agents such as N2O3.   
 
The chemical biology of NO has been defined as, ‘the pertinent chemical 
reactions which occur in biological systems’ (104).  These reactions can be 
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categorised into direct and indirect effects.  The reactions where NO interacts 
directly with biological molecules can be considered to be direct effects.  NO is also 
known to form RNOS and the chemical reactions of RNOS with biological 
molecules are known as indirect effects.  Direct effects are generally seen at lower 
levels of NO (<1µM), such as those seen through constitutively generated nitric 
oxide, whereas indirect effects are generally seen at higher concentrations (>1µM) 
(105).  Indirect effects can be further broken down into nitrosative, oxidative and 
nitrative chemistry (105). 
 
NO is known to directly interact with metalloproteins such as haem containing 
enzymes but does not react directly with molecules containing thiol or amines.  
However, under aerobic conditions, NO can react with O2 or superoxide to form 
reactive nitrogen oxide species such as peroxynitrite.  One of the modes of chemistry 
of these nitrosating agents is to nitrosate amines and thiols to form N-nitrosamines 
and S-nitrosothiols (106).  This is known as nitrosative stress.  Peroxynitrite, under 
certain circumstances, can exert oxidative stress as well as nitrative stress (such as 
the formation of nitrotyrosine from ONOO
-
).  At a neutral pH, ONOO
-
  HOONO 
and this is a reactive intermediate, which can oxidise various biological substrates or 
simply isomerise to nitrate (107).  Although able to exert oxidative stress, the 
oxidation mediated by peroxynitrite is influenced by the relative amounts of NO and 
superoxide formed (108,109).  In the presence of excess NO or superoxide, 
peroxynitrite is converted to nitrogen dioxide (1) (109) and this can rapidly react 
with NO to form the nitrosating species N2O3 (2). 
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H  +  ONOO
-
  +  NO    H  + NO2   +  NO2
-    
        (1) 
 
                                         NO2 + NO    N2O3                                                  (2) 
 
Thus the concentrations and relative amounts of NO and superoxide will 
impact on the chemistry of peroxynitrite in vivo.  
 
NO reacts with O2 to produce NO2, which exists in equilibrium with the 
nitrosating agents N2O3 and N2O4 (110).  Both N2O3 and N2O4 are capable of 
reacting with water to form NO2
-
 and NO3
-
.  Nitrite is oxidised to nitrate in the 
presence of haemoglobin and is the urinary excretion product of nitric oxide.  The 
reaction of NO with O2 in both gaseous and aqueous phases is a complicated 
process.  The reaction rate is first order in O2 and second order in NO (111).  
Because of the second order NO dependency, the half-life of NO
 
is inversely 
proportional to its concentration (111).  The formation of N2O3 and N2O4 are 
favoured in solution compared to the gaseous phase.  The intracellular half-life of 
NO may be affected by reaction with compounds such as haem-Fe
2+
.  As well as 
reacting with molecular O2, NO also reacts rapidly with superoxide (O2
-
) to form 
peroxynitrite (ONOO
-
).  The half life of NO in biological systems is estimated to be 
4-50 seconds (112).  In a similar fashion to O2, NO can migrate in and out of cells in 
part because it is a highly lipophilic molecule (113).  This means that there should be 
25 
 
time for NO to travel several cell diameters to reach target sites before being 
consumed by molecular O2.   
 
It is also known that biological carriers, such as S-nitroso thiols exist in vivo 
and these allow NO to move via the circulation to tissues distant from the origin of 
the NO. 
 
One of the direct effects of NO is the reaction with metal complexes (114).  NO 
reacts with some transition metals to form stable metal nitrosyl complexes, such as 
Fe-NO complexes.  One of the most facile NO reactions with metalloproteins is that 
of NO reacting with proteins containing haem moieties.  The most relevant reactions 
in biological systems include those with haem proteins such as guanylate cyclase, 
cytochrome P450 and NO synthase.  The reaction between NO and guanylate 
cyclase produces an Fe-nitrosyl complex that becomes activated to form cGMP.  
The concentration of NO required to activate guanylate cyclase is relatively low, 
with an EC50 of 100nM (115).  cGMP is a key messenger mediating numerous 
regulation functions (116).  A significant number of biological effects of NO are 
mediated through guanylate cyclase.  Another haem/NO interaction is of NO with 
cytochrome P450.  Cytochrome P450 activity is inhibited by NO in both a reversible 
and irreversible manner.  Reversible inhibition occurs when NO binds to haem to 
prevent O2 binding.  Irreversible inhibition is mediated through RNOS formed from 
NO. As cytochrome P450 is involved in the synthesis and catabolism of numerous 
biomolecules, inhibition can result in important pathophysiological sequelae.  NO 
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synthase can also be inhibited by NO in a similar fashion to that in which 
cytochrome P450 is inhibited.  NO has also been shown to react directly with 
various metal-oxygen complexes.  An important direct effect of NO is the reaction 
with oxyhaemoglobin to form methaemoglobin and nitrate (117) as shown in the 
reaction (3): 
 
         Hb(Fe-O2)   +   NO    metHb(Fe(III))    +    NO3         (3) 
 
This reaction is the primary mechanism by which movement and concentration 
of NO are controlled in vivo.  Due to the high concentration of oxyhaemoglobin and 
its rapid reaction with NO, this is one of the primary metabolic fates of NO (118). 
 
1.7.2 Carcinogenesis of Nitric Oxide 
 
The major nitrosating agents produced from nitrite under aqueous acidic 
conditions are N2O3, NO
+
 and H2NO2
+
, none of which reacts with protonated amines 
(119).  Only unprotonated amine can be nitrosated.  Nitrosation by N2O3 and N2O4 at 
neutral pH is rapid because of the relatively high concentration of free amine.  As 
has been discussed previously N-nitrosocompounds are themselves carcinogenic.  
Thus NO can exert a carcinogenic effect through N-nitrosocompounds by reacting 
with O2 to form the nitrosating compound N2O3 (120). 
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Another mechanism through which NO may be carcinogenic is through DNA 
damage mediated by RNOS such as N2O3 and peroxynitrite.  Nitrosation of primary 
amines results in deamination.  Acidic nitrite can deaminate purines, pyrimidines 
and various forms of RNA and DNA, through a pathway in which protonation of 
nitrite leads to formation of N2O3.  N2O3 reacts with unprotonated amino groups of 
DNA in the presence of water (121).  In the early 1990s NO was reported to 
accelerate base deamination in vitro (122) and cause deamination-induced genetic 
changes in living cells, but only in the presence of O2 (123). Changes in DNA 
resulting from deamination are consistent with the types of mutations seen in many 
cancers.  Deamination of cytosine will result in uracil formation.  Removal of uracil 
by uracilglycolase without restoration of cytosine would leave an abasic site, a 
lesion often misrepaired by insertion of adenine opposite the site during replication.  
If the cytosine is methylated, the deamination of methylcytosine would result in the 
formation of thymine in the DNA chain.  This change is especially important for 
mammalian DNA where methylation patterns are critical to gene regulation and 
differentiation. Nguyen et al took mammalian cells of TK6 human lymphoblastoid 
cells in vitro and added high concentrations of NO gas to the medium.  There were 
39 and 47 fold increases in xanthine and hypoxanthine bases formed within these 
cells.  These bases are the product of deamination of guanine and adenine, 
respectively (122).  There have been other in vitro experiments performed showing 
mutagenicity of NO (124,125).  One of the criticisms of these experiments, at the 
time, was of the high concentrations of NO used in the experiments and that these 
did not represent physiological conditions.  While this may be the case for the many 
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areas of the human body, it has been observed that the concentrations of NO at the 
gastroesophageal junction are the highest found in the body (43).  There have also 
been studies, such as that by Delaney et al in 1993, where they reported stimulated 
NO formation in rat Islets of Langerhans cells, which was shown to cause DNA 
damage, as measured by the ‘comet’ assay (126). 
 
As well as exerting nitrosative stress through N-nitrosocompound formation, 
there may be the potential for oxidative stress from nitric oxide.  The potent 
oxidative species peroxynitrite (ONOO
-
) and hydroxyl radical (HO
.
) are formed 
from NO after its reaction with superoxide as shown in equations (4) - (6) below: 
 
                         NO
       
+       O2
-
          ONOO-                         (4) 
 
                        ONOO
-      
+     H
+   
        ONOOH                    (5) 
 
                        ONOOH             OH.    +    NO2
. 
                    (6) 
 
Peroxynitrite has strong oxidising properties towards biomolecules including 
thiols, deoxyribose and membrane phospholipids (127).  The hydroxyl radical reacts 
with DNA, leading to several types of DNA damage, including strand breaks, cross 
links, abasic sites and modified bases (128).  8-Hydroxyguanine, one of the products 
of base oxidation, can be used as a marker of oxidative DNA damage (128). 
Although it should be pointed out that the amount of peroxynitrite which reacts with 
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the biological target is minimal if the NO flux is in excess.  In fact, in some studies, 
it has been shown that NO has abated XO and peroxide mediated damage to DNA 
(129).   
 
RNOS have a particularly high affinity for amino acids containing thiol 
residues (130).  This suggests that enzymes which have thiol residues critical to their 
function may be inhibited.  It is thought that very often this effect is caused 
indirectly by NO through the RNOS N2O3.  Through this mechanism NO can 
inactivate DNA repair enzymes such as O
6
-alkyltransferase (131). Another 
mechanism through which NO can affect DNA repair mechanisms is by affecting 
DNA interacting proteins that contain a zinc finger motif.  Zinc finger motifs contain 
either two or four cysteine residues.  It has been suggested that N2O3 nitrosates the 
thiol residue, resulting in the ejection of the zinc, allowing degradation of the 
structural integrity of the protein.  This has been shown for the DNA repair enzymes 
formaminodopyrimidine DNA-glycolase (Fpg protein) which repairs alkylation 
damage due to guanine (132).  In this way the Fpg protein was shown to be 
inactivated in the presence of aerobic NO (133). Whether this leads to any damage 
will depend on whether luminally generated NO reaches the adjacent cells. 
 
1.8 Ascorbic acid  
 
Ascorbic acid is a potent aqueous antioxidant.  It has been recognised that the 
healthy stomach actively secretes ascorbic acid and its concentration in fasting 
gastric juice is several times that in plasma (96,134-136).  It is a hydrophilic 
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molecule.  In its reduced form it is present as ascorbic acid and in its oxidised form it 
is present as dehydroascorbic acid.   
 
Ascorbic acid inhibits the formation of N-nitrosocompounds by competing for 
the nitrosating agents formed from nitrite.  When ascorbic acid reacts with a 
nitrosating agent, such as N2O3, it is oxidised to dehydroascorbic acid.  For each 
mole of ascorbic acid oxidised, two moles of NO are formed (137).  This reaction is 
rapid and there is therefore the potential for effective removal of nitrosating agents.  
However, in the presence of O2, NO may be reconverted to nitrosating species, 
thereby negating the inhibitory effect.  Net removal of nitrite equivalents occurs only 
upon oxidation of N2O4 to nitrate (NO3
-
), or by physical processes such as the in vivo 
absorption of nitrite across the gastric mucosa, or in vitro by the loss of volatile 
species such as NO.  The reaction of ascorbic acid with nitrite in an acidic media can 
be shown by the equation (7): 
 
                   ASC + NOX  DHA + 2NO + H+ + X- + H20             (7) 
 
Where NOX = N2O3, NO
+
, NOSCN or NOCl 
 
In the presence of thiocyanate and chloride both exert catalytic activity.  This 
can be attributed to formation of their nitrosyl species and their reaction with 
ascorbic acid (138-140).  Thiocyanate is a much better catalyst and this can be 
attributed to differences in the equilibrium constants of reactions (138,140).  The 
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reaction shown above (7) accounts for all the loss of ascorbic acid, but none of the 
loss of total nitrite.  The nitrite is lost by oxidation to nitrate and transfer of NO and 
NO2 to the gas phase.  Given that when ascorbic acid reacts with nitrosating species 
the major product formed is NO, then the loss of nitrite from this system is mainly 
through transfer of NO in the gas phase.  Thus, while ascorbic acid does not remove 
total nitrite directly, it increases the rate of the removal process.  The effective 
stoichiometry of the reaction between ascorbic acid and nitrite depends on the 
competition between the recycle of NO back into nitrosating species and the removal 
of NO via mass transfer (139).  The rate determining step in the recycling of NO is 
the reaction with O2 producing dinitrogen tetroxide, as shown in equation (8) 
 
                2NO + O2  N2O4                                 (8) 
 
The recycling process is therefore second order as regard NO while mass 
transfer is essentially first order.  This means that as the NO concentration is 
increased, the recycling reaction will increase faster than physical removal.  Acidity, 
thiocyanate and chloride are known to increase the rate of reaction between ascorbic 
acid and nitrite, and therefore, this tends to favour recycling and increases the 
effective stoichiometric ratio of ascorbic acid consumption to nitrite removal. The 
reaction between NO and O2 is first order with regard to the O2 concentration.  This 
means that decreasing the O2 concentration will decrease the rate of recycling, and 
ascorbic acid will be more effective in inhibiting nitrosation.  The equilibrium 
concentration of dissolved O2 is an inverse function of temperature, meaning that O2 
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concentration is reduced as the temperature is increased.  However, increasing the 
temperature increases the rate of formation of NO from nitrosating species in the 
presence of ascorbic acid.  So, temperature changes can shift the effective 
stoichemistry between ascorbic acid and nitrite in either direction depending on the 
conditions (139). 
 
The inhibition of bacterially mediated nitrosation of morpholine by ascorbic 
acid at neutral pH in vitro was noted as early as 1989 (141).  In an in vivo study, 
using healthy male volunteer’s, inhibition of endogenous NPRO from exogenous 
precursors requires more than the 2:1 molar ratio of ascorbic acid to nitrite that has 
been demonstrated in vitro.  A ten times molar excess of ascorbic acid over the 
available nitrite concentration in the stomach was required to achieve complete 
inhibition of endogenous nitrosation of proline in this study (142). 
 
In the human stomach, chemical interaction occurs between the nitrite and 
thiocyanate delivered in the saliva and the ascorbic acid secreted into acidic gastric 
juice.  Acidified nitrite forms N2O3 or reacts with the thiocyanate anion to form 
NOSCN, both of which can be reduced to NO by ascorbic acid.  The ascorbic acid is 
itself oxidised to dehydroascorbic acid.  The NO formed in this way can react with 
dissolved O2 to reform nitrous acid.  This reformed nitrite can further react with any 
remaining ascorbic acid.  This recycling of nitrite will continue until either all the 
ascorbic acid is converted to DHA or the O2 is depleted.  Following ingestion of 
nitrate and subsequent increase in delivery of nitrite to the proximal stomach, there 
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was a four fold fall in gastric juice concentration of ascorbic acid, due to its 
conversion to dehydroascorbic acid, as there was accumulation of nitrite within the 
gastric juice (143).  The consumption of ascorbic acid in an acidic environment after 
the addition of nitrite has been shown to be greater in the presence of dissolved O2 
(144).  The increased consumption of ascorbic acid by nitrous acid in the presence of 
O2 is thought to be due to recycling of NO generated (144).   
 
1.9 Lipid antioxidants 
 
 
1.9.1 Overview 
 
In biological systems there are lipid antioxidants as well as aqueous 
antioxidants.  Lipid antioxidants are, in part, present to prevent lipid membrane 
peroxidation. Three major chain breaking lipid antioxidants are α-tocopherol, β-
carotene and butylated hydroxytoluene (BHT).  Αlpha-tocopherol is the major 
vitamin E compound found in the lipid fraction of living organisms.  It is thought to 
be one of the most powerful naturally occurring lipid antioxidants known (145).  β-
carotene is another naturally occurring antioxidant that has been found in many 
biological systems (146).  BHT is a synthetic phenolic lipid antioxidant that is used 
in food preservatives (147). 
 
1.9.2 Vitamin E  
 
1.9.2.1 Introduction to vitamin E 
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Eighty five years ago vitamin E was discovered as a micronutrient essential for 
reproduction in female rats (148).  Despite many studies the essential functions in 
humans are still not fully understood.  Deficiencies in vitamin E primarily cause 
neurological dysfunctions.  Vitamin E is an antioxidant and because of this is 
thought to be important in diseases where oxidative stress occurs such as cancers, 
chronic inflammatory conditions and cardiovascular disease. Vitamin E refers to one 
or more of the structurally related phenolic compounds called tocopherols and 
tocotrienols.  These compounds are hydrophobic, peroxyl radical trapping, chain 
breaking antioxidants, found in the lipid fraction of living organisms.  The principle 
function of vitamin E is thought to be the protection of the lipid material of an 
organism from the undesirable effects of uncontrolled, spontaneous autooxidation.  
The most abundant tocopherol found in animal tissue is called α-tocopherol.  The 
relative and absolute effectiveness of chain breaking antioxidants depends primarily 
on their reactivity towards peroxyl radicals.  The most effective tocopherol to 
undergo this reaction is α-tocopherol.  This has been shown by kinetic studies (149).  
These kinetic studies suggest that this faster rate of reaction can be explained by the 
stereoelectronic make up of α-tocopherol, whereby the p-types lone pair can overlap 
with the orbital containing the unpaired electron and so stabilise the phenoxyl radical 
(149).  
 
The major mechanism of action of α-tocopherol is thought to be the scavenging 
of lipid peroxyl radicals (LOO
.
) generated during lipid peroxidation, resulting in 
inhibition of the free radical chain reaction (150).  It has been shown that 
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peroxynitrite can oxidise α-tocopherol predominately by either a two-electron 
pathway generating α-tocopherone cation or via a minor one electron pathway 
forming α-tocopheroxyl radical (150).  Studies performed in the late 1990s showed 
that NO reacting with peroxynitrite in the lipid bilayer was preventing lipid 
peroxidation (151,152).  Prior to this there had been suggestions that NO reacted 
directly with α-tocopherol to generate α-tocopheroxyl radical (153-155).  This 
reaction was examined further by Nagata et al, who examined the reaction between 
NO and both α-tocopherol and the α-tocopherol analogue 2,2,5,7,8-Pentamethyl-6-
chromanol (PMC), in the presence and absence of O2.  At all different ratios of NO 
to O2, there was a reduction product of α-tocopherol and this included when NO 
reacted with PMC or α-tocopherol even in the absence of O2 (156).  There is 
conflicting evidence in regard to this study (157) and further investigation into the 
reaction between NO and α-tocopherol concluded that NO does not react with α-
tocopherol directly (158).  This work suggested that previous experiments showing a 
direct reaction between NO and α-tocopherol were in fact due to the experiments 
containing NO gas that may have been contaminated with a little O2.  However, 
oxidation products of NO in the form of N2O3 and related species will oxidise α-
tocopherol to both α-tocopheroxyl radical and α-tocopheryl quinone (158).  In a 
paper by Hogg et al, it is suggested that under biological conditions, if α-tocopherol 
oxidation is due to oxidised metabolites of NO, then the relevance to biological 
systems is questionable, as the reaction of NO with O2 to form N2O3 is extremely 
slow (159).  While this may be true of the concentrations of NO formed from NO 
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synthase within human cells, at the concentrations of NO that have been found at the 
gastroesophageal junction this would be relevant chemistry. 
 
1.9.2.2 In vivo effects of α-tocopherol 
 
Administration of antioxidants including
 α-tocopherol has been found to 
prevent oxidative stress in the
 
retina and heart of diabetic rats and to partially inhibit
 
the development of retinopathy in these rats, where chronic elevation of NO is 
thought to be important (160). In erectile dysfunction there are changes in corpus 
cavernosal vascular smooth muscle cells cells that are induced by glucose changes in 
protein C and NO expression and activity within the cell.  Α-tocopherol has also 
been shown to prevent these glucose-induced changes in protein kinase C and NO 
(161).  In pancreatic islet cells that were preincubated with α-tocopherol there was 
significant improvement in the cells’ resistance to toxic doses of NO.  This is 
significant as, in vitro, NO has been identified as the most potent islet toxic product 
of inflammatory macrophages (162).  While it was suggested by Burkart et al (162), 
that the inhibition of toxic effects on the cells was likely to be due to direct effects of 
α-tocopherol on NO, it is more likely that the inhibitory effect was of α-tocopherol 
on nitrosating species.  Mergens et al, was the first to show that α-tocopherol, in its 
reduced form, was protective against amine induced hepatotoxicity and in the same 
paper showed destruction of nitrite in an in vitro model of gastric juice (163).  In 
Mergens et al studies, α-tocopherol was found to react with nitrosating agents both 
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in lipophilic and aqueous environments and they also described greater nitrosamine 
inhibition when α-tocopherol and ascorbic acid were used together (163). 
 
1.9.2.3 The vitamin E/vitamin C interaction and possible recycling 
 
Synergistic inhibition between vitamin C and vitamin E was first suggested in 
1941 when it was found that although ascorbic acid alone was a very poor 
antioxidant for lard and oil, it enhanced the antioxidant activity of tocopherols (164).  
It was not until 1968 that Tappel suggested that vitamin C might reduce the 
tocopheroxyl radical formed from tocopherol during the scavenging of free radicals 
in vivo, permitting a single molecule of vitamin E to scavenge many radicals (165).   
 
Further work has been performed to evaluate the synergy of ascorbate and 
tocopherols and to look at the possibility of recycling of tocopherol by ascorbate.  In 
electron spin resonance studies regeneration of vitamin E from the chromanoxyl 
radical by GSH and vitamin C was detected (166,167).  In experiments investigating 
the effect of vitamin E and vitamin C on methyl linoleate peroxidation, vitamin E 
was kept in the reduced state as long as there was vitamin C present (168).  The 
synergistic effects of vitamin C and E were evaluated in preventing lipid 
peroxidation of NADPH/iron-ADP-supplemeneted rat microsomal fractions.  In 
these experiments, it was found that any protective effect was due to ascorbic acid 
reducing vitamin E, which was then active and could act as a chain breaking 
antioxidant (169).  It should be noted that these studies do not distinguish prevention 
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of α-tocopherol oxidation from regeneration of α-tocopherol.  Therefore, they do not 
provide unambiguous evidence for tocopheroxyl radical repair.  In similar studies 
using lipid peroxidation in liposomes, there has been the suggestion of recycling of 
vitamin E by ascorbic acid, since the ascorbate consumption in liposomes with α-
tocopherol was much more rapid than would be expected from regeneration of 
tocopheroxyl radicals, based on the rate of tocopherol depletion in the absence of 
ascorbate (170,171).  There was direct evidence of recycling in human LDL by 
Kagan et al.  They created vitamin E radicals in LDL by ultraviolet rays and found 
reduction of these radicals by water soluble antioxidants such as ascorbic acid.  It is 
thought that this increases the antioxidant effect of LDL (172).  It was found that 
when α-tocopherol was oxidised to α-tocopheroxyl radical by NO in an anaerobic, in 
vitro experiment, ascorbic acid was depleted and α-tocopherol was regenerated.  
Gorbunov et al suggested that recycling of vitamin E may be necessary for effective 
protection against NO-induced damage (153).  It has been proposed that effective 
hydrogen transfer between ascorbic acid and α-tocopherol can take place because the 
polar phenoxy head group of α-tocopherol is located near the polar lipid-water 
interface (173). 
 
The first explicit, in vivo, test of ascorbate α-tocopherol recycling suggested 
conflicting results with the in vitro studies discussed (174).  This study measured the 
turnover kinetics of α-tocopherol in several tissues from guinea pigs fed diets 
containing different levels of ascorbate.  Because guinea pigs cannot synthesise 
ascorbate, rates of α-tocopherol turnover were expected to vary inversely with 
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ascorbate status.  In fact, in these studies, the α-tocopherol turnover kinetics were 
unaffected by ascorbate status in all tissues examined and it was concluded that 
ascorbate-dependent recycling of α-tocopherol was of negligible importance, in vivo, 
in guinea pigs that were not oxidatively stressed.  However subsequent studies have 
failed to confirm the absence of an in vivo recycling mechanism.  Rat hepatocytes 
incubated with various doses of ascorbic acid were compared to cells that were 
incubated in the absence of ascorbic acid.  Measurements of α-tocopherol, α-
tocopherolquinone, ascorbic acid and dehydroascorbic acid were made.  In the 
absence of ascorbic acid, α-tocopherol was undetected at the completion of the 
experiment, while levels of α-tocopherolquinone were high, whereas in those rat 
hepatocytes incubated with ascorbic acid there were varying concentrations of α-
tocopherol and little α-tocopherolquinone (175).  It has also been suggested that 
ascorbate within intact human erythrocytes protects α-tocopherol in the cell 
membrane by a direct recycling mechanism.  This was the first study to evaluate 
recycling occurring across a cell membrane (176).  A proposed mechanism for this 
recycling of α-tocopherol by ascorbate is shown in Figure 1.2. 
 
There has been some controversy in this field regarding the synergy between 
the two vitamins and part of the function of our study was to investigate this 
phenonomen further, in a model of nitrosative stress at the gastroesophageal 
junction. 
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Figure 1.2: Representation of the proposed chemistry coccuring when α-tocopherol 
is regenerated from the tocopheroxyl radical by ascorbate.  Alpha-
tocopherol is shown to reduce the peroxyl radical (LOO
.
) to its 
antioxidant derived peroxyl radical (LOOH) and in so doing 
tocopheroxyl radical has been formed.  The tocopheroxyl radical is then 
reduced by ascorbate back to the antioxidant α-tocopherol (adapted from 
Liebler (170)). 
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1.10 Duodenal refluxate, bile acids and carcinogenesis in the upper 
gastrointestinal tract 
 
Many patients with Barrett’s oesophagus have been found to have, not only 
gastric acid exposure, but also duodenal juice exposure of the oesophagus.  The 
prevalence of increased bilirubin exposure significantly increases between the 
groups of patients with no mucosal injury (30%), oesophagitis (62%) and long 
segment Barrett’s oesophagus (85%) (41,177-181). Several investigators have 
shown that duodeno-gastroesophageal reflux per se can induce Barrett’s oesophagus 
to form oesophageal adenocarcinoma in rats (182-186).  
 
There is information on the toxicity of bile acids on the oesophageal mucosa 
(187), gastric mucosa (188-190), colonic mucosa (191,192) and hepatocytes 
(193,194).  However, the mechanism of action for bile refluxate causing 
oesophageal damage is not clear.  It has previously been shown that bile, in itself, is 
not mutagenic, in the Ames test (195).  There is the suggestion that at more alkaline 
pH, in their unionised form, bile acids can cross mucosal cell membranes and enter 
the cell, where they are noxious to the cell mitochondria.  Also, due to its pKa, 
taurine is unionised at a low pH and will therefore be able to enter cells across their 
membranes.  There have been reports of toxic synergism between taurine conjugates 
and acid in mucosal damage of the oesophagus (187).  The accumulation of bile 
acids in the oesophageal mucosa has been a proposed method of toxicity for many 
years, after they were shown to accumulate in rat oesophageal mucosa (196).  To 
elucidate the carcinogenic effects of duodenal contents, many researchers have 
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addressed the bile acids and pancreatic juice (197-199).  It is known that conjugated 
bile acids, in the form of amides, are a target for nitrosative stress, leading to 
nitrosated compounds that are carcinogenic.  The bile acids are the major source of 
nitrosatable amides in the body (200).  Glycocholic acid, shown to make up 60% of 
the total bile acid composition of reflux into the oesophagus of patients with GORD 
(201), can be nitrosated under simulated gastric conditions to form N-
nitrosoglycocholic acid, which is known to be highly mutagenic to bacteria and 
mammalian cells (200,202).  N-nitroso bile salts such as N-nitrosoglycocholic acids 
and N-nitroso-taurocholic acids were also shown to be mutagenic and carcinogenic 
in rat stomachs as early as 1985 (197).  Such bile salts have been implicated in 
gastric cancer as well as gastric stump carcinogenesis post gastrectomy (185).  More 
recently, it has been demonstrated that bile acids can induce DNA breaks and 
oxidative damage in oesophageal cell lines and tissue (203-205) and importantly, 
duodenoesophageal reflux has been shown to be potentially mutagenic in rat models 
of Barrett’s oesophagus (206). 
 
In a rat model of oesophageal adenocarcinoma, induced by gastroduodenal 
reflux, it was found that the nitrite scavenger thioproline (207) was effective in 
inhibiting the development of oesophageal adenocarcinoma (208).  In this rat model, 
there is reflux of duodenal contents but the stomach retains its normal function 
(209).  This model simulates the situation of patients with duodeno-gastroesophageal 
reflux, including reflux of both duodenal contents and gastric juice into the 
oesophagus.  In this study, thioproline inhibited the development of oesophageal 
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adenocarcinoma and iNOS protein was over expressed in Barrett’s oesophagus of 
both the control and thioproline group.  Thioproline could not suppress the 
overexpression of iNOS.  The suggested mechanism of thioproline inhibiting 
oesophageal adenocarcinoma was summarised as follows by Kumagai et al: 
‘thioproline inhibits production of nitroso compounds by nitrite-reducing bacteria 
but also reactive nitrogen species such as NO, peroxynitrite and N-
nitrosocompounds derived from reflux of duodenal contents’.  This study therefore 
suggests that oesophageal adenocarcinoma is associated with reactive nitrogen 
species (such as NO, peroxynitrite and N-nitrosocompounds) derived from bile salts 
in the oesophagus (208). 
 
It has been established that bile salts are implicated in colon cancer.  
Epidemiological studies have shown that high levels of secondary bile acids are 
found in the faeces of patients with colon carcinoma (210).  It is also known that 
patients with Barrett’s esophagus have a significantly higher incidence of colonic 
polyps and adenomas (211).  It is therefore attractive to hypothesise that, as a high 
fat diet promotes the flow of bile, the excessive amount of bile acids in the 
alimentary tract may be a contributing factor which enhances carcinogenesis, not 
only in the colon, but also in the upper gastrointestinal tract, through reflux of 
gastro-duodenal content.  
 
It is interesting to note that one of the few other cancers to have an increase in 
its incidence over the last couple of decades is cholangiocarcinoma.  Studies have 
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shown that NO generated in response to inflammation may initiate malignant 
transformation of biliary epithelia and/or promote progression of established 
cholangicarcinoma (212).  NO inactivation of DNA repair enzymes may provide a 
link between
 
inflammation and the initiation, promotion, and/or progression
 
of 
cholangiocarcinoma.
 
This tumour also provides an insight into the potential 
mechanisms underlying NO induced malignancy, in a cancer also increasing in 
incidence.  It is attractive to suggest that, perhaps, in this tumour there is also 
indirect carcinogenesis through nitrosation of bile acids. 
 
It can be seen that the nitrosation of bile acids is an important carcinogenic 
mechanism and an environment rich in bile acid amides and nitrosative stress would 
potentially be a site of increased cancer risk.  In this thesis we explore nitrosative 
stress in the upper gastrointestinal tract where there is the potential for bile acid 
refluxate. 
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1.11 Enterosalivary recirculation and NO generation at and around the GO 
junction 
 
There are two mechanisms through which there can be nitrate circulating in the 
bloodstream.  The first of these involves dietary nitrate.  The increased nitrogen 
fertiliser use since the Second World War has resulted in an increase in nitrate 
concentrations in the diet (213). Nitrate is swallowed in the diet and then a large 
percentage of this is absorbed across the small intestine into the bloodstream (214).  
There is also a smaller contribution to the overall circulating nitrate concentration 
from endogenously produced nitrate, as the end product of enzymatically 
synthesised NO.  Approximately 25% of the total nitrate in the bloodstream is 
actively taken up by the salivary glands and secreted into the mouth (214).  The 
resulting concentration of nitrate in saliva is 10-20 times higher than that in the 
circulating blood (215).  A significant proportion of salivary nitrate is then rapidly 
reduced to nitrite in the mouth by the action of nitrate reductase bacteria, colonised 
densely on the dorsum of the tongue (216,217) (Figure 1.3).  Due to this 
enterosalivary recirculation of nitrate and subsequent conversion of nitrate to nitrite, 
human saliva contains very high concentrations of nitrite.  Under fasting conditions 
the nitrite concentration of saliva is 10-1000µmol/l (143,215) and this rises 2-5 fold 
for several hours after the ingestion of nitrate containing foods (143).  This is 
thought to be potentially beneficial to humans, as the nitrite formed on the tongue 
may then be acidified through encounter with the acid environment around the teeth 
and periodontal tissues, provided by the dental plaque microflora (218).  The 
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acidification of nitrite produces nitrogen oxides as well as nitrous acid.  The nitrous 
acid will spontaneously decompose to NO and nitrogen dioxide.  NO has been 
shown to be produced here (219).  This NO produced has an inhibitory effect on 
periodontal bacteria (220). 
 
Previous studies, using validated microdialysis probes, have provided useful 
information regarding the localisation of chemistry into regions of the upper 
gastrointestinal tract (221,222). It has been shown that the most proximal cardia 
region of the stomach has the chemical conditions most favourable for luminal 
generation of N-nitrosocompounds (221).  The concentrations of nitrite found in 
saliva are found in similarly high concentrations throughout the length of the 
oesophagus (45).  It is known that approximately 1.5 litres of saliva is produced 
every 24 hours and all of this nitrite rich saliva passes down into the stomach.  It has 
been observed that nitrite concentrations are highest in the cardia region of the 
stomach, consistent with where nitrite in swallowed saliva enters into the gastric 
cardia from the oesophagus (221).  The more distal stomach has less nitrite present, 
in part due to dilution and also in part due to acidic gastric juice converting nitrite to 
nitrous acid and NO, with NO then able to pass into surrounding mucus and tissues.  
When this saliva reaches the proximal stomach, it is immediately converted to 
nitrous acid and nitrosating species including N2O3 and NO
+
.  As well as taking up 
and secreting nitrate, the salivary glands also actively take up and secrete 
thiocyanate and its concentration in saliva is approximately 1mmol, and even higher 
in smokers (223).  This anion may also be secreted directly into gastric juice (223).  
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In determining localised regional chemistry, it was found that high concentrations of 
thiocyanate are present throughout the upper gastrointestinal tract but the 
concentrations in the proximal and distal stomach were 80% and 50% of those found 
in the saliva (221).  Thiocyanate reacts with NO
+
 to form NOSCN which is 
particularly potent as a nitrosating species (98,99).  There is then the capability of 
nitrosating species to react with nitrosatable compounds such as amines and amides 
to generate potentially carcinogenic N-nitrosocompounds.  
 
The main inhibitor of luminal acid-catalysed N-nitrosation is the aqueous 
antioxidant ascorbic acid, which is known to be present in gastric juice at high 
concentrations.  Ascorbic acid is known to be actively secreted into gastric juice 
(96,134). In the study by Suzuki et al, it was shown that intragastric ascorbic acid 
and total vitamin C were lower in the cardia region of the stomach, as compared to 
the mid and distal stomach (221).  A combination of the cardia of the stomach 
having the lowest ascorbic acid and highest nitrite means that the ratio of ascorbic 
acid to nitrite is significantly lower in the cardia.  The ratio of ascorbic acid to nitrite 
is a critical determinant of acid nitrosation (139,224).  When ascorbic acid is present 
in excess, acid nitrosation is prevented (139,224).  Therefore, in this way the 
conditions for luminal acid nitrosation are maximal at the cardia region, as compared 
to the rest of the stomach.  How much of a part this mechanism will play, depends, 
in part, upon the availability of ascorbic acid.  When ascorbic acid is available to 
excess, significant NO will be generated. 
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Ascorbic acid is oxidised to dehydroascorbic acid in reducing nitrosating 
species to NO.  Peak concentrations of NO generated in this way occur in the cardia 
of the stomach, as have been shown in previous studies by our group (43).  There is 
a process of recycling of nitrite that will occur here, in the presence of initial excess 
ascorbic acid.   It is through nitrosative stress generated by NO that our group 
proposes that dietary nitrate may have a role in carcinogenesis in the apparently 
healthy acid secreting stomach.  This thesis explores such chemistry in the upper 
gastrointestinal tract. 
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Figure 1.3: The process of enterosalivary recirculation of dietary nitrate and 
subsequent conversion to nitrite by bacteria on the dorsum of the tongue 
is illustrated in this figure.  Once nitrite is swallowed in saliva it meets 
the acidic gastric juice and in the presence of vitamin C is converted to 
NO.  The red arrows represent the passage of nitrate while the blue 
arrow represents the pathway for nitrite.   
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1.12 Overall 
 
It has been shown that there are potentially three mechanisms of nitrosative 
stress, with two of these occurring maximally at the cardia region of the stomach and 
the gastroesophageal junction.  Two of the three mechanisms, luminal acid 
nitrosation and nitrosation from denitrifying bacteria are well established in the 
literature.  However, the third mechanism of nitrosative stress in the healthy acid 
secreting stomach, from swallowed nitrite, with NO formation and the possibility of 
subsequent diffusion of NO into tissues, is a relatively recent addition to our 
understanding of nitrosative stress in the gastrointestinal tract.  The purpose of this 
study was to look further at NO related nitrosative stress in models of the upper 
gastrointestinal tract and to take this into an in vivo setting, to assess nitrosative 
stress. 
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Chapter 2:  Materials and Methods 
 
Throughout the studies, there were several techniques and analyses that were 
regularly undertaken and these will be described in this chapter.  For each series of 
experiments, there were more specific materials, methods and experimental design 
used and these will be described within the respective chapters. 
 
2.1 Methods 
 
2.1.1 NO Determination by Amperometry 
 
 NO was measured using a World Precision Instruments (WPI) ISO-NO
TM 
Mark 
II NO sensor (World Precision Instrument, Sarasota, Florida).  This type of 
biosensor has been used in experiments to measure NO since 1993 (225)
 
and has 
been used in many different experimental situations since then 
(43,226,227,228,229).  This was a 2mm diameter stainless steel shielded sensor as 
shown in figure 2.1.   
   
 This probe was amperometric.  NO diffused through a selective gas permeable 
membrane and was oxidised at an electrode, resulting in an electrical current.  This 
redox current was proportional to the NO concentration of the sample.  The sensors 
were connected to a WPI ISO-NO NO meter (World Precision Instrument, Sarasota, 
Florida) which showed both the NO concentration and the redox current.  The sensor 
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could measure NO concentrations down to 1nM.  The meter was connected to a 
computer which converted the electrical signal (pA) to NO concentrations in µM.   
 
 The probe was calibrated to ensure accurate NO measurements.  Calibration was 
achieved using the chemical generation of NO.  A set of calibration sodium nitrite 
(NaNO2) standards were created from a 100mM NaNO2 stock solution.  The method 
of calibration is based on the following reaction: 
 
2NaNO2   +   2KI    +   2H2SO4     2NO   +   I2   +   2H2O +   2NaSO4 
 
where a known amount of NaNO2 was added to produce a known amount of NO.  
KI and H2SO4 were added to excess, making KNO2 the limiting reagent.  Since the 
reaction goes to completion, the equation above states that the ratio between NaNO2 
and NO is 1:1.  Therefore the amount of NO generated in the solution will be equal 
to the amount of NaNO2 added.  The final concentration of NO will be equal to the 
diluted concentration of NaNO2 in the solution.  As the ISO-NO sensor responds to 
partial pressure of NO, as opposed to the concentration, the temperature of 
calibration had to be the same as the temperature of the experimental setting.  H2SO4 
(0.1M) and KI (0.1M) were added to a glass vial and a small magnetic stirrer was 
added to the bottom of the vial.  This was then placed in a water tank containing 
deionised H2O, maintained at 37
o
C on a heater magnetic plate in a fume cupboard.  
The NO probe was suspended in the solution and allowed to settle until a steady 
baseline was achieved.  A known NaNO2 calibration standard was then added and 
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the highest pA reading achieved was recorded.  The baseline recording is subtracted 
from this reading to ensure that all the change in pA is due to NO and not just from 
background noise.  This was repeated for different NaNO2 concentrations, allowing 
the sensor recording to drop to the baseline in dH2O before adding the probe to the 
next standard.   The response was linear for the range of concentrations measured.  
From these readings a calibration curve was created each time the sensor was used 
(figure 2.2). 
 
 The standard curve enabled us to determine the unknown NO concentration of a 
sample.  For any sample that had been diluted a conversion factor was allowed based 
on the degree of dilution.  The concentrations of NO determined were given in µM.  
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Figure 2.1: Schematic diagram representing the World Precision Instruments ISO 
NO
TM
 Mark II NO probe.  The probe is composed of a stainless steel 
sleeve, with a gas permeable membrane tip, filled with an electrolyte 
conducting solution.  The electrode was linked to a computer recording 
the data as a pA output.   
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Figure 2.2: Typical NO calibration curve determined by a set of known sodium 
nitrite standards that generate 1µM NO per 1µM of sodium nitrite.  The 
electrical current generated by the gaseous NO diffusing across the gas 
permeable membrane of the NO senor is recorded in pAs.  NO is 
generated by using set concentrations of sodium nitrite standards.  The 
pA generated is plotted against the given nitrite concentration.  By 
fitting the best fit straight line through the peak pA reached per 
standard, a slope is created that can determine the pA per 1µM NO. 
Slope = pA/µM 
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2.1.2 Oxygen determination by amperometry 
 
 
 A World Precision Instrument ISO2 meter and its associated OXEL-1 probe 
(World Precision Instrument, Sarasota, Florida) were used to measure O2 levels 
within the experimental design.  The sensor amperometrically measured the 
concentration of O2 in an aqueous mixture.  The O2 probe housed a platinum 
working electrode and a silver reference electrode inside a stainless steel sleeve of 
66mm length.  The tip diameter was only 2mm, allowing detection in small vials.  At 
the tip end of the sleeve there was a gas permeable polymer membrane which 
allowed O2 to pass.  O2 was then reduced at the platinum cathode, which was held at 
-0.7V when the instrument was on, thus resulting in an electrical current.  The 
magnitude of the electrical current was determined by the rate of diffusion to the 
electrode, which was proportional to the partial pressure of O2 outside the 
membrane.  Measurement modes were percent O2, parts per million, and O2 
reduction current in nanoamperes. This could then be converted to µM 
concentration.  The lower detection limit for ISO2 (in liquid phase) was 0.1 ppm or 
0.1%. O2 concentration, around 0.5 ppm or 0.5% and upward, could be routinely 
measured in the gaseous or in the liquid phases.  The accuracy of the sensor was 
+1.5% with a 0.1ppm resolution. 
 
 The ISO2 sensor probe was calibrated at the same temperature (usually 37
o
C) as 
was used in the experiment.  Calibration took place in water saturated with nitrogen 
as per the manufacturers instructions.  
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2.1.3 Protein measurement 
 
2.1.3.1 Introduction to protein measurement 
 
 Protein concentrations were measured using the Bio-Rad Protein Assay (Bio-Rad 
Laboratories Ltd, Hertfordshire, UK).  This is based on the absorbance for an acidic 
solution of Coomassie Brilliant Blue G-250 shifting from 465nm to 595nm when 
binding to protein occurs (230,231).  Protein based samples were added to dye 
reagent concentrate and measured against bovine serum albumin standards on a 
colorimetric spectrophotometer (Dynatech MR 500, Dynatech Laboratories, 
Billingshurst, W. Sussex, UK).  The Bio-Rad kit came complete with dye-reagent 
concentrate, which was a solution of dye, phosphoric acid and methanol, and bovine 
serum albumin standardised plasma protein.  The dye reagent required a dilution of 1 
volume dye reagent concentrate with 4 volumes dH2O, with subsequent filtering 
through Whatman No. 1 paper (RA Lamb Ltd, East Sussex, UK).   The Bio-Rad 
method was used because it is sensitive down to 1 µM of protein, is easy and rapid 
to use and has less in the way of chemical interference compared to the more basic 
Lowry and Biuret methods.   
 
2.1.3.2 Protein Standards and use of assay 
 
 Bovine serum albumin was used as the protein standard.  The stock standard was 
20 mg/100mL water.  To make up a working standard, the stock was diluted 1:5 
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with dH2O (4mg/100mL).  Standards were made of 0.25 – 2.5 mg/100mL by 
diluting the original working standard with deionised water.  A standard curve was 
prepared each time the assay was performed.  The standard (0.2 mL) and its 
dilutions were placed into a test tube.  A 0.2 mL sample buffer was in a ‘blank’ test 
tube.  Diluted dye reagent (0.1 mL) was added, and the samples inverted several 
times to allow mixing.  After 15 minutes the OD595 was measured against the 
reagent blank using the colorimetric plate reader at wavelength 595nm.  The OD595 
was then plotted for the standards and the unknowns were read from the standard 
curve.  When this assay was used for tissue samples, random, human and rat, biopsy 
samples were obtained from different regions of the upper gastrointestinal tract to 
show that there was no difference in the linearity of protein from within this 
heterogeneous group of samples.  
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2.1.4 Nitrite analysis using the modified Greiss reaction 
 
 There are many different ways to measure nitrite.  These can be divided into four 
main categories: spectroscopic detection, electrochemical detection, chromatography 
and capillary electrophoresis.  Spectroscopic methods are by far the most widely 
used and within this category the Greiss Assay is the most extensively assessed 
(232).  This assay was first developed in 1879. 
 
Samples in this study were analysed against known concentrations of nitrite 
(NaNO2) using the modified Greiss reaction (233).  The Greiss reagent method is 
based on the reaction shown in figure 2.3, where the reaction of nitrite and sulfanilic 
acid in an acidic environment produces an azo dye detected spectrophotometrically 
at 540 nm (232). 
 
The Greiss reagent was made up with sulphanilamide, concentrated HCl, 
dH2O and NEDD (N-1-Napthylethylene diamine dihydrochlorlide).  In this 
arrangement of the Greiss reaction the NEDD is an aromatic amine acting as the 
coupler, while the sulphanilamide is the target aromatic amine.  The detection limit 
was 0.1 µM.   
 
NaNO2 standards were made up in PBS at different concentrations.  The 
general standards that were made up were 10 µM, 25 µM, 50 µM, 75 µM and 100 
µM. 
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Using a 96 well plate (Labtech International Ltd, East Sussex, UK), 60 µL of 
standard solutions and samples were added to the wells before, immediately, adding 
60 µL of Greiss reagent and 60 µL of dH2O.  Three ‘blank’ wells were created, by 
adding only dH2O.  The reaction was left at room temperature for thirty minutes 
before the optical density at 540 nm was measured on the Dynatech MR 500 
colorimetric plate reader.  All samples and standards were analysed in triplicate. 
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Figure 2.3: The chemical reaction of the Greiss reaction 
 
                                                     
 
 
 
 
 
                                                              
                                                                                
 
 
 
                                                                                 
 
Figure 2.3: The Greiss reaction involves the reaction of nitrite (NO2
-
) under acidic 
conditions, with aromatic amines, such as sulphanilic acid, to form a 
diazonium cation; in a second step, this ion reacts with a further 
aromatic amine, such as NEDD, as a target coupling amine to form a 
purple azo dye.   
HO3S NH2 
NO2
-
 
+ NH(CH2)2NH2 NH2+ HO3S 
 
HO3S  N=N NH(CH2)2NH2 
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2.1.5 Nitrate analysis 
 
Nitrate was measured indirectly by the reduction of nitrate to nitrite by the 
bacterial enzyme nitrate reductase.  The nitrate reductase was made up into a 
reaction buffer in the presence of β-Nicotinamide Dinucleotide Phosphate (NADPH) 
and Flavin Adenine Dinucleotide (FAD), Phosphate Buffer Solution (PBS) and 
dH2O.  PBS is present as the reaction will only take place at pH 7.2-7.4.  One unit of 
nitrate reductase will reduce 1.0 µM of nitrate per minute in the presence of NADPH 
at 25
o
C.  Nitrate reductase (10 units) was added to 4 mg of NADPH and 33.2 mg of 
FAD to make up the reaction buffer.  The total volume of reaction buffer that was 
used was 4000 µL which was made up of the following:  NADPH 4 mg in 800 µL, 
FAD 33.2 mg in 800 µL, PBS (pH 7.4) 800 µL, dH2O 1520 µL, nitrate reductase 10 
U/450 µL 80 µL. The reaction of nitrate reduction with nitrate reductase converts the 
nitrate to nitrite, and the nitrite is subsequently measured by the Greiss reagent 
method as described above.  As the nitrate method does not take into account any 
nitrite within the sample to start with, we also plated nitrite standards and samples 
on a separate well plate.  This nitrite concentration was subtracted from the 
concentration from the nitrate well samples.  The reaction of nitrate reductase relies 
on the pH of the sample being between pH 7.2 – 7.4 and therefore for alkali samples, 
from rat studies, adjustment using a ‘superbuffer’ was performed.  The superbuffer 
consisted of 0.1 M NaOH and a half volume 0.3 M HCl. 
  
Well plates for nitrate (Plate I)/nitrite (Plate II) analysis were set up as follows.  
In both plates there were three 60 µL water ‘blanks’, then three 60 µL standards for 
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each concentration of nitrite.  In the nitrate plate (Plate I), there were also three wells 
for each 60 µL nitrate concentration.  Sample (60 µL) was added to each of three 
sample wells.  To plate I, 30 µL of reaction buffer was added, while 30 µL of water 
was added to each well of plate I.  Both plates were incubated at 25
o
C, in the dark, 
for 2 hours, to allow the reaction buffer to convert nitrate to nitrite.  At the end of 2 
hours, 60 µL Greiss reagent and 30 µL distilled water was added to each well of 
both plates.  The plates were then left at room temperature, for 20 minutes, before 
being analysed on the colorimetric plate reader (Dynatech MR 500).  The original 
nitrate in samples was calculated from the nitrate standard curve. 
 
The reaction principle of nitrate reductase is 
 
 
          β-NADPH + Nitrate ------------------------------- β-NADP + Nitrite + H2O 
                                                         Nitrate reductase 
 
 
  
64 
 
2.1.6 
15
N analysis 
 
Analysis for 
15
N was undertaken in studies to examine the effectiveness of 
cleaning samples deliberately exposed to K
15
NO2 and K
15
NO3.  The analysis for 
total 
15
N content (ng) was undertaken in collaboration with Dr T Preston who kindly 
performed the analysis on a tandem mass spectrometer (ThermoFinnigan, Hemel 
Hempstead, UK). 
 
2.1.7 S-Nitrosothiols 
 
Nitrosothiols were measured at pH 7.4, using the release of NO from 
nitrosothiols by copper in an acidic environment, in the presence of glutathione 
acting as an excess reducing agent (234,235).  The NO was measured using the WPI 
NO probe, as described above in Chapter 2.1.1. The copper used was in the form of 
copper nitrate.  To calibrate the NO probe, nitrite standards (of concentration 20, 40, 
60 and 80 µM) were used, as in the presence of excess glutathione all the nitrite 
would be converted to nitrosothiols before the NO is then released by the copper. 
 
The following reagents were used 
 
a. pH 7.4 50 mM H3PO4/K2HPO4 Buffer.  This acts to keep the reaction at pH 7.4.  
H3PO4 of 50 mM is made up by adding 0.5 mL H3PO4 (concentrate) in 100 mL 
dH2O to give a pH of 1.7.  K2HPO4 of 50 mM is made up by dissolving 0.871g 
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of K2HPO4 in 100 mL of dH2O to give a pH of 8.9.  K2HPO4  solution was put 
into a beaker and the pH adjusted by adding H3PO4 solution to give a pH of 7.4 
(roughly H3PO4:K2HPO4 = 6:100) 
b. 500 mM Cu(NO3
-
)2.  This provides copper, which, when added to a 
nitrosothiol, displaces the NO from the GSNO thiol group, liberating NO.  To 
make up this solution, 0.938 g of Cu(NO3
-
)2 was dissolved in 10 mL of pH 2.5 
HCl.     Cu(NO3
-
)2 was used at 5mM final concentration. 
c. 100mM Glutathione (GSH).  This acts as a reducing agent and also a thiol 
donor for the production of nitrosothiols.  0.307 g of GSH is dissolved in 10 
mL of dH2O.  GSH was used as a final concentration of 1 mM 
 
From these standards a graph can be plotted and, from the graph, we can 
determine the NO release from the unknown samples (Figure 2.4). 
 
Human biopsy samples were acidified to pH 2.5 by adding 19 µL of 0.1 M 
HCl.  GSH (1 mM) was added to act as a thiol donor group and reducing agent, thus 
allowing any nitrite present to be converted to nitrosothiols.  In a separate 1 ml 
plastic Eppendorf test tube 99 µL of buffer solution and 1 µL of 100 mM GSH were 
added together.  The 80 µL sample was then added to 100 µL of buffer based 
solution. A calibrated WPI NO probe was placed into the Eppendorf tube before the 
NO was liberated. To the 200 µL solution, 2 µL of 500 mM of Cu(NO3
-
)2  (5mM) 
was added to liberate NO.  NO production was recorded and the peak measurement 
obtained.   
66 
 
 
 
 
            
 
 
Figure 2.4: Standard calibration curve for NO release from nitrosothiols.  Nitrite 
samples of known concentration were mixed with glutathione as 
standards.  In the presence of excess glutathione all the nitrite is 
converted to nitrosothiols, which can then be measured through the 
release of NO.  NO is released by the reduction of nitrosothiols by 
copper in an acidic environment.  Since there is a linear relationship 
between pA and µM from known concentrations of nitrite standards, in 
the sample, unknown nitrosothiol concentrations can be calculated.   
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2.1.8 Ascorbic acid/total vitamin C analysis 
 
2.1.8.1 Collection and preparation of samples 
 
The aqueous phase of bench top model studies was sampled at times 0, 1, 2, 5, 
10 and 15 minutes through a sampling port.  The sample (100 µL) was added to 900 
µL of dH2O and split into two test tubes.  Both test tubes contained 0.5 mL of 2% 
metaphosphoric acid/0.5% sulphamic acid and one of the test tubes also contained 
6mg/ml dithiothreitol (DTT).  The DTT was used to regenerate ascorbic acid from 
any dehydroascorbic acid in the sample, allowing quantification of total vitamin C 
levels.  The sulphamic acid was added to remove any remaining nitrite.  
 
Ascorbic acid (ASC) and total vitamin C (TVC) samples were immediately 
frozen in a -70 
o
C freezer after being obtained.  Stored samples were analysed within 
4 weeks.  Prior to analysis, samples were thawed and centrifuged briefly at 1000 g, 
using a microcentrifuge (DJB Labcare Ltd, Buckinghamshire, UK). 
 
2.1.8.2 Analysis of sample by HPLC 
 
ASC and TVC levels were measured by high performance liquid 
chromatography (HPLC), employing an electrochemical detector.  This method is 
based on a previously validated method for ascorbic acid measurement in gastric 
juice (43,143,221,222,236).  The instruments comprised of an automated sample 
injector (Shimadzu SIL-10AD VP) with a 50 µL loop, a pump (Shimadzu LC-10AT 
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VP), an electrochemical detector (Shimadzu L-ECD-6A) set at 350 mV and 0.2 µA 
and an integrator (Shimadzu model C-R3A Chromatopac).  ASC was separated 
using the reverse phase, ion pair chromatography on a Phenomenex 5µM C18 Luna 
150 x 4.6 mm analytical column (Phenomenex, Macclesfield, UK) protected by a 
guard column (Anachem, UK, 20 x 3 mm) hand packed with Lichroprep RP-18 (25-
40 µm, BDH-Merck Ltd, Poole, UK).  A precolumn (Phenomenex Security guard 
C18 ODS Octadecyl filters 4 x 3 mm id) was also used.  The mobile phase consisted 
of 0.1 M sodium acetate containing 0.1 M ocytlamine and 15% acetonitrile with a 
final pH of 4.3, adjusted with glacial acetic acid.  The flow rate was 0.8mL/min and 
the retention time of ASC was approximately three minutes.  An aqueous stock 
standard solution (1 mg/mL) was prepared by adding 5 mL of ASC stock solution to 
5ml of DTT (3.5 mg/mL).  Working standards were prepared by diluting appropriate 
volumes of the stock solution on the day of analysis.  The autosampler was 
programmed to inject 25 µL of standards, quality control and samples.  The first 
injection was DTT solution to remove oxidising sites on the column.  A blank 
sample of 1:1 metaphosphoric acid : sulphamic acid (MS) diluted 1 in 2 using dH2O 
was processed for each run and subtracted from the measured ascorbic acid of the 
samples, as the MS solution had a positive ASC reading when analysed. 
 
After obtaining a value for both total vitamin C and ASC, the dehydroascorbic acid 
could be calculated.  All measurements were expressed in µg/mL.   
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2.1.9 Vitamin E analysis 
 
The analysis of α-tocopherol which was used was based on a method 
previously described for non biological samples, using high performance liquid 
chromatography (HPLC) employing an electrochemical detector.  The analysis with 
HPLC and electrochemical detection offers more sensitivity and selectivity 
compared with HPLC and UV-visible or fluorescent detection (237). The 
instruments comprised of an automated sample injector (Shimadzu SIL-10ADvp) 
with a 50µL loop, a pump (Shimadzu LC-10AT) and an electrochemical detector 
(Applied Biosystems 980 Programmable Fluorescent detector, Applied Biosystems, 
Warrington, UK) with excitation 295 nm and emission 340 nm.  
 
Α-tocopherol was separated from the rest of the sample using a Jones 
Spherisorb 5µ silica analytical column (25 x 4 mm) with a C18 guard.  The mobile 
phase consisted of HPLC grade methanol.  The flow rate was 0.8 mL/min, giving a 
column pressure of approximately 600psi and the retention time of α-tocopherol was 
approximately 4 minutes.   
 
Stock solutions of α-tocopherol were used to generate a standard curve.  92mg 
of α-tocopherol was weighed out and dissolved in 100 mL methanol, giving a 
standard stock of 920 µg/m or 2.14mM.  Before preparing the standard curve, the 
stock solution was diluted in methanol to final concentrations of 2140µM, 1070µM, 
535µM, 268µM, 134µM, 67µM and 33µM.  The autosampler was programmed to 
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inject 10µL of standards, quality control and samples.  The autosampler dilutor 
solution used was filtered and degassed 50% methanol and distilled water. 
 
Data collection and processing was via Viglen p5/166 Genie ATX and Jones 
Chromatography software (Jones Chromatogarphy Ltd, Mid Glamorgan, UK).  
Linear regression was carried out within the program.  The quality control and 
unknown sample results were calculated from parameter values generated. 
 
Using this method allowed separation of α and β-tocopherol individually but 
under the chromatographic conditions γ and δ-tocopherol could not be separated.  In 
the experiments performed throughout this thesis, we were primarily interested in α-
tocopherol and measurement of γ and δ tocopherol was not relevant. 
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2.1.10 N-nitrosamine measurement 
 
Nitrosamine analysis has improved greatly over the past twenty years but 
nitrosamines remain technically difficult to analyse, due the range of chemical 
interactions that they can undergo.  It is considered best for volatile nitrosamines to 
be measured by gas chromatography (GC) mass spectrometry (MS) and ideally by 
tandem mass spectrometry.  Nitrosamines present several problems in terms of their 
analysis.  In principle, any secondary nitrogen atom can be nitrosated, with the 
resulting formation of the corresponding N- nitrosocompound.  The potential range 
of analytes is further increased by differences in the polarity, volatility, size and 
solubility of the molecule containing the N-nitroso moiety.  The nitrosamines that 
we are interested in are the volatile nitrosamines, as they are more widely implicated 
in biological tissues.   
 
Another problem is artefactual formation of the nitrosamine.  If the sample 
contains artefactual nitrite, formation of the N-nitrosocompounds may occur during 
the analysis, as a result of secondary nitrogen compounds in the sample.  It is 
therefore necessary, as a first step, to destroy the nitrite with a suitable agent.  
Sulphamic acid is suitable for this and forms a nitrogen gas on reacting with the 
nitrite.  The sulphamic acid more rapidly destroys nitrite in the presence of an acidic 
pH and it is therefore important to make a solution of sulphamic acid that is acidic 
for this purpose.  In our experiments we use a solution of 0.08 M HCl in 
combination with sulphamic acid and saturated NaCl solution.   
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2.1.10.2 N-nitrosamine extraction from aqueous phase 
 
A 1 mL aqueous phase aliquot was added to 0.5 mL 0.08 M HCl and 5% 
sulphamic acid solution in saturated 6 M NaCl, in a 2 mL glass tube.  This sample 
was then well mixed by inversion and 10 µL of the internal standard 0.01% NDBA 
was added.  This sample was again mixed well before adding 0.5 mL of an 
extraction solvent mix (45: 55 v/v dichloromethane: diethylether).  This sample was 
mixed and allowed to separate into two distinct layers.  The density of the extraction 
solvent mix was 1.03.  The density of dichloromethane on its own is such that 
separation of the aqueous phase from the solvent phase is difficult, therefore, 
diethylether is added. This meant that the solvent formed the upper layer, with the 
nitrosamine extracted into the solvent.  The upper layer from this sample was 
removed by glass pipette and transferred to a tapered glass vial.  The extraction was 
carried out twice.  The sample was concentrated under a gentle stream of nitrogen, to 
concentrate the sample down to 100 µL.  The glass vial was crimp capped and stored 
at -20
o
C until further analysis. 
 
2.1.10.3 Extraction of N-nitrosamine from lipid phase 
 
A 500 µL sample was taken with a glass pipette from the lipid phase and 50 µL 
0.01% NDBA was added as an internal standard.  The lipid was then subjected to 
solid phase extraction, to remove the nitrosamines from the lipid tributyrin phase.  
The solid phase extraction process involved adding 1000 µL of dichloromethane to 
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the lipid phase.  This was mixed and 500 µL of the lipid/dichloromethane mix was 
added to 1.5 mL of hexane before further mixing.  A DSC-Diol solid-phase 
extraction cartridge (500 mg, 3 mL) (Phenomenex, Macclesfield, UK) was then 
conditioned with solvent before the lipid mix was eluted drop-wise into the column.  
The column was washed with 1 mL hexane.  The nitrosamines were eluted into a 
glass vial using 2.5 mL methanol.  The methanol nitrosamine mix was concentrated 
to 500 µL using 35
o
C Gyro-vap (Howe, Banbury, UK) for 10 minutes.  The glass 
vial was crimp capped and stored at -70
o
C before analysis by tandem mass 
spectrometry.  Only NPIP and NMOR were measured within the lipid phase due to 
difficulty with our solid phase extraction method for the more volatile nitrosamine 
NDMA.  
 
2.1.10.4 N-nitrosamine analysis by gas chromatography tandem mass 
spectrometry 
 
To measure N-nitrosamine concentrations, a gas chromatography ion trap 
tandem mass spectrometer, on a TRACE GC 2000 Series gas chromatograph 
(ThermoFinnigan, Hemel Hempstead, UK) interfaced to a Polaris Q mass 
spectrometer (ThermoFinnigan, Hemel Hempstead, UK), was used.  On the mass 
spectrometer there was an AS2000 autosampler and programmable temperature 
vaporising (PTV) injector.   
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The N-nitrosamines within a sample were separated by chromatography on a 
ZB-5MS’fused silica capillary column, internal diameter 30m x 0.25mm, 0.5µm fill 
thickness (Phenomenex, Macclesfield, UK)). The oven temperature programme was 
as follows: 37
o
C (held for 2 minutes) to 160
o
C at 10
o
C/min, to 250
o
C at 30
o
C/min 
(held for 2 minutes).  Helium was used as a carrier gas, at a flow rate of 1ml/min.  
The PTV injector was programmed from 36
o
C to 115
o
C (held for 2 minutes) at 
10
o
C/min and a pressure of 22psi, prior to a cleaning phase at 325
o
C (held for 12 
minutes).   
 
Acquisition and treatment of data obtained was performed on Xcalibur version 
2 (ThermoFinnigan, Hemel Hempstead, UK).  All samples were spiked with 10µL 
internal standard (0.01 NDMA), and tandem mass spectrometer spectra were 
calibrated with spiked standard N-nitrosamines solutions, covering concentrations 
from 0-70 µM.  The response was linear for the concentrations studied. 
 
A standard trace obtained for NDMA, NDEA, NDBA, NPIP and NMOR 
standards is shown in figure 2.5.  The amount of N-nitrosamine present is shown by 
the area under the curve.  It is from the area under the curve that calculations can be 
made of how much actual sample is present, adjusting for differences between 
individual nitrosamines.  Calculations are also based on a correction factor for the 
internal standard.  There is therefore both an internal and external standard.   
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Figure 2.5: Chromatogram of GC-MS/MS for the N-nitrosamine standards.  Due to 
different volatilities and mass of daughter compounds, the various 
nitrosamines have different retention times within the mass 
spectrometer and are detected at different times. Their abundance is 
shown on the y axis representing the signal intensity. (RT=retention 
time, AA=area under curve, SN=signal intensity). 
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2.2 Materials - Chemical Reagents Used 
 
Sigma-Aldrich (Poole, UK) 
Acetonitrile HPLC grade (15%), Ascorbic acid, Butylated hydroxytoluene (BHT), 
Copper nitrate (Cu(NO3
-
)2), Dichloromethane, Diethylether Flavin adenine 
dinucleotide (FAD), Glutathione Hexane, Hydrochloric acid, Dibasic potassium 
phosphate (K2HPO4), Metaphosphoric acid (2%), N 1-Naphthylethylenediamine 
dihydrochloride (NEDD), N-acetyl cysteine (NAC), Nitrate reductase, Octylamine 
(0.1M), Phosphate buffer solution (PBS), Phosphoric acid (H3PO4), Potassium 
iodide (KI), Pronase E from Streptomyces griseus, Sodium acetate, Sodium nitrate 
(NaNO3
-
), Sodium nitrite (NaNO2
-
), Sodium thiocyanate (NaSCN), Sulphamic acid 
(0.5%), Sulphanilamide, Sulphuric acid (H2SO4), Triacetin (Glyceryl triacetate), 
Tributyrin (Glyceryl tributyrate), α-tocopherol,β Nicotinamide dinucleotide 
phosphate (NADPH), β-carotene  
 
Qmx Laboratories (Thaxted, UK) 
N-nitrosodibutylamine, N-nitrosodiethylamine, N-nitrosodimethylamine, N-
nitrosomorpholine, N-nitrosopiperidine  
 
Bio-Rad (UK) 
Bio-Rad Protein Assay Kit 
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BDH Ltd (Liverpool, UK) 
EDTA 
 
Rathburn Chemicals (UK) 
Methanol (HPLC grade) 
 
RA Lamb Ltd (Eastbourne, UK) 
Whatman No1 paper 
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2.3 Statistical Methods  
 
Using online statistical software, Smiths Statistical Package, median values 
with 1
st
 and 3
rd
 quartile values were obtained.  Where appropriate, the data was 
analysed in this way to allow for inter individual variation to be shown without 
altering the statistical pattern of results.  Statistical significance was determined 
using a 1-sample Wilcoxon test for paired data and Mann-Whitney U test for 
unpaired data.   
 
Smith Statistical Package was also used to obtain mean values, standard 
deviation and analysis of variance (F Statistics for p value analysis).   
 
Correlation analysis was performed using Mini Tabs statistical analysis 
software to determine Spearmans’ rank correlation coefficient (p value) for non 
parametric rank testing and Pearson coefficient of correlation (r
2
) for parametric 
testing. 
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Chapter 3 Nitrosamine formation in a single and two-phase model 
representing the healthy gastroesophageal junction  
 
3.1 Introduction 
 
The relationship between dietary nitrate and ascorbic acid induced nitrosative 
stress, at the gastroesophageal junction and cardia of the stomach, has been the 
subject of increasing research (43,44,144,221,238,239).  It had previously been 
thought that nitrosative stress was inhibited within the upper gastrointestinal tract by 
ascorbic acid (240-242).  This is explained by the antioxidant effect of ascorbic acid 
on nitrite, forming NO within the lumen.  However, in the upper gastrointestinal 
tract there is both a luminal compartment and a lipid rich environment.  There are 
two major sources of lipids:  the first is the mucosa where there is both a lipid 
bilayer formed by epithelial cells, which also creates intraepithelial compartments, 
and there is also lipid within the cells.  A high intracellular fat content is found in 
intestinal metaplastic epithelium (243), the same epithelium in which there is 
development of gastroesophageal junction cancers.  Unlike normal gastric or 
oesophageal epithelium, intestinal metaplasic epithelium absorbs luminal fat, a 
process facilitated by bile salts (243).  As well as lipids from the mucosa, it has been 
shown that lipids sit within the more proximal region of the stomach in the 
postprandial state (244).  There are, therefore, two potential areas where lipid will 
alter the chemistry within the upper gastrointestinal tract.   
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The aim of this study was to generate a model to simulate the chemistry at 
the gastroesophageal junction and cardia of the stomach, that allowed the addition of 
a lipid phase, to examine the effect this had on the nitrosative chemistry.  The model 
prepared would also allow chemical manipulation of the lipid phase. 
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3.2 Experimental design 
 
 
3.2.1 Bench Top Model 
 
A bench top model was designed to enable us to study the influence of lipid 
on the nitrite chemistry occurring when nitrite swallowed in saliva encounters 
gastric acid (figure 3.1).  The model consisted of a 250 mL specially designed glass 
beaker containing 50 mL HCl pH 1.5 representing the stomach.  The pH of 1.5 was 
chosen as it has previously been shown that this is the pH in the post prandial 
situation in the proximal region of the stomach (245).  NaSCN (1mM) was also 
added to the gastric compartment, representing its physiological concentration in 
gastric juice.  EDTA (1mM) was added to chelate metals known to be present in 
chemical reagents.  Secondary amines were added to the aqueous solution to allow 
us to monitor N-nitrosation, by measuring the generation of N-nitrosamines.  The 
secondary amines used were one of morpholine (5mM), piperidine (5mM) or 
dimethylamine (5mM).  Experiments were performed with and without ascorbic acid 
(1mM).   
 
To investigate the influence of lipid, studies were undertaken with and 
without lipid added to the acidic aqueous solution.  Two different lipids were used, 
tributyrin (glyceryl tributyrate) and triacetin (glyceryl triacetate).  These two lipids 
both have a higher density than water and sink, forming a layer in the case of 
triacetin, and a globule in the case of tributyrin, in the bottom of the beaker.  The 
lipid was added by slowly injecting the lipid out of a syringe with a 21 gauge needle  
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Figure 3.1: Bench top model used to represent the gastroesophageal junction in 
single and two-phase models.  The aqueous phase total volume was 50 
mL, consisting of HCl (pH 1.5), NaSCN (1 mM), EDTA (1 mM), 
secondary amine (5 mM) and NaNO2 (range of concentrations) ± 
ascorbic acid (1 mM).  To create a two-phase model a lipid (tributyrin 
or triacetin) was added. 
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(outer diameter 0.813mm, internal diameter 0.495mm) into the bottom of the 
aqueous phase. Varying volumes of lipid were added, giving ratios of aqueous to 
lipid ranging from 50:1 to 5:1.  The majority of the studies were performed with a 
ratio of 10:1 aqueous to lipid, as this is most likely to represent the luminal 
conditions of the upper part of the stomach.  It is known that 20-30% of solid 
ingested food is present as a form of fat.  This will also be diluted by gastric juices, 
hence the reason we chose 10% as a percentage of fat to other contents in the model 
stomach.  Secondary amines were also added to the lipid phase in some of the 
experiments.  The three secondary amines (morpholine, piperidine or 
dimethylamine), were added to the lipid phase, at a concentration of 5mM.  The 
experiments were all performed at 37
o
C, for a time period of 15 or 60 minutes.  The 
contents of the beaker were constantly stirred using a magnetic stirrer suspended in 
the aqueous phase.  The experiments were initiated by adding NaNO2 (100 µM). 
 
Throughout the study dissolved O2 and NO concentrations were monitored in 
the aqueous phase, using the probes and sensors as described in Chapter 2.1.1 and 
2.1.2.  Samples (100 µL) were obtained at 0, 1, 2, 5, 10, and 15 minutes after adding 
nitrite, for determination of ascorbic acid and total vitamin C.  At the end of the 15 
minute experiment, a 1 mL aqueous sample was removed for N-nitrosamine 
measurement.  A 500 µL sample of the lipid phase with ascorbic acid present, from 
experiments involving piperidine and morpholine, was taken at 15 minutes for 
analysis of the nitrosamine content in the lipid phase.   In experiments lasting 60 
minutes a 500 µL aqueous sample was taken at times 15 and 60 minutes. 
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3.2.2 Increasing the surface area of the lipid phase 
 
As well as having the tributyrin lipid phase present as only one single 
globule at the bottom of the beaker, a model was also created where several globules 
of tributyrin were present.  Tributyrin was injected into the aqueous phase using a 
needle and syringe.  In order to create different globules the injection had to be 
started and stopped such that the 5 mL volume was separated into four equal parts of 
1.25 mL.  These four globules then had to remain distinct and not coalesce during 
the 15 minutes over which the experiment was run for the results to be recorded.  
NO and O2 concentrations were monitored and samples were taken for ascorbic acid 
and N-nitrosamine, as previously described. 
 
3.2.3 Triacetin as the lipid phase 
 
Experiments were performed using the lipid triacetin as a substitute for 
tributyrin.  Like tributyrin, triacetin has a higher density (d=1.16 g/mL at 25
o
C)) than 
water and therefore sinks into the aqueous phase.  A difference with triacetin is, that 
rather than forming a globule, it sinks to the bottom of the beaker model to form a 
bottom layer.  Experiments were then performed as for tributyrin, although we were 
unable to form globules with this lipid. 
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3.3 Results 
 
3.3.1 Studies in aqueous solution with no lipid (single phase model) 
 
3.3.1.1 In the absence of ascorbic acid 
 
When nitrite was added to HCl pH 1.5 containing thiocyanate (1mM) but without 
ascorbic acid, nitrosation of the secondary amines was observed.  After 15 minutes 
6.71 (±0.82) µM NMOR, 0.014 (±0.005) µM NPIP and 0.58 (±0.21) µM NDMA 
were present (figure 3.2).  In these experiments, the addition of nitrite produced only 
a very small increase in the concentration of NO.  This increase was small and 
steady throughout the 15 minutes of the experiment, to a maximal concentration of 2 
µM (figure 3.3).  There was only a small decline over time of the O2 concentration 
from 180 µM to 175 µM (figure 3.3).  
 
3.3.1.2 In the presence of ascorbic acid 
 
The presence of ascorbic acid markedly inhibited the nitrosation of each of 
the secondary amines.  The concentration of each N-nitrosamine formed was 
significantly less for each amine (figure 3.2). NMOR and NDMA concentrations 
were just over 5% of the total found in the absence of ascorbic acid, with mean 
values of 0.37 (±0.08) µM and 0.03 (±0.01) µM, while the concentration for NPIP 
was only 0.01 (±0.005) µM compared to 0.014 (±0.005) µM. 
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In the presence of ascorbic acid (1mM), the addition of nitrite produced a 
rapid increase, followed by slow decline in NO concentrations.  Within 60 seconds 
of adding nitrite (100µM) the dissolved NO concentration was approximately 80µM.  
This rapid rise in NO was followed by a rapid fall in the dissolved O2 concentration.  
Within 60 seconds of adding the nitrite, no dissolved O2 was detected until 10 
minutes later, when the concentration slowly increased to reach 5–10% of its 
maximal concentration (figure 3.4). 
 
The addition of nitrite also produced a fall in the ascorbic acid concentration.  
It rapidly fell from its original concentration of 970 (± 75) µM to 580 (±40) µM at 2 
minutes and then slowly fell to 480 (± 40) µM at 15 minutes (Figure 3.5). 
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Figure 3.2: N-nitrosamine (µM) produced in a single phase system, both in the 
presence (red column) and absence (blue column) of ascorbic acid (1 
mM), for the three secondary amines morpholine, piperidine and 
dimethylamine, after the addition of nitrite (100 µM). Data labels show 
mean nitrosamine concentration.  Error bars represent 1 standard 
deviation. (n=18) 
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Figure 3.3: Mean NO (blue line with diamond markers) and O2 concentrations (red 
line with square markers) in a single phase system, after the addition of 
nitrite (100µM) over 15 minutes (n=18) 
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Figure 3.4: Aqueous NO and aqueous O2 concentrations in a two-phase model 
representing the chemistry occurring at the gastroesophageal junction, 
after the addition of sodium nitrite (100 µM).  The acidic aqueous phase 
contained the aqueous antioxidant ascorbic acid to an excess 
concentration of 1000 µM.  The experiment was performed over 15 
minutes. (n=18) 
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Figure 3.5: Ascorbic acid and dehydroascorbic acid concentrations in a two-phase 
model representing the chemistry occurring at the gastroesophageal 
junction after the addition of sodium nitrite (100 µM).  The acidic 
aqueous phase contained the aqueous antioxidant ascorbic acid, to an 
excess concentration of 1000 µM, at initiation of the experiment.  The 
experiment was performed over 15 minutes. (n=18) 
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3.3.2 Studies in aqueous solution containing 10% tributyrin globule (two-phase 
model) 
 
3.3.2.1 Aqueous phase in absence of ascorbic acid with amine in both   
phases (two-phase model) 
 
When nitrite was added to HCl pH 1.5 containing thiocyanate (1 mM), no 
ascorbic acid and a 10% globule of tributyrin, nitrosation of the secondary amines 
was observed.  The concentrations generated were different from those found in the 
single phase study in the absence of ascorbic acid (p<0.001) although the same 
pattern was seen. Aqueous phase mean concentrations observed were 4.33 (±0.8) 
µM NMOR, 0.19 (±0.07) µM NPIP and 0.64 (±0.29) µM NDMA (figure 3.6).  
 
3.3.2.2 Aqueous phase in presence of ascorbic acid with amine in both 
phases (two-phase model) 
 
In marked contrast to the observations in the absence of the lipid globule, the 
addition of ascorbic acid did not inhibit the generation of N-nitrosamines in the 
presence of the lipid globule.  Indeed, in the presence of the lipid globule, the 
ascorbic acid actually increased the concentration of N-nitrosamine formed. The 
degree to which this happened varied with the different secondary amines.  The 
concentration of NMOR formed in the absence of ascorbic acid (4.82 µM ± 0.60 
µM) was only slightly, and not significantly, higher than that in the absence of 
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ascorbic acid.  However, the concentration of NDMA formed in the presence of 
ascorbic acid (2.18 µM ± 0.31 µM) was approximately four fold higher than in the 
absence of ascorbic acid.  The most dramatic effect occurred with piperidine, where 
the concentration of NPIP formed in the presence of ascorbic acid (6.15 µM ± 0.54 
µM) was thirty-two fold higher than in the absence of ascorbic acid (figure 3.6). 
 
In the presence of lipid, the addition of nitrite produced similar changes in 
the concentrations of NO, O2 and ascorbic acid to those seen in the absence of lipid.   
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Figure 3.6: Aqueous N-nitrosamine (µM) produced in a two-phase system, both in 
the presence (red column) and absence (blue column) of ascorbic acid, 
for the three secondary amines morpholine (MOR), piperidine (PIP) and 
dimethylamine (DMA), after the addition of 100µM nitrite.  The second 
phase is formed by the lipid tributyrin in a ratio of 1:10 with the 
aqueous phase volume.  Error bars represent 1 standard deviation. 
(n=18) 
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3.3.2.3 Aqueous phase N-nitrosamine in absence of ascorbic acid with amine 
(5mM) in aqueous phase only (two-phase model) 
 
The concentrations of N-nitrosamine generated in the aqueous phase were not 
significantly lower for NMOR and NDMA, than when the amine was present in both 
phases in the absence of ascorbic acid.  The mean concentrations formed for the 
individual nitrosamines were 3.90 (±0.42) µM NMOR and 0.41 (±0.15) µM NDMA.  
This compares to 4.33 (±0.8) µM for NMOR and 0.64 (±0.29) µM for NDMA when 
amine was present in both phases.  However, there was significantly less NPIP when 
the amine was present only in the aqueous phase as compared to when it was in both 
phases.  The mean NPIP concentration when piperdine was present ony in the 
aqueous phase was 0.013 (±0.02) µM compared to 0.19 (±0.07) µM when piperidine 
was present in both phases (p=0.0003). 
 
3.3.2.4 Aqueous phase N-nitrosamine in absence of ascorbic acid with amine in 
lipid phase only (two-phase model) 
 
The concentrations of NMOR and NDMA were nearly half those seen when 
amine was present in both phases in the absence of ascorbic acid.  The mean 
concentrations of NMOR and NDMA generated were 2.64 (±0.37) µM and 0.31 
(±0.15) µM respectively.  The mean concentration of NPIP was not statistically 
different from those seen when amine was in both phases in the absence of ascorbic 
acid, with a mean concentration of 0.24 (±0.09) µM. 
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3.3.2.5 Aqueous phase N-nitrosamine in presence of ascorbic acid with amine in 
aqueous phase only (two-phase model) 
 
There was a dramatic reduction in the nitrosamines formed in this system 
with amine present in the aqueous phase only, as compared to the same model but 
with amine present in both phases.  The mean NMOR concentration in the aqueous 
phase at 15 minutes was only 0.08 (±0.01) µM, the lowest concentration of NMOR 
found in any of the experiments.  Mean NPIP and NDMA concentrations were also 
very low, with mean values of only 0.01 (±0.01) µM and 0.02 (±0.01) µM generated 
within this system, suggesting little partitioning of these amines in that time period. 
 
3.3.2.6 Aqueous phase N-nitrosamine in presence of ascorbic acid with amine in 
lipid phase only (two-phase model) 
 
The concentrations in these experiments were the closest of any where the 
amine was omitted from one phase compared to when amine was present in both.  
The mean concentrations of NMOR, NPIP and DMA in this model were not 
significantly different when compared to concentrations in a two-phase model in the 
presence of ascorbic acid with amine present in both phases.  The mean 
concentrations were 4.20 (±0.66) µM, 6.43 (±0.85) µM and 2.12 (±0.58) µM for 
NMOR, NPIP and NDMA respectively. 
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3.3.2.7 Lipid phase in the presence of ascorbic acid (1mM) with amine in both 
phases (two-phase model) 
 
Measurement of N-nitrosamine concentration was undertaken in two-phase 
15 minute experiments, where ascorbic acid (1mM) was present, fifteen minutes 
after the addition of sodium nitrite (100µM).  N-nitrosamines measured in the lipid 
phase were present in higher concentrations than in the corresponding aqueous 
phase.  The mean NMOR present in lipid was 11.5 fold higher (55.3 ± 6.7µM) and 
NPIP 17.8 fold higher (109.7 ± 17.5µM) than that of the aqueous phase with amine 
present in both phases in the presence of ascorbic acid (1mM).    
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3.3.3 Aqueous phase N-nitrosamine in two-phase studies wth ascorbic acid 
present with prolonged time period 
 
When experiments were allowed to run for 60 minutes rather than just 15 
minutes there was a significant increase in N-nitrosamine production.  The 
concentration increase however, was not proportional to the increase in time.  There 
was just over double the concentration of NMOR and NPIP when the time interval 
was increased four fold.  The mean NMOR concentration at 60 minutes was 10.14 
(±1.12) µM compared to 4.82 (±0.6) µM after 15 minutes.  The mean NPIP 
concentration increased from 6.15 (±0.5) µM at 15 minutes to 14.02 (±1.84) µM at 
60 minutes.  During this time NO and O2 were both still present, as was ascorbic 
acid.  The NO concentration gradually fell to approximately 15µM, while O2 
concentrations were 100 µM at the end of the 60 minute experiment.  Ascorbic acid 
continued to be gradually consumed but there was still 220 (±36) µM present at the 
end of the 60 minute experiment. 
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3.3.4  Two-phase studies with different volumes of tributyrin in the presence of 
ascorbic acid with amine in both phases 
 
Increasing the ratio of the lipid phase tributyrin to the acidic aqueous phase 
increased the concentration of N-nitrosamine produced in the aqueous phase at 15 
minutes.  For all three of the N-nitrosamines examined, there was a non linear 
relationship between the volume increase in tributyrin and concentration of N-
nitrosamine produced.  For NMOR, the mean concentration produced increased 
from 2.03 (±0.5) µM with a ratio of 1:50 to 4.82 (±0.6) µM with a ratio of 1:10.  The 
concentration of NMOR produced was greater again when a ratio of 1:5 was used 
with 8.74 (±0.72) µM produced giving over a four fold increase in NMOR 
production when increasing the lipid volume ten fold.  There were similar 
percentage increases in NPIP and NDMA concentrations with increasing tributyrin 
to aqueous ratios.   NPIP concentrations increased from 2.75 (±0.30) µM to 6.15 
(±0.51) µM when the tributyrin ratio was increased from 1:50 to 1:10 and to 10.26 
(±0.52) µM when the ratio was increased further to 1:5.  The rise in concentration of 
NDMA with increasing volumes of tributyrin followed a similar pattern, with 
concentrations 0.80 (±0.29) µM, 2.18 (±0.0.31) µM and 3.82 (±0.57) µM NDMA in 
experiments with tributyrin to aqueous ratios of 1:50, 1:10 and 1:5 respectively 
(figure 3.7). 
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Figure 3.7: N-nitrosamine production with ascorbic acid present in a two-phase 
system with different ratios of lipid to aqueous phase.  The ratio was 
altered by adjusting the volume of lipid placed in the aqueous solution.  
The three ratios assessed were 1:5 (blue column), 1:10 (red column) and 
1:50 (green column).  The aqueous solution remained at a fixed 50mls.  
One of three secondary amines (5mM) was present in both aqueous and 
lipid phases: morpholine (MOR), piperidine (PIP) or dimethylamine 
(DMA).  The corresponding N-nitrosamine concentration was measured 
from the aqueous phase.  The mean values are annotated and the error 
bars represent 1 standard deviation.  (n=12) 
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3.3.5 Two-phase studies with varying surface area of lipid in the presence of 
ascorbic acid with amine in both phases 
 
With the greater surface area provided by the division of the volume of 
tributyrin into smaller globules, there was a significant increase in the aqueous 
concentration of N-nitrosamine produced.  For both NMOR and NPIP there was a 
more than two fold increase in the production of the nitrosamine.  The mean NMOR 
concentration was increased from 4.82 (±0.60) µM when a single lipid globule was 
present to 9.93 (±0.72) µM when the same total volume of tributyrin was divided 
into four globules, in a 15 minute experiment.  A similarly significant increase in 
mean NPIP concentration was observed with 13.25 (±1.11) µM NPIP formed when 
4 globules were present compared to 6.15 (±0.54) µM with a single globule (figure 
3.8). 
 
There was no measurable statistically significant difference in NO and O2 
concentration within the aqueous phase in the presence of four globules of tributyrin 
compared to a single globule (data not shown). 
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Figure 3.8: Mean N-nitrosamine concentrations (µM) from two-phase model 
experiments where the lipid phase is either a single globule (blue 
column), or the tributyrin is divided into four globules (red column).  
These experiments were performed for two secondary amines, 
morpholine (MOR) and piperidine (PIP), with the corresponding 
nitrosamine measured from the aqueous phase.  Experiments were run 
over 15 minutes after the addition of 100µM nitrite to an acidic 
aqueous phase containing 1mM ascorbic acid.  Error bars represent 1 
standard deviation. (n=12) 
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3.3.6 Triacetin as the lipid phase 
 
In two-phase studies where the lipid triacetin was used in place of tributyrin 
as the lipid phase, very similar results were observed.  In the absence of ascorbic 
acid, mean concentrations of NMOR, NPIP and NDMA in the aqueous phase were 
4.13 (0.30) µM, 0.11 (0.02) µM and 0.42 (0.17) µM.  In the presence of excess 
ascorbic acid there was a mean NMOR concentration of 4.21 (0.44) µM, mean NPIP 
concentration of 5.28 (0.63) µM and a mean NDMA concentration of 1.84 (0.28) 
µM, 15 minutes after the addition of 100 µM nitrite.  These results are not 
statistically different from the results from experiments using tributyrin as the lipid 
phase. 
 
NO, O2 and ascorbic concentrations were all comparable in experiments 
where triacetin was used in place of tributyrin (data not shown). 
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3.4 Discussion 
 
These studies indicate that the presence of lipid profoundly alters the 
nitrosative chemistry in the bench top model.  The lipid is able to convert the 
influence of ascorbic acid from one that protects against nitrosation to one that 
promotes it.  This effect is due to the ability of the NO formed by the ascorbic acid 
within the aqueous phase to regenerate nitrosative species within the lipid. 
 
In the studies performed without lipid, and without ascorbic acid, the 
addition of nitrite to HCl pH 1.5 containing thiocyanate resulted in nitrosation of the 
three secondary amines.  The main nitrosating species formed under these conditions 
is NOSCN (137,223,246).  It reacts with the secondary amine, in its unprotonated, 
uncharged state (247).  The amount of the secondary amine, in its nitrosatable form, 
depends upon its –log dissociation constant (pKa).  The pKa of the amines studied is 
8.33 for morpholine, 10.68 for dimethylamine and 11.123 for piperidine.  The 
amount of the secondary amine in a form available for nitrosation by NOSCN will, 
therefore, be greatest for morpholine and least for piperidine. The differences in pKa 
can partly explain why different concentrations of the three N-nitrosamines were 
generated.   
 
In the above experiments performed in the absence of lipid, the addition of 
ascorbic acid effectively prevented the nitrosation of the three amines.  This can be 
explained by the ascorbic acid competing with the secondary amines for the NOSCN 
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(239,240).  In the reaction between ascorbic acid and NOSCN, the latter is reduced 
to NO and the former oxidised to dehydroascorbic acid.  Consistent with this, we 
observed a rapid rise in the concentration of NO and a fall in the ascorbic acid 
concentration.  There was also a rapid fall in the O2 concentration.  This can be 
explained by the NO reacting with dissolved O2 to form N2O3 (248,249).  The N2O3 
formed in this way is a nitrosating species and again preferentially reacts with 
ascorbic acid and is reduced back to NO (243).  This recycling continues until either 
the O2 or the ascorbic acid is consumed.  Under our experimental conditions the O2 
was the first to be depleted.  Stoichemically one mole of ascorbic acid can reduce 
two moles of nitrite to NO.  The greater consumption of ascorbic acid observed is 
due to this recycling of NO. 
 
In the presence of the lipid, nitrosamines were formed despite the presence of 
ascorbic acid.  Indeed, the concentrations of the nitrosamines formed were higher in 
the experiments with lipid and ascorbic acid than experiments without lipid and 
without ascorbic acid.  This was particularly the case for NPIP, where the 
concentrations formed in the experiments with ascorbic acid and lipid were 440 
(6.15 μM in the presence of lipid versus 0.014μM in the absence of lipid) times 
higher than those without lipid and without ascorbic acid.  Though the presence of 
lipid markedly altered the amount of the nitrosamine formed in the experiments with 
ascorbic acid, it did not alter the changes in the concentrations of NO, O2 or ascorbic 
acid. 
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What is the explanation for the ability of the lipid to convert the effect of the 
ascorbic acid from being an inhibitor to a promoter of nitrosation?  The effect 
observed is likely to be mediated by the NO produced by the reaction between the 
ascorbic acid and the nitrosating species.  In the absence of the lipid this NO can 
react with O2 to form the nitrosating species N2O3 (248,249).  However, in the 
aqueous phase the N2O3 formed in this way does not nitrosate the secondary amines 
as it preferentially reacts with the ascorbic acid which reduces it back to NO (243).  
The ascorbic acid, in the aqueous phase, thus protects against nitrosation by both the 
nitrosating species NOSCN, formed by the acidification of nitrite in the presence of 
the thiocyanate, and by N2O3 formed by the NO (produced by the reaction between 
NOSCN and ascorbic acid) and O2 (250).  However, when a globule of lipid is 
present, the NO, formed by the reaction between the nitrosating species and ascorbic 
acid, diffuses into the lipid and within it reacts with O2 to form N2O3.  As ascorbic 
acid is not lipid soluble, it will be unable to enter the lipid and, thus, the N2O3 
generated within the lipid will be able to nitrosate the secondary amines within the 
lipid.  The N-nitrosamines generated within the lipid in this way will then diffuse out 
of the lipid and produce the rise in their concentration observed in the aqueous 
compartment. 
 
The potential of NO to generate nitrosating species by reacting with O2 was 
recognised many years ago.  More recently the potential for this reaction to occur 
preferentially within lipids was recognised.  Liu et al (251) demonstrated that the 
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reaction between NO and O2 was 300 times faster in lipid than in aqueous solutions 
and that this was due to the increased solubility of both gases in lipids. 
 
These studies also indicated that the relative extent to which the lipid 
promoted nitrosation varied between the different secondary amines studied.  In the 
absence of lipid and absence of ascorbic acid, morpholine was nitrosated to a greater 
extent than dimethylamine and the latter more than piperidine.  As discussed above, 
this can be explained by their different pKa and, consequently, the proportion present 
in protonated form, with the resulting susceptibility to nitrosation by NOSCN and 
N2O3.  However, in the studies with lipid and with ascorbic acid, piperidine was 
nitrosated more than morpholine and the latter more than dimethylamine.  Previous 
studies have shown that this nitrosation of secondary amines in organic solvents is 
unrelated to their pKa (253).  The relative lipid solubility of both the amine and N-
nitrosamine may explain the results observed.  Piperidine is the most hydrophobic 
and therefore more of the secondary amine is likely to accumulate in the lipid phase, 
compared to morpholine and dimethylamine (252).   
 
The importance of the nitrosation occurring within the lipid can be seen in 
the two-phase experiments, where the availability of the secondary amine was 
changed from being in both phases to being present in one or other of the lipid or 
aqueous phase.  When the amine was present in the lipid phase only, in the presence 
of ascorbic acid, the concentrations of the three N-nitrosamines produced was not 
significantly different from those observed when amine was in both phases of the 
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model.  When the amine was present only in aqueous phase in the presence of 
ascorbic acid the concentrations of the N-nitrosamines were only just detectable.  
This also shows that the partitioning of these amines into the lipid phase does not 
occur, as these experiments took place over 15 minutes.  If there had been more 
rapid partitioning of amine into the lipid phase, then it could be expected that more 
amine would have been nitrosated and hence detectable after 15 minutes.   
 
  These studies also show that changing the surface area and therefore the 
interface between the aqueous and lipid phase, has an effect on the concentration of 
N-nitrosamine generated.  By simply increasing the surface area, by splitting one 
lipid globule into four, around double the concentration of N-nitrosamine was 
generated.  This suggests that the increased surface area allows more NO to diffuse 
over and also increases the diffusion back into the aqueous phase of generated N-
nitrosamine, dependent on its partition co-efficient.  This has relevance for the 
situation we would expect to find in vivo.  There are two potential situations in the 
upper gastrointestinal tract where this lipid chemistry is important.  Firstly, with 
regard to ingested fat in foodstuffs (244), and secondly in relation to lipid within the 
surrounding epithelial cells (243).  As regards ingested fat, it is unlikely that all of 
this will sit as one globule within the proximal stomach but rather would be expected 
to form a larger surface area by being split up.  The other area of lipid is within the 
epithelial layer of cells in the gastric cardia and the gastroesophageal junction.  The 
surface area here is potentially very large, giving more in the way of an interface 
between the aqueous and lipid phases, thus allowing increased NO diffusion into the 
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epithelial cells.  The ratio of lipid to aqueous phase also makes a difference to the 
generation of N-nitrosamine.  This may simply be due to the larger surface area of 
the globule resulting from the increased volume since the increase in total volume is 
not matched by a proportionate increase in the N-nitrosamine generated.  These 
studies highlight the importance of the interface between the lipid and aqueous phase 
for the nitrosative chemistry occurring.  
 
The explanation of why the presence of lipid lowers the concentration of 
NMOR found at 15 minutes is not entirely clear.  In these two-phase model studies 
in the presence of ascorbic acid, where morpholine is replaced by piperidine, the 
concentration of piperidine is slightly higher than in a single phase model, while 
when dimethylamine is substituted as the amine there is no statistical difference.  It 
would be attractive to suggest from these studies that NMOR has a higher affinity 
for lipid than the other two N-nitrosamines.  However, NMOR has a low lipid 
solubility while the the lipid solubility of NPIP is the highest of the three N-
nitrosamines used in this study (ClogP 0.73 compared with ClogP of -.033 for 
NMOR and 0.01 for NDMA).  It is therefore not clear why the NMOR present in the 
aqueous phase is significantly lower in the absence of ascorbic acid in a two-phase 
model compared to a single phase model.  Differences in partitioning of the amines 
and N-nitrosamines between the lipid and aqueous phase may contribute to the 
differences.  It is important to note that partition coefficients into a lipid may not 
fully represent what will happen in vivo.  This is because, for small nonelectrolytes, 
Overton’s rule of permeability coefficients correlating well with oil/water 
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coefficients cannot be applied to lipid bilayer membranes.  The membrane behaves 
more like a polymer than a liquid hydrocarbon (254). 
 
Within the lipid phase of two-phase studies, the measured NMOR and NPIP 
were significantly higher than the concentrations found in the aqueous phase, in the 
presence of ascorbic acid.  The mean concentration of lipid NMOR was 11.5 times 
higher than aqueous concentrations and mean NPIP lipid concentration was 17.8 
times higher than aqueous  There were technical difficulties measuring NDMA 
using the methods described above.  However, further published work shows that 
NDMA concentrations are also higher in the lipid phase as compared to the aqueous 
phase (255) when a suitable method of measuring NDMA within the lipid was used.  
This once again suggests that the generation of N-nitrosamines is occurring within 
the lipid layer.  The proposed mechanism for this is shown in figure 3.9.  The higher 
percentage increase in NPIP formation over NMOR formation can be explained by 
the lipophilicity of both piperidine and NPIP being higher than the lipopholicity of 
morpholine and NMOR (253).  This means that there will be more amine present 
within the lipid to be nitrosated by NO and its nitrosating products, and also that the 
N-nitrosamine generated within the lipid is more likely to stay within the lipid layer 
than diffuse into the aqueous phase. 
 
The shift in nitrosative chemistry from the aqueous to the lipid phase in the 
presence of ascorbic acid is not confined to one form of lipid.  The results discussed 
so far have related to tributyrin.  However, when triacetin replaced tributyrin in two-
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phase models, nitrosative stress was again shown when NO was formed from 
acidified nitrite in the presence of ascorbic acid.  The concentrations of NMOR, 
NPIP and NDMA were similar when comparing the lipid triacetin and tributryin for 
the different experimental conditions measured.  
 
The above studies highlight the way in which lipid can profoundly alter acid 
induced nitrosative chemistry.  Our studies were stimulated by the chemistry 
occurring when salivary nitrite enters the acidic stomach.  Traditionally, the ascorbic 
acid secreted in gastric juice has been considered to be beneficial, by converting the 
nitrosating species to NO and thus inhibiting generation of potentially carcinogenic 
N-nitrosocompounds, within the gastric lumen.  However, the NO produced in this 
way may itself induce nitrosation as it diffuses into lipid in the lumen or in the lipid 
bilayer membrane of the epithelial cells.  The ascorbic acid therefore appears to have 
the potential to transfer the nitrosative stress from the aqueous phase into the 
adjacent lipid compartments.   
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Figure 3.9: The proposed mechanism of N-nitrosamine formation in the lipid layer 
of a two-phase model of the gastroesophageal junction.  The aqueous 
antioxidant ascorbic acid (ASC) shifts nitrosative stress from the 
aqueous to lipid phase. 
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Chapter 4 Lipid antioxidant effect on nitrosative chemistry in a model of the 
gastroesophageal junction 
 
4.1 Introduction and Aims 
 
The generation of N-nitrosocompounds within the upper gastrointestinal tract 
has been the subject of much research.  Studies in Chapter 3 showed that, as well as 
acid-catalysed nitrosative stress in the absence of the aqueous ascorbic acid, there is 
a potential for NO induced nitrosative stress in the presence of ascorbic acid when 
lipid is present.  These studies have shown that fat counteracts the ability of ascorbic 
acid to prevent nitrosation. 
 
In biological systems there are lipid antioxidants as well as aqueous 
antioxidants.  The interaction between lipid and aqueous antioxidants is thought to 
be important within these biological systems.  Three major chain breaking lipid 
antioxidants are α-tocopherol, β-carotene and butylated hydroxytoluene (BHT).  Α-
tocopherol is the major vitamin E compound found in the lipid fraction of living 
organisms (256-258).  It is thought to be one of the most powerful naturally 
occurring lipid antioxidants known (145,259) and has previously been shown to 
inhibit the formation of nitrosamines in an in vitro gastrointestinal model system 
(260).  Β-carotene is another naturally occurring antioxidant that has been found in 
many biological systems (261).  BHT is a synthetic phenolic lipid antioxidant that is 
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used in food preservatives (147,262).  These, and other, lipid antioxidants may be 
important in preventing nitrosative stress occurring at the gastroesophageal junction. 
 
The aim of the studies described in this chapter was to assess the effect on 
nitrosative stress, as determined by nitrosamine formation, of the lipid antioxidants 
α-tocopherol, β-carotene and butylated hydroxytoluene in a model simulating the 
chemistry occurring at the gastroesophageal junction. 
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4.2 Experimental design 
 
A two-phase bench top model was created to assess the chemistry occurring at 
the gastroesophageal junction as described in Chapter 3.  This model was modified 
such that a given concentration of one of three antioxidants, α-tocopherol, β-carotene 
or BHT was present within the lipid phase tributyrin (figure 4.1).   This model 
consisted of a 250 mL glass beaker.  Into this beaker an aqueous phase consisting of 
50 mL HCl (pH 1.5) was added together with NaSCN (1mM) and EDTA (1mM).  
Ascorbic acid (1mM) was added to the aqueous phase in certain experiments.  This 
provided an excess of ascorbic as compared to the later added nitrite.  In other 
experiments a smaller dose of ascorbic acid was added such that all available 
ascorbic acid would be consumed.  The aqueous phase represents the lumen of the 
stomach, with solutions present in physiological concentrations.  Into the beaker was 
added 5 mL of a lipid, to generate a second phase.  The two lipids used were 
tributyrin and triacetin.  A secondary amine was added to both the lipid and aqueous 
phases to allow monitoring of the nitrosative stress, by measuring the generation of 
N-nitrosamines.   The three secondary amines used were morpholine, piperidine and 
dimethylamine at concentrations of 5 mM.  To determine the effect of various 
antioxidants on nitrosative stress, one of the lipid antioxidants α-tocopherol, β-
carotene or BHT was added in various concentrations to the lipid.  The 
concentrations used were 1 µM, 10 µM, 100 µM, 1 mM, 10 mM and 100 mM. 
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The contents of the beaker were stirred with a magnetic stirrer during the 
course of the experiment.  Experiments were performed at 37
o
C, the temperature 
being kept constant by having the beaker set up in a heated water bath.  The 
experiments were initiated by adding NaNO2 to the aqueous phase.  Nitrite 
concentrations of 25 µM and 100 µM, after addition to the aqueous phase, were used 
in different experimental conditions. 
 
Dissolved O2 and NO concentrations were monitored in the aqueous phase 
throughout the study.  At the end of the experiment, or at a given time point, a 1 mL 
aqueous sample was removed through a sampling device in the upper port of the 
beaker model for measurement of the relevant N-nitrosamine.  Experiments were 
performed over 15 minutes, except in those studies where the time interval was 
being evaluated and in these experiments the time interval for sampling was 30 and 
60 minutes. 
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Figure 4.1: This schematic diagram represents the two-phase bench top model used 
to represent the gastroesophageal junction with lipid antioxidant.  The 
aqueous phase consisted of 50 mL HCl (pH 1.5), NaSCN (1mM) and 
EDTA (1mM) +/- ascorbic acid (either 25µM or 1mM).  The addition of 
nitrite (either 25µM or 100µM) initiated the experiments.  The addition 
of the lipid tributyrin to an aqueous phase created a two-phase model.  
The lipid had varying concentrations of lipid anti-oxidant present. AO = 
antioxidant. 
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4.3 Results 
 
4.3.1  Two-phase studies with presence of lipid antioxidant in lipid and 
ascorbic acid (1mM) in aqueous phase 
 
4.3.1.1  Α-tocopherol Present in the Lipid 
 
The presence of α-tocopherol in the lipid component of the experimental design 
inhibited nitrosation at concentrations of 10 µM and greater, when nitrite (100 µM) 
was added to an acidic aqueous phase (figure 4.2).  This was the same for all three 
nitrosamines measured.  Addition of only 1 μM of α-tocopherol had no statistically 
significant effect on the concentration of any of the aqueous N-nitrosocompounds 
(p>0.05) with a mean NMOR concentration of 4.64 (±0.76) μM, mean NPIP 
concentration of 6.32 (±0.53) μM and mean NDMA concentration of 2.04 (±0.48) 
μM.  When 10 µM of α-tocopherol was added to tributyrin, and the experiments run 
over 15 minutes, 1.11 (±0.24) µM NMOR, 1.28 (±0.22) µM NPIP and 0.93 (±0.13) 
µM NDMA were measured in the aqueous phase.  This reduction in mean N-
nitrosocompounds concentration is statistically significant (p<0.00002).  A 
concentration of α-tocopherol of 100 μM and above resulted in only 0.01 (±0.01) 
µM of the respective N-nitrosamines being produced.  NO and dissolved O2 
concentrations followed a pattern consistent with that found when there was no 
antioxidant in the lipid.   When the lipid triacetin was used in place of tributyrin 
similar results were found (data not shown). 
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Figure 4.2: Mean aqueous N-nitrosamine concentrations for three different 
secondary amines are shown.  The blue columns represent mean NMOR 
concentration, the red columns mean NPIP concentration and the green 
column NDMA concentration.  In these experiments 100µM nitrite was 
added to an acidic aqueous phase containing 1mM ascorbic acid.  The 
ratio of lipid to aqueous phase was 1:10.  The concentration of α-
tocopherol present in the lipid phase is shown on the x axis.  
Experiments were performed over 15 minutes.  Mean values of the 
nitrosamine concentration are labeled.  Error bars represent 1 standard 
deviation. (n=18)   
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4.3.1.2 Β-carotene present in the lipid 
 
Β-carotene concentrations of 1 mM and greater were required to have a 
significant inhibitory effect on nitrosation.  In the aqueous phase, 15 minutes after 
the addition of nitrite (100 μM) to HCl (pH 1.5) in the presence of thiocyanate 
(1mM) and ascorbic acid (1mM) and with 1mM β-carotene present in the lipid 
tributyrin 1.17 (±0.24) μM NMOR, 1.34 (±0.28) μM NPIP and 0.74 (±0.12) μM 
NDMA were measured.  This compared to 4.36 (±0.23) μM NMOR, 5.85 (±0.52) 
μM NPIP and 2.24 (±0.41) μM NDMA when 100µM beta carotene was present in 
the tributyrin (figure 4.3).  While these concentrations show a slight reduction from 
results when there is no antioxidant present, they are not statistically significant 
(p>0.05).  NO and dissolved O2 concentrations during the 15 minute experiment 
were similar to those obtained when no antioxidant was present in the lipid.  When 
the lipid triacetin was used in place of tributyrin for the lipid phase, similar results 
were found (data not shown). 
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Figure 4.3: Mean aqueous N-nitrosamines concentration for three different 
secondary amines are shown.  The blue columns represent mean NMOR 
concentration, the red columns mean NPIP concentration and the green 
column NDMA concentration.  In these experiments 100 µM nitrite was 
added to an acidic aqueous phase containing 1mM ascorbic acid.  The 
ratio of lipid to aqueous phase was 1:10.  The concentration of β-
carotene present in the lipid phase is shown on the x axis.  Experiments 
were performed over 15 minutes.  Mean values of the nitrosamine 
concentration are labeled.  Error bars represent 1 standard deviation. 
(n=18)   
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4.3.1.3  BHT present in the lipid 
 
Of the three antioxidants used in our studies, Butylated Hydroxytoluene (BHT) 
had the least inhibitory effect on nitrosation.  Concentrations of 10mM and greater 
BHT in tributyrin were required to inhibit nitrosation after the addition of 100μM 
nitrite to HCl (pH 1.5) in the presence of thiocyanate and ascorbic acid in the 
aqueous phase.  With a BHT concentration of 10 mM, 0.13 (±0.05) μM NMOR, 
0.13 (±0.02) µM NPIP and 0.15 (±0.02) µM NDMA were measured in the aqueous 
phase (figure 4.4).  When only 1 mM BHT was present within the lipid 3.27 (±0.54) 
µM NMOR, 5.26 (±0.22) µM NPIP and 1.49 (±0.26) μM NDMA were measured.  
The NO and dissolved O2 concentrations measured in the aqueous phase were 
similar to those in the experiments where no antioxidant was present in the lipid 
phase.  Results for the lipid phase with triacetin in place of tributyrin were similar to 
those seen with tributyrin.   
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Figure 4.4: Mean aqueous N-nitrosamine concentrations for three different 
secondary amines are shown.  The blue columns represent mean NMOR 
concentration, the red columns mean NPIP concentration and the green 
column NDMA concentration.  In these experiments 100µM nitrite was 
added to an acidic aqueous phase containing 1mM ascorbic acid.  The 
ratio of lipid to aqueous phase was 1:10.  The concentration of BHT 
present in the lipid phase is shown on the x axis.  Experiments were 
performed over 15 minutes.  Mean values of the nitrosamine 
concentration are labeled.  Error bars represent 1 standard deviation. 
n=18   
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4.3.2   Two-phase study with aqueous phase containing nitrite (25µM) and 
ascorbic acid (25µM) with a range of α-tocopherol concentrations in the 
lipid phase 
 
In this experiment, there is not an excess of ascorbic acid, but rather, the 
ascorbic acid should all be consumed in the reaction with nitrite to generate NO.  
There was a mean NO concentration produced of 21 µM, maximal at 30 seconds.  
There was a loss of O2 after 30 seconds, but this was measurable in the aqueous 
phase again just after 3 minutes (Figure 4.5).  This therefore suggests there should be 
less nitrosative stress.  Despite this, it was found in these experiments that some of 
the inhibition of nitrosation seen with the smaller concentrations of α-tocopherol was 
lost.  Compared to the model where there was an excess of ascorbic acid, where a 
concentration of only 10 μM α-tocopherol was enough to prevent nitrosation, a 
concentration of 10 mM is required to achieve near complete inhibition of 
nitrosative stress in these experiments.    In the absence of any lipid antioxidant the 
mean NMOR concentration produced was 1.53 (±0.26) μM.  There was a 
statistically significant degree of inhibition with α-tocopherol concentrations of 10 
µM and above but even at 1mM concentrations the mean NMOR concentration was 
0.47 (±0.05) μM showing there is still nitrosation occurring (figure 4.6).  
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Figure 4.5: Mean aqueous NO and O2 concentration (µM) over time after the 
addition of nitrite (25 µM) to an acidic aqueous phase in the presence of 
ascorbic acid (25µM).  Error bars represent 1 standard deviation.  
(n=18) 
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Figure 4.6: Aqueous NMOR concentrations produced over a 15 minute period in a 
single and two-phase system with ascorbic acid present.  In a two-phase 
system there is either no alpha tocopherol or a range concentrations 
from 1 μM to 10 mM.  Only 25 µM ascorbic was present in the aqueous 
phase and 25 µM nitrite was added. Data labels represent mean values.  
Error bars represent 1 standard deviation. (n=18) 
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4.3.3 Two-phase studies with nitrite (25 µM) but no ascorbic acid in the 
aqueous phase and either no, or one of a range of concentrations of α-
tocopherol  
 
In a single phase system there is generation of NMOR as expected due to acid-
catalysed nitrosation with a mean NMOR concentration of 1.73 (±0.38) μM.   The 
concentration of NMOR is not significantly lower when there is lipid without any 
antioxidant.  However there is a trend towards there being slightly less NMOR, with 
a mean NMOR concentration in the aqueous phase of 1.58 (±0.20) μM.  
Concentrations of α-tocopherol in the lipid phase of 1 and 10 µM do not 
significantly change the concentration of NMOR produced (p>0.05).  Higher 
concentrations of 100 μM, 1 mM and 10 mM α-tocopherol do result in significantly 
less NMOR concentrations of 1.08 (±0.13) μM, 0.84 (±0.05) μM and 0.74 (±0.12) 
µM respectively (p=0.0007) (figure 4.7).  However these concentrations are 
significantly greater than those found when there was ascorbic acid present, whether 
in excess or only at a concentration of 25 µM (p<0.000003).  
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Figure 4.7: Aqueous NMOR generation in a single and two-phase system with 
single dose of 25μM nitrite but no ascorbic acid present.  In the two-
phase system there was increasing concentrations of a-tocopherol from 
0μM to 10mM.  Data labels show mean values of µM NMOR.  Error 
bars represent 1 standard deviation. n=12 
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4.3.4  Two-phase studies (increased time interval) with α-tocopherol present 
and ascorbic acid (1mM) and nitrite (100µM) present in the aqueous 
phase  
 
Increasing the time interval from 15 to 60 minutes increased the NMOR 
concentration produced, for all concentrations of α-tocopherol examined.   There 
was a three fold increase in NMOR concentrations with increased time from 15 to 60 
minutes, for α-tocopherol concentrations of 100 µM and 1 mM (p=0.0006).  Where 
10 µM α-tocopherol was present as lipid antioxidant there was a greater increase in 
NMOR produced, such that at 60 minutes there was a concentration of 8.46 (±0.90) 
µM (figure 4.8).  This is 20 times the concentration of NMOR observed with 100 
µM and 1 mM α-tocopherol at the same time interval.  This concentration of 8.46 
µM is significantly nearer the concentration found when there is no lipid antioxidant 
present (NMOR concentration of 10.14 µM). 
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Figure 4.8: Aqueous NMOR concentrations in a two-phase model with nitrite (100 
µM) added to an aqueous phase containing ascorbic acid (1mM).  In the 
lipid phase system there was a range of concentrations of α-tocopherol 
(0μM to 10mM).  The concentration of α-tocopherol used is shown on 
the x axis labels.  Data is shown for both 15 minute experiments (blue 
column) and 60 minute experiments (red column).  Data labels show 
mean values of µM NMOR.  Error bars represent 1 standard deviation. 
n=12 
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4.4 Discussion 
 
These results indicate that both lipid and aqueous antioxidants are required to 
prevent nitrosation in a model simulating the gastroesophageal junction.  We have 
previously demonstrated an inhibitory effect of ascorbic acid in preventing acid 
nitrosation in a single aqueous phase system.  This inhibitory effect is lost when 
lipid is added as a second phase into this model.  However, the combination of 
ascorbic acid with any of the lipid antioxidants is effective in having an inhibitory 
effect on nitrosative stress, if sufficient concentrations are present.  The 
concentrations required to achieve this inhibition can be very low (10µM), as can be 
seen for α-tocopherol.  The co-operative and synergistic effect of lipid and aqueous 
antioxidants has been extensively researched over the past five decades (171,263-
266). 
 
The aqueous antioxidant ascorbic acid competes for acidified nitrite (240, 
267,268).  The reaction product from this is NO.  NO is a small, gaseous, lipophilic 
molecule.  It diffuses from the aqueous phase into the lipid phase as it is 9 times 
more soluble in lipid (251).  In the lipid, NO meets O2.  NO reacts readily with O2 to 
form the nitrosating species N2O3 (250).  The rate of this reaction is related to the 
square of the NO concentration multiplied by the O2 concentration.  The reaction is 
therefore favoured by high NO concentrations, such as those generated when 
swallowed nitrite meets acidic gastric juice.  The reaction of NO with O2 is some 
300 times faster in lipid than in an aqueous phase (251).  The resulting nitrosating 
species N2O3 is then able to nitrosate the secondary amine to form the corresponding 
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N-nitrosamine (98).  Previous work by Mergens et al had demonstrated that α-
tocopherol may be able to prevent N-nitrosamine formation (269). The models used 
in these experiments were both an emulsified aqueous solution of α-tocopherol in 
vitro and the addition of α-tocopherol to shredded tobacco to prevent NDMA 
formation in tobacco smoke.  Mergens et al have also shown that α-tocopherol may 
be able to prevent formation of nitrosamines in an in vitro model of the 
gastrointestinal system, although this was in the context of nitrosative stress from 
luminal acid-catalysed nitrosation in the absence of ascorbic acid (260).  It is thought 
that, although NO does not react directly with α-tocopherol, it can react through 
oxidation products such as N2O3 (158). 
 
The experiments performed in our model of the gastroesophageal junction 
confirm that α-tocopherol, as well as other lipid antioxidants, are able to prevent 
nitrosative stress in the presence of ascorbic acid.  We found a concentration of 10 
µM of α-tocopherol, 1 mM β-carotene and 10 mM BHT was sufficient to prevent 
nitrosamine formation in the presence of excess ascorbic acid.  These findings are in 
keeping with the relative and absolute effectiveness of various lipid chain breaking 
antioxidants (270).  Howard et al found that α-tocopherol was the most powerful 
lipid antioxidant > other vitamin E compounds > β-carotene > BHT based on rate 
kinetics when assessing styrene autoxidation.  The antioxidant activities of these 
compounds are the same as their biological activities (256).  Stereoelectronic factors 
relating to the position of the methoxy group on the aromatic ring, and also the 
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stabilising effect of the ethereal O2 on the phenoxy radical, can explain the superior 
reactivity of α-tocopherol (145,148). 
 
In the studies with ascorbic acid present and α-tocopherol added to the lipid 
compartment at concentrations of 10 µM and greater, the nitrosative stress is 
inhibited.  With concentrations of 10 µM α-tocopherol nitrosamines are still formed 
(1.1 µM NMOR, 1.1 µM NPIP and 0.9 µM NDMA) but to a lesser extent than in 
studies in which no lipid antioxidant is added.  This would suggest that the α-
tocopherol is being overwhelmed to some extent.  An α-tocopherol concentration of 
10 µM is still, however, a surprisingly low concentration to be able to inhibit the 
nitrosative stress from 100 µM nitrite in this model.  The stoichiometry of chain 
breaking lipid antioxidants is complex.  In a classical inhibitory scheme two peroxyl 
radicals are consumed for every antioxidant molecule oxidised (148).  However, 
radical intermediates may drain antioxidants from the system.  It is still, therefore, 
surprising that α-tocopherol of such a low concentration (10µM) can be effective.  
This may possibly be explained by the recycling, or ‘sparing’, of α-tocopherol by 
ascorbic acid.  Over the past 60 years there has been ongoing debate as to whether 
recycling between ascorbic acid and α-tocopherol exists.  Tappel et al first 
postulated the concept that ascorbic acid is able to replenish the reducing capacity of 
α-tocopherol (165).  In vitro evidence to support the concept of recycling in both 
homogenous solutions and liposomal membrane systems is extensive 
(171,173,263,264,265,271).  This does not, however, seem to be borne out when 
some in vivo studies are undertaken (174) while others have postulated an in vivo 
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process of recycling does exist (175).  Our own unpublished in vitro studies 
presented in Chapter 5 of this thesis, using the same model as in these current 
experiments, suggest that there may be recycling, as ascorbic acid is consumed to a 
greater extent when α-tocopherol is present. 
 
As the incubation time was increased from 15 to 60 minutes there was a similar 
effect on N-nitrosamine generation in the presence α-tocopherol as there was in the 
presence of a two-phase model in the absence of a lipid antioxidant.  There was a 2-
3 fold increase in mean N-nitrosamine concentrations.  The exception to this was at 
concentrations of only 10 µM α-tocopherol.  In 15 minute experiments this 
concentration had only inhibited N-nitrosation to a limited degree.  When the time 
interval was increased to 60 minutes there was eight times more N-nitrosamine 
generated.  The final NMOR concentration, at 60 minutes, was only slightly less 
than the concentration of NMOR generated when there was no lipid antioxidant.  
This suggests that the α-tocopherol was overwhelmed in this scenario.  It may be 
that the ascorbic acid was not sufficient to replenish the α-tocopherol, although it is 
unlikely that the ascorbic acid in the system was totally depleted as ascorbic acid 
was present in excess.  Unfortunately ascorbic acid was not measured in the aqueous 
phase during these experiments, although in retrospect this would have been useful. 
 
When the concentration of the nitrite entering this system was lowered to 25 
µM in the absence of ascorbic acid, the mean NMOR concentration measured in the 
aqueous phase in the absence of α-tocopherol was 1.58 µM.  This was only slightly 
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less than the mean concentration in a single phase system with no lipid where 1.73 
µM NMOR was generated.  These mean concentrations are less than half the 
concentrations seen when 100 µM nitrite was added to the system.  This acid-
catalysed nitrosation appears to be inhibited at lower concentrations of α-tocopherol 
when 25 µM nitrite was added as compared to 100 µM nitrite being added.  
Concentrations of 100 µM α-tocopherol were effective in inhibiting nitrosation when 
25 µM nitrite was added compared to 10 mM being required when 100 µM nitrite 
was added.  This shows that the generation of nitrosating compounds is less and 
suggests that smaller concentrations of α-tocopherol were able to compete for the 
nitrosating species. 
 
In the experiments discussed thus far we have observed that either a very high 
concentration of α-tocopherol in the absence of ascorbic acid, or a very low 
concentration of α-tocopherol in the presence of excess ascorbic acid, results in 
inhibition of nitrosation.  While in the immediate post prandial state there may be 
excess production of ascorbic acid relative to nitrite at the gastroesophageal junction 
and gastric cardia (221), this may not always be the case.  There may be more of a 
balance between nitrite and ascorbic acid concentrations.  In studies using 25µM 
ascorbic acid and 25µM nitrite the α-tocopherol concentration required to inhibit 
nitrosation was considerably greater than when there was an excess of ascorbic acid.  
A proposed mechanism for this is that all the ascorbic acid is oxidised to 
dehydroascorbic acid in the initial reaction with nitrite.  When ascorbic acid is 
present to excess it will replenish the reducing capacity of α-tocopherol, but when all 
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the ascorbic acid is oxidised to dehydroascorbic acid in the initial reaction with 
nitrite this will not occur. 
 
In our studies β-carotene and BHT require higher concentrations than α-
tocopherol to have an inhibitory effect on nitrosamine production.  Β-carotene is 
present in many tissues throughout the human body and has an important antioxidant 
role to play.  BHT is a synthetic antioxidant that is present in food preservatives.  
There is some in vitro and in vivo evidence that β-carotene together with both 
vitamins C and E provides synergistic protection against oxidation by peroxynitrite 
(266).  The mechanism proposed for this is similar to the replenishment of 
tocopherol by ascorbic acid, in that there is an electron transfer reaction in which β-
carotene radical is repaired by vitamin C.  BHT has not been shown to have a 
capacity to be replenished by aqueous antioxidants.  However, it may work in a co-
operative manner with other antioxidants.  Our studies, thus far, have not 
investigated for synergism between β-carotene and ascorbic acid, or between lipid 
antioxidants, although this may be worthwhile in the future. 
 
It is interesting to note that concentrations of vitamin E in the human stomach 
are highest in the more proximal regions, in subjects who are Helicobacter pylori 
negative.  In the presence of Helicobacter pylori there is a loss of proximal vitamin 
E, while more distal stomach concentrations are maintained.  This may represent 
mobilization of antioxidant defenses to the sites of maximal stress (272).   
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The model in which we have assessed the effectiveness of antioxidants in 
preventing nitrosative stress is one designed to represent the gastroesophageal 
junction.  Gastroesophageal junction and gastric cardia cancers have been increasing 
over the past 20 years in the Western World.  The mutagen behind this rise is as yet 
unknown, but the carcinogenic potential from nitrite is currently being explored.   It 
has been shown that the potential for generation of harmful N-nitrosocompounds 
exists within the area of the upper gastrointestinal tract where swallowed nitrite 
meets acidic gastric juice.  Antioxidants, such as those studied in this model, may 
have a role in preventing the formation of harmful N-nitrosocompounds within the 
upper gastrointestinal tract. 
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Chapter 5 Interaction between ascorbic acid and α-tocopherol  
 
5.1 Introduction and Aims 
 
The synergistic activity between vitamins C and E was first suggested in 1941, 
when it was found that although ascorbic acid alone was a very poor antioxidant for 
lard and oil, it enhanced the antioxidant activity of tocopherols (164).  It was not 
until 1968 that Tappel suggested that vitamin C might reduce the tocopheroxyl 
radical formed from tocopherol during the scavenging of free radicals in vivo, thus 
permitting a single molecule of vitamin E to scavenge many radicals (165).  There 
has been some controversy in this field regarding the synergy between the two 
vitamins. 
 
In experiments performed in Chapter 4 of this thesis, using a two-phase model, 
it was noticed that the concentration of α-tocopherol required to prevent nitrosation 
was much smaller than expected, with 10 µM of α-tocopherol inhibiting nitrosation 
when 100 µM of nitrite was added to a two-phase model generating NO.  This could 
be explained by ascorbic acid reducing the tocopheroxyl radical produced in 
inhibiting nitrosation.  This would, therefore, allow one molecule of α-tocopherol to 
reduce many nitrosating species.  It was also found that, in two-phase experiments 
where we used only the same concentration of ascorbic acid as of nitrite, the 
concentration of α-tocopherol that had been effective in inhibiting nitrosation in 
experiments with an excess of ascorbic acid was now much less effective.  This 
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suggests, that in experiments where there was an excess of ascorbic acid, ascorbic 
acid was replenishing the reducing capacity of α-tocopherol.  In experiments where 
the ascorbic acid concentration was reduced, ascorbic acid became more deplete in 
the initial reaction with nitrite and subsequently was not so readily available to 
replenish the α-tocopherol. 
 
The aim of the experiments in this chapter was to determine if there was any 
interaction between vitamin C and E in experimental models representing the 
chemistry occurring at the gastroesophageal junction. 
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5.2 Experimental Design 
 
5.2.1 Single and two-phase models of the GO junction 
 
Bench top models were used as in experiments in Chapters 3 and 4 (figures 3.1 
and 4.1).  These models were adjusted to provide different chemical environments.  
 
5.2.1.1 With reduced ascorbic acid concentration 
 
In these experiments there was not an excess of ascorbic acid using just the 
same concentration of ascorbic acid as that of sodium nitrite which was used to 
initiate the experiment.  This should mean that there is no excess of ascorbic acid 
present to react with other compounds such as α-tocopherol.  Therefore, 100 µM 
nitrite was added to the acidic environment containing 100 µM ascorbic acid.  These 
experiments were performed over 30 minutes.  
 
5.2.1.2 Several pulsed boluses of nitrite 
 
Sodium nitrite at various concentrations (1 µM, 2.5 µM and 10 µM) was added 
to the aqueous phase at times 0, 7.5, 15 and 22.5 minutes.  The concentration of 
ascorbic acid in the aqueous phase of these experiments was 100 µM.  The purpose 
of adding several boluses of nitrite to the experimental model was to simulate the in 
140 
 
vivo situation.  It has previously been shown that after a nitrate-rich meal there are 
boluses of salivary nitrite reaching the acidic gastric juice (213).  
 
 
5.2.2 Three-phase model of the GO junction 
 
 
 
Our experiments thus far in this thesis have only looked at the aqueous layer as 
a provider of ascorbic acid leading to generation of NO in an acidic environment 
and.  It is consumption of ascorbic acid from this phase that has previously been 
observed.  A three-phase model was constructed as a better way of representing the 
in vivo environment.  This three-phase model consisted of two aqueous layers and a 
lipid layer (figure 5.1).  The lipid layer provided complete separation of the aqueous 
layers but allowed the passage of NO and O2.  This allowed analysis of ascorbic acid 
away from the initial site of its antioxidant reactions in the luminal side of the 
model.  It allowed for examination of ascorbic acid consumption in the epithelial 
compartment to see if it is consumed when there is the potential for nitrosative stress 
in this compartment.   
 
A modified cylindrical Delrin model was constructed.  Delrin is an engineering 
plastic also known as polyoxymethylene.  The model was made to a total volume of 
6700 µl.  The model was constructed in two halves to allow the creation of all 
replaceable three layers.  The two halves could be tightened together without any 
leak of aqueous contents.  The lower half had a port through which sodium nitrite 
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could be added to initiate the generation of NO in this lower layer.  This lower port 
was sealable with a plastic cap.  
 
The upper layer had a total volume of 4000 µl.  It consisted only of 150 µM 
ascorbic acid in PBS to a pH 7.4.  It was from this layer that samples were taken to 
measure ascorbic acid and total vitamin C concentrations.  WPI NO and O2 probes, 
as described in Chapter 2.1.1 and 2.1.2, were placed at the bottom of this layer, just 
above the middle layer, to continuously monitor NO and O2 concentrations during 
the experiment. The middle layer was made up of a composite membrane used in the 
design of NO probes (Donation from World Precision Instruments, Sarasota, 
Florida)), with 800 µL of the liquid lipid triacetin spread evenly over the surface of 
the membrane.  The composite membrane was known to allow free passage of NO 
and O2 through the membrane.  The lipid used was triacetin as its density at 37
o
C is 
such that it forms a layer.  In some of the experiments α-tocopherol was added to the 
lipid.  The concentrations of α-tocopherol varied from 10 µM.  The lower layer was 
an aqueous layer designed to resemble the chemistry at the gastroesophageal 
junction.  In this layer HCl provided an acidic environment with a pH of 1.5.  
NaSCN (1 mM) and EDTA (1 mM) were added, together with ascorbic acid (1 
mM).  The ascorbic acid was added in a concentration that was in excess of the 
concentration of sodium nitrite (100 µM) used to initiate the experiment.  This layer 
was used to generate NO.  The total volume of the lower layer was 1900 µl. 
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In terms of relating this in vitro model to conditions in the human upper 
gastrointestinal tract, the upper layer represents the intracellular compartment, while 
the middle layer represents the lipid membrane.  The lower layer represents the 
lumen of the upper gastrointestinal tract 
 
Experiments were performed at 37
o
C for 30 minutes.  The temperature was kept 
constant by performing the experiments on a hot plate.  Samples (100µL) were taken 
at time 0, 1, 2, 5, 10, 16, 23 and 30 minutes from the upper layer of the model for 
ascorbic acid and total vitamin C. The usual methods for processing ascorbic acid 
samples had to be adapted.  This occurred because the initial procedure involved 
diluting the samples twenty fold and it was noticed that the samples were being 
diluted beyond the point where the ascorbic acid was detectable.   Therefore, 80 µL 
of upper layer aqueous sample was taken from the top layer of the model.  This was 
equally divided and the 40 µL samples added to 120 µL of either MS or MS:DTT. 
This gave a final dilution of 1 in 4.  In all experiments there was a control sample of 
MS and MS:DTT which was analysed to make sure the sample was the source of 
ASC.  The model had an open top through the upper layer allowing oxygen to enter.  
Samples were then analysed as described in Chapter 2.1.8. 
 
To ensure that the model was suitable for purpose, NO diffusion across the 
lipid layer was monitored in the upper phase.  In all experiments NO was detected to 
be entering into the upper aqueous phase after diffusion through the middle lipid 
layer.  There was a standard pattern of diffusion, with a gradual increase in the NO 
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concentration recordings from time 2 minutes after the nitrite was added to the lower 
phase.  The maximum mean NO concentration achieved was 20 µM after 30 minutes 
(figure 5.2).  
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Figure 5.1: Representation of the Delrin model and constituents used to form a 
three-phase model.  The lower layer was representative of acidic gastric 
juice and experiments were initiated by adding 100 µM nitrite.  The 
middle layer was composed of the lipid triacetin sitting on a composite 
hydrophobic membrane.  The upper layer consisted of 150 µM ascorbic 
acid in a neutral environment. 
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Figure 5.2: NO and O2 concentrations in the upper phase of a three-phase model.  
The concentrations of NO and O2 were measured just above the middle 
layer in a three-phase model, over a 30 minute period, representing the 
chemistry at the gastroesophageal junction after the addition of 100 µM 
sodium nitrite to an acidic lower layer containing 1 mM ascorbic acid.  
Data labels show the mean NO concentration at a given time.  n=18 
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5.3 Results 
 
5.3.1  Two-phase model with α-tocopherol present in the presence of excess 
ascorbic acid (1mM) relative to nitrite (100µM) with increased time 
 
In 15 minute two-phase experiments in the presence of ascorbic acid it has been 
seen that concentrations of 10 µM α-tocopherol and greater were enough to almost 
fully inhibit nitrosation, as only 0.01 (±0.01) µM NMOR was produced for 
concentrations of 100 µM, 1 mM, 10 mM, while a mean concentration of 1.11 
(±0.24) µM NMOR was produced when 10 µM α-tocopherol was present.  When the 
time period of the experiment was increased to 60 minutes the NMOR concentration 
generated was significantly increased in all experiments using different 
concentrations of α-tocopherol.  However, the biggest increase occurred with 10 µM 
α-tocopherol, as eight times NMOR was produced at 60 minutes (p=0.00004), 
compared to three times for greater concentrations of α-tocopherol (p>0.0002). 
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5.3.2 Two-phase model with α-tocopherol and reduced ascorbic acid  
(100µM) relative to nitrite (100µM) 
 
The NMOR concentration produced in these experiments was higher for 
concentrations of 10 µM α-tocopherol and greater than those NMOR concentrations 
seen using 100 µM nitrite with an excess of ascorbic acid.  In a system containing no 
α-tocopherol there was a mean NMOR concentration of 2.45 (±0.6) µM.  A 
concentration of 10 µM α-tocopherol partially inhibited NMOR generation such that 
the mean NMOR concentration at 15 minutes was 1.23 (±0.16) µM (p=0.0001).  
Even at the higher concentration of 1 mM α-tocopherol the mean NMOR 
concentration was 0.38 (±0.09) µM at 15 minutes (p=0.00006) (figure 5.3).  These 
results show a similar pattern to those seen in the experiments in Chapter 4.3.2, 
where smaller doses of 25µM nitrite and ascorbic acid were used in the experimental 
design.  
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Figure 5.3: Mean aqueous phase NMOR concentrations (µM) at 15 minutes from a 
two-phase model where experiments were initiated by the addition of 
nitrite (100µM) to an acidic aqueous phase containing only 100µM 
ascorbic acid.  In this model the lipid phase contains concentrations of 
α-tocopherol (AT) ranging from 0 to 10 mM.  Data labels show the 
mean value for each experimental condition.  Error bars represent 1 
standard deviation. n=12 
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5.3.3 Two-phase model with α-tocopherol with reduced ascorbic acid  
(100µM) relative to nitrite (100µM) with increased time interval  
 
NMOR concentrations changed dramatically with increased time.  After 15 
minutes, at concentrations of 10 µM and above, α-tocopherol had managed to 
provide a significant degree of inhibition of nitrosation, although the degree of 
inhibition was not as great as when there was an excess of ascorbic acid.  However, 
after 60 minutes the inhibition was almost completely lost where concentrations of 
10 µM and 100 µM α-tocopherol were used with mean NMOR concentrations of 
9.55 (±0.71) µM and 9.28 (±1.17) µM respectively.  These concentrations of NMOR 
were not significantly different from the mean NMOR concentration in a two-phase 
model in the absence of lipid antioxidant which was 10.1 (±1.1) µM. 
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5.3.4 Ascorbic acid consumption during 30 minute experiments in a single and 
two-phase model in the presence and absence of α-tocopherol when 
ascorbic acid (1mM) is present in excess relative to the nitrite 
concentration (100µM) 
 
In single phase experiments the mean percentage of ascorbic acid present at 30 
minutes compared to the starting ascorbic acid was 37.2 (±4.1) %.  The biggest drop 
in ascorbic acid concentration occurs within the first few minutes after the addition 
of nitrite.  Similar mean percentages of ascorbic acid remaining at 30 minutes were 
found in a two-phase model using tributyrin, and also in a two-phase model where 
the lipid was made into several globules.  The mean percentages of ascorbic acid 
remaining at 30 minutes were 33.6 (±2.1) % for lipid in single globule and 36.2 
(±3.6) % for lipid in the form of several globules.  There is no statistical significance 
between any of the percentage ascorbic acid remaining at 30 minutes for these 
experiments (p=0.068). 
 
In a 2 phase model where the lipid antioxidant α-tocopherol was present, at a 
concentration of 10 mM (a concentration shown to inhibit nitrosation), the ascorbic 
acid present at 30 minutes was only 14.6 (±5.1) % that of the concentration.  This is 
a statistically significant reduction in the available ascorbic acid (p=0.00007).  There 
was no statistically significant difference when the lipid was present in globules with 
α-tocopherol present (p=0.29).  Similar results were found for α-tocopherol 
concentrations of 100µM and 1mM (figure 5.4). 
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Figure 5.4: The mean percentage ascorbic acid remaining at 30 minutes in different 
experimental models is shown.  In all experiments there was an initial 
excess of ascorbic acid to nitrite in the aqueous phase (1mM ascorbic 
acid to 100µM nitrite).  In 2 phase experiments the lipid had either no α-
tocopherol present or 10mM α-tocopherol (AT) present.  The lipid was 
either present as a single phase or as multiple globules (glob).  Data 
labels show mean percentages for each experimental condition.  Error 
bars represent 1 standard deviation. n=18 
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5.3.5 Ascorbic acid consumption during 30 minute experiments using pulsed 
nitrite in a single phase two-phase model with and without α-tocopherol  
 
There was rapid oxidation of ascorbic acid using several boluses of nitrite as 
compared to a single bolus.  When 10µM nitrite was added at time 0, 7.5, 15 and 
22.5 minutes, there was no detectable ascorbic acid at 30 minutes.  On changing the 
dose to 1µM nitrite there was little difference in the ascorbic acid concentrations at 
the beginning and end of the experiments.  A midrange nitrite concentration of 
2.5µM, pulsed into the two-phase model, at the same time intervals as before, was 
used in the absence of lipid antioxidant.  At the end of the 30 minute experiment the 
mean ascorbic acid percentage remaining was 61.6 (±17.2) %.  There was a 
considerable reduction in the concentration of ascorbic acid remaining when 
concentrations of 100 µM α-tocopherol and higher were present in the lipid phase 
(figure 5.5).  The mean percentage ascorbic acid remaining when 100 µM α-
tocopherol was present was 8 (±4) %.  With concentrations greater than 1 mM there 
was no ascorbic acid present at the end of the experiment and only a mean ascorbic 
acid percentage of 5 (±2) % at 15 minutes. 
 
 
 
 
 
 
 
 
 
153 
 
 
 
 
 
Figure 5.5: The mean % ascorbic acid remaining at given time intervals is shown 
for three different lipid designs in a two-phase model.  Into an acidic 
aqueous phase containing 100 µM ascorbic acid was added a 2.5 µM 
bolus of nitrite at times 0, 7.5, 15 and 22.5 minutes (this is represented 
by the arrows at the top of the diagram).  The lipid phase had one of: no 
antioxidant (AO) (green line), 100 µM α-tocopherol (red line) or 1mM 
present (blue line).   n=12 
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5.3.6 Α-tocopherol concentration from 2 phase model experiments in the 
presence of excess ascorbic acid (1mM) and in conditions where ascorbic 
acid (100 µM) will be consumed 
 
In 30 minute two-phase experiments with 100 µM α-tocopherol present in the 
lipid phase in the presence of excess ascorbic acid (1 mM) relative to nitrite (100 
µM), the mean α-tocopherol present at the end of the 30 minute experiment was 34 
(±7) µM.  In experiments where 100 µM ascorbic acid and 100 µM nitrite were 
added to otherwise the same experimental design, there was statistically significant 
reduction (p<0.01) in the mean α-tocopherol present, with a concentration of 8 (±6) 
µM.  When smaller concentrations of α-tocopherol were assessed, the results were 
more dramatic:  In experiments where 10 µM α-tocopherol was used in the lipid, 
with an excess of ascorbic acid (1mM), and 100 µM nitrite added, the mean α-
tocopherol concentration at 30 minutes was 7.2 (±0.4) µM.  However, when 100 µM 
nitrite was added to aqueous solution containing 100 µM ascorbic acid, there was no 
α-tocopherol present at 30 minutes in all twelve replicate experiments. 
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5.3.7 Ascorbic acid consumption in a three-phase model 
 
In the upper layer of a three-phase system, where the lipid phase has no 
antioxidant present, there was a mean % ascorbic acid, remaining at 30 minutes, of 
77.3 (±4.6) %.  The available ascorbic acid at 30 minutes when there was 10mM α-
tocopherol present was 71.9 (±3.1) % of the starting concentration.  The difference 
in available in ascorbic acid at 30 minutes in experiments with α-tocopherol is 
statistically significant (p=0.004) (figure 5.6).  
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Figure 5.6: Mean percentage ascorbic acid in the upper layer of a three-phase model 
compared to the original concentration is shown against the 30 minutes 
of the experiment.  The upper layer contained 150 µM ascorbic acid at 
pH 7.4 at the start of the experiment.  Experiments were initiated by 
adding 100 µM nitrite into a lower phase containing 1 mM ascorbic acid 
in an acidic aqueous phase.  NO generated in this lower aqueous phase 
diffuses through a middle lipid layer into the upper layer.  The middle 
layer was composed of triacetin supported on a hydrophobic membrane, 
with 10 mM α-tocopherol (AT) either present (red line) or absent (blue 
line).  n=12 
 
0
10
20
30
40
50
60
70
80
90
100
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30
% 
ascorbic 
acid
time (mins)
no AT
AT 10mM
p=0.004 
157 
 
5.4 Discussion 
 
The possible replenishment of the reducing capacity of α-tocopherol by 
ascorbic acid has been an area of interest for five or six decades.  Previous studies 
have provided contradictory evidence for this recycling process 
(174,175,263,264,265).  The experiments performed within this chapter would 
suggest that this process does occur, at least in an in vitro setting representative of 
the chemistry occurring at the gastroesophageal junction.   
 
Initially, our interest in this area of antioxidant recycling was stimulated by 
finding that the concentration of α-tocopherol required to inhibit nitrosation was 
only 10µM.  This is a surprisingly low concentration of antioxidant to inhibit the NO 
concentrations of over 80µM which were generated within this system.  This 
suggests that one molecule of α-tocopherol is able to scavenge many radicals. 
Normally one molecule of α-tocopherol would reduce one molecule of NO by a one 
or two electron transfer reaction (150).  Therefore 10µM of α-tocopherol would only 
be expected to reduce 10µM of NO.  We also found that when the time course of the 
experiment was increased from 15 to 60 minutes, the inhibitory effect of α-
tocopherol was largely overcome, as 9.55 (±0.71) µM NMOR was produced at 60 
minutes when 10µM α-tocopherol was present in the lipid phase.  This loss of 
inhibition of nitrosative stress was also observed when a smaller concentration of 
aqueous ascorbic acid relative to initiating nitrite concentration was used in a two-
phase model.  It is known that one molecule of ascorbic acid will convert two 
molecules of NO (137).  Therefore, in the model used, the ascorbic acid would be 
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expected to be consumed and this was confirmed in our experiments.  In fact, 
ascorbic acid was consumed within 5 minutes of the addition of nitrite.   A proposed 
explanation for the results seen in our model using low concentrations of ascorbic 
acid is that a small concentration of ascorbic acid was quickly consumed in 
inhibiting nitrosative stress within the lipid phase, so that there was little 
regeneration of oxidised α-tocopherol by ascorbic acid.  Therefore, nitrosation of the 
morpholine was able to take place uninhibited after the small concentration of α-
tocopherol was consumed.  Consequently, this means that NMOR produced in a 
two-phase model with 10µM α-tocopherol, and a reduced concentration of ascorbic 
acid, is much greater than the NMOR concentration where ascorbic acid 
concentrations are in excess. 
 
In the models used in these experiments we were able to control the aqueous 
and lipid phases, and also able to sample relevant concentrations of the chemical 
reagents from them.  This allowed us to measure directly the ascorbic acid and α-
tocopherol concentrations.  This required minor revisions to our method of ascorbic 
acid measurement, as initially some of the samples were too dilute.  Nevertheless, 
once this problem was overcome, accurate measurements of ascorbic acid 
concentration were able to take place.   
 
In a single phase model, where ascorbic acid was in the aqueous phase to 
excess compared to the nitrite concentration added, the ascorbic acid concentrations 
fell quickly in the initial few minutes, and then there was only a gradual loss of 
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ascorbic acid and increase in dehydroascorbic acid.  This reflects the fact that the 
ascorbic acid is initially reacting with nitrous acid to generate NO.  This reaction 
occurs rapidly in the first few minutes and thereafter there is a recycling of this 
process, as NO reacts with O2 to form RNOS such as N2O3, and ascorbic acid reacts 
with this to form further NO (248).  This process gradually reduces the available 
ascorbic acid.  In our single phase model there was initially total consumption of the 
O2, but after 10 minutes there was once again a measurable O2 concentration within 
the system.  Despite O2 being present there was not complete consumption of all 
ascorbic acid within this model.  There was a mean concentration of just over a third 
of the starting ascorbic acid available at 60 minutes.  In two-phase models, for both 
single globule and multiple globules of tributyrin, the ascorbic acid concentration 
profile with time, showed no significant difference to that found in the single phase 
system.  Although the aqueous chemical reactants were not changed by adding the 
lipid phase, given that NO is very lipophilic (251) it would be expected to diffuse 
into the lipid.  Despite this, the measurable NO and O2 were not significantly 
different in the single and two-phase models. Therefore, it is not surprising that the 
ascorbic acid concentrations were similar in these models.  However, in a two-phase 
model where α-tocopherol was present there was a significant reduction in ascorbic 
acid concentration as NMOR production is inhibited.  A proposed model for the 
chemical reactions occurring to account for these findings is shown in figure 5.7.   
 
At the gastroesophageal junction in humans it has been suggested that pulses, 
rather than a one off bolus of NO, are generated after foodstuff has been swallowed 
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(221).  The pulsing of NO leads to pulses of nitrosative stress and this appears to be 
more effective than a single bolus in overwhelming the antioxidant effect of ascorbic 
acid and α-tocopherol.  In our experiments using several boluses of nitrite there was 
a considerable increase in the oxidation of ascorbic acid to dehydroascorbic acid, 
and even at low concentrations of initiating nitrite, ascorbic acid was very quickly 
consumed. 
 
The three-phase model allowed us to look at an experimental model where the 
ascorbic acid was present in an environment with a constant O2 supply.  We were 
also able to control the delivery of NO into the acid rich environment with ascorbic 
acid present as the NO diffused through a lipid layer into the aqueous environment 
from where the ascorbic acid was measured.  The phase from which the ascorbic 
acid was being measured was representative of the epithelial compartment.  This 
means that the ascorbic acid in this compartment was in a different aqueous phase 
from the ascorbic acid that was involved in the generation of NO from nitrite.  This 
may partly explain why the consumption of ascorbic acid in this phase was not as 
great as had been seen in two-phase experiments with the same concentrations of α-
tocopherol present. It is likely that most of this difference was due to the 
concentration of NO that was present in the upper layer.  Nonetheless the difference 
in ascorbic acid oxidation between experiments where higher concentrations of α-
tocopherol were present and absent was statistically significant.  There was not a 
significant difference in ascorbic acid oxidation when the concentration of α-
tocopherol was less than 1mM.  This may be due to effective recycling of the α-
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tocopherol by ascorbic acid from the lower compartment.  It is likely that most of the 
nitrosative stress was occurring at the interface between the lower and middle layers. 
 
The in vitro models do not fully represent the in vivo setting, in that there was 
neither the full array of chemical reactants in the epithelial compartment to generate 
all the possible nitrosating compounds nor the physical conditions such as blood 
flow.  However, the experiments discussed in this chapter add to the body of 
evidence to support a process of recycling between ascorbic acid and α-tocopherol. 
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Figure 5.7: Proposed method of recycling of α-tocopherol by ascorbic acid.  In the 
reaction of NO with O2 in the luminal compartment nitrite is formed.  
Nitrite is reduced to NO by ascorbic acid, which is oxidized to 
dehydroascorbic acid.  In the lipid NO and O2 react to form nitrite and 
nitrosating species such as N2O3.  In the presence of α-tocopherol N2O3 
forms NOx (including NO) while α-tocopherol is oxidized to 
tocopheroxyl radical.  The ascorbic acid is able to replenish α-
tocopherol through its conversion from the tocopheroxyl radical.  In this 
process the nitrosation of amines is inhibited.  
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Chapter 6  Development of silastic tubing model suitable for measuring in vivo 
nitrosative stress 
 
6.1  Introduction and Aims 
 
N-nitrosation from dietary nitrate may be, in part, responsible for the increasing 
incidence in adenocarcinoma at the gastroesophageal junction.  Work presented in 
this thesis adds to the growing body of evidence, (44,144,221,222) from in vitro 
work, suggesting that there is the chemical potential for nitrosation at and around the 
gastroesophageal junction in the healthy acid-secreting stomach.  However, there has 
not been any previous in vivo work that effectively assesses N-nitrosation, in the 
presence of ascorbic acid, in this region.  The purpose of the following study was to 
develop an in vitro model that would measure nitrosation and could subsequently be 
used in vivo.  The tubing had therefore to be suitable not only to allow nitrosation 
within the lumen, but also be comfortable for a human subject to swallow.  The 
tubing would thereafter sit within the oesophagus and stomach, straddling the 
gastroesophageal junction.  It was considered important to know what was 
happening chemically along the length of the tube at various sites within the upper 
gastrointestinal tract, therefore the tubing had to be compartmentalised into 
chemically distinct and intact segments of a given length.  There have been previous 
studies examining nitrosative stress in bench top models, using silastic tubing to 
form an epithelial compartment (44).  These studies showed that in conditions 
simulating the healthy proximal stomach and gastroesophageal junction, there was 
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accumulation of nitrite and N-nitrosamine within an amine rich neutral environment, 
contained in a silastic tube lumen.  The silastic tubing used in these experiments was 
very thin, with an internal diameter of 500µm and wall thickness of 250µm.  Such 
tubing would therefore not be suitable for easy passage into the upper 
gastrointestinal tract, and the volumes contained within a 1cm section of this tubing 
would be very small, resulting in too small a volume for chemical analysis.  The aim 
of this chapter was to develop the silastic tubing model further, such that it could be 
used in human subjects.  
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6.2  Experimental design 
 
6.2.1 Silastic Tubing 
 
It has been shown in vitro that a hydrophobic silastic membrane has similar 
properties to an epithelial membrane, in terms of NO and O2 diffusion (273-276).  
Previous work has shown nitrosative stress within the lumen of the tubing made 
from such material, when NO has been present outside and a nitrosatable compound 
inside (44).  Silastic tubing from Altec was used (Altesil High Strength Silicone 
Tubing, Altec, UK).  This is a blended silicone elastomer tubing which is non toxic 
and translucent, also known as polydimethylsiloxane.  It withstands a maximum 
temperature of 220
o
C and a minimum temperature of -55
o
C with a density of 
1.13g/cm
3
.  The core diameter had to allow a volume adequate for subsequent 
analysis of a contained liquid, while the thickness of the silastic wall had to be 
suitable for diffusion of O2 and NO.  Silastic tubing of core diameter 2.5 mm and 
wall diameter 0.5 mm was chosen, as this allowed internal content of 80-100 µL per 
1.5 cm length of the tube, while allowing diffusion of NO and O2 through the wall. 
 
6.2.2 Compartmentalisation of silastic tubing 
 
In order to determine nitrosation occurring at different sites along the upper 
gastrointestinal tract, the silastic tube had to be compartmentalised into chemically 
distinct sections.  Compartments were made at approximately 1.5 cm intervals along 
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the tubing after filling the lumen with a solution of pH 7.4, with a range of 
concentrations of morpholine present.  To ensure that the tubing was adequately 
compartmentalised and that each individual compartment would not receive 
contamination from neighbouring compartments, the tubing was twisted at the 
appropriate length (1.5 cm).  Over the top of this twist a double knot was applied 
using vicryl suture ties (Ethicon, Gibco, Paisley, UK).  The double knot was placed 
at both ends of the twist.  
 
Several studies were performed to ensure that the compartmentalisation was 
successful, both in terms of direct fluid contamination between segments, and also as 
regards gaseous contamination along the length of the tubing.  In order to be of any 
value the silastic tubing had to be compartmentalised into sections that could later 
provide detail on nitrosative stress related to the anatomy of the upper 
gastrointestinal tract.  The integrity of the sections, therefore, had to be maintained 
both in the liquid and gaseous phases.  This is particularly important as it is known 
that NO diffuses through lipids rapidly (251,273).  Such diffusion could alter where 
nitrosative stress would appear to be occurring in relation to sections of the tubing, 
thus misrepresenting the true site.  Fluid volume from within the lumen was 
removed using a glass syringe and this sample was subjected to analysis for nitrite 
and NMOR concentrations. 
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6.2.3 Experimental models used 
 
 
Four different models were used in the following experiments.  All of the 
models are similar but there are significant differences that allow different aspects of 
the chemistry, and of the silastic tubing, to be assessed. 
 
Model 1 - This was the basic model used within this chapter. It can be used to 
generate NO in aqueous phase with silastic tubing present.  It was set up as follows: 
A 50 mL glass scintillation vial was filled with:  Hydrochloric acid pH 1.5, 
ascorbic acid (1 mM), EDTA (1 mM), NaSCN (1 mM), and varying concentrations 
of NaNO2 (10-100µM). 
Silastic tubing, filled with varying concentrations of the secondary amine 
morpholine (5 mM, 10 mM, 25 mM and 100 mM) buffered to pH 7.4 using 100 mM 
PBS, was placed into the scintillation vial and completely surrounded by the 
aqueous solution within the glass vial (figure 6.1). 
 
The model was placed in a water bath at 37
o
C for 15 minutes.  From previous 
studies we know that in an acidic environment in the presence of a reducing agent 
such as ascorbic acid, the nitrous acid formed in an acidic environment from nitrite, 
is converted to NO.  It can therefore be expected that NO will be formed in the 
aqueous environment in the scintillation vial.  This will diffuse through the silastic 
tubing wall and, through the formation of nitrosating species (principally N2O3), will 
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nitrosate the morpholine to form NMOR.  A large accumulation of nitrite would also 
be expected intraluminally in the silastic tubing.   
 
At the end of the 15 minute incubation, the silastic tubing was taken out of the 
scintillation vial and laid lengthwise along a bench.  The fluid from each individual 
compartment was then removed, using a 100 µL steel Thomson syringe.  Of this 
volume, 10 µL was taken for nitrite analysis and 40 µL was subjected to an 
extraction process for NMOR.  These experiments were repeated twelve times. 
 
Model 2 – This was a modification of the basic model to allow for assessment 
of diffusion of NO along the length of the tubing causing contamination of 
neighbouring compartments which had not been directly exposed to NO.  In order to 
do this we modified the in vitro experiment to only submerge half of the tube rather 
than the entire length.  Therefore only four out of the eight were being exposed 
directly to NO.  Morpholine (25 mM) was present in the tube to allow assessment of 
nitrosation.  If nitrite and NMOR were detected in the unexposed compartments it 
would suggest that there had been diffusion through either the wall of the tubing, or 
through the knots which are meant to be compartmentalising the tube.  In all 
experiments involving model 2, the added nitrite concentration was 100 µM (Figure 
6.2). 
 
Model 3 – In this model there was a coating of α-tocopherol on either the 
inside or outside of the silastic tubing.  To coat the outside of the tubing 
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concentrated >96% a-tocopherol was smeared along a length of it.  To coat the 
inside of the tubing concentrated >96% a-tocopherol was injected into the lumen and 
then squeezed through the inside of the tube to form a thin film along its length.  The 
tubing was then placed such that it passed through two beakers.  In Beaker 1 it was 
exposed to an aqueous environment in the presence of nitrite, and in Beaker 2 the 
aqueous environment had ascorbic acid in addition to the nitrite.  This allowed us to 
determine the effect of HNO2 versus NO.  The nitrite concentration used was 1mM 
NaNO2, to allow for more in the way of α-tocopherol induced nitrosative stress, in 
the absence of ascorbic acid, to occur.  The concentration of ascorbic acid present in 
Beaker 2 was increased to 5mM to allow for excess ascorbic acid over nitrite in 
these experiments.  The silastic tubing was compartmentalised such that in each 
beaker there was one compartment with α-tocopherol either inside or outside the 
tubing.  In all experiments, the incubation lasted 15 minutes before removing the 
silastic tubing fluid for nitrite analysis (Figure 6.3).   
 
Model 4 - In this model experiments were performed with α-tocopherol 
smeared on the outside of the tubing, while varying the pH of the tubing contents 
through 0.6, 1.5, 2.5, to 4.5.  Thiocyanate was also either present or absent within 
the tubing.  The surrounding conditions in the aqueous phase were HCl (pH 1.5), 
EDTA (1 mM), NaNO2 (1 mM) and NaSCN (1 mM).  There was no ascorbic acid in 
the aqueous phase (Figure 6.4).  All experiments were replicated twelve times.  
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Figure 6.1: Model 1 was composed of two parts.  A silastic tubing filled with a 
range of concentrations of the secondary amine morpholine buffered to 
pH 7.4 by PBS.  The silastic tubing was surrounded by an aqueous 
phase within a glass scintillation vial.  The aqueous phase consisted of 
HCl (pH 1.5), ascorbic acid (1 mM),  EDTA (1 mM), NaSCN (1 mM), 
and a reaction forming NO was initiated by the addition of varying 
concentrations of NaNO2 (10 µM, 25 µM, 50 µM, 100 µM).  The model 
was placed on a magnetic hot plate to keep the aqueous phase at 37
o
C, 
under constant stirring. 
 . 
 
Magnetic hot plate 
Silastic tubing: pH 7.4 PBS 
With varying concentrations 
MOR 
Aqueous phase: HCl (pH 
1.5), ASC (1mM), EDTA 
(1mM), NaSCN (1mM), 
varying concentrations 
NaNO2 (10-100µM).  Total 
volume 50 mL. 
Waterbath: 
Temp 37
o
C 
Magnetic stirrer 
Scintillation vial 
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Figure 6.2: In model two the silastic tube contained 25 mM morpholine buffered to 
pH 7.4 by 100 mM PBS.  The tube was compartmentalized into 8 
sections.  Only sections 3-6 of the tubing were exposed to the aqueous 
phase contained within a glass scintillation vial.  Sections 1, 2, 7, 8 lay 
exposed to air only.  Section numbers are shown in the above diagram.  
The aqueous phase had a total volume of 50 mL, and consisted of HCl 
(pH 1.5), EDTA (1 mM), NaSCN (1 mM) and ascorbic acid (1 mM).  
100 µM NaNO2 was added to the aqueous phase to initiate the 
generation of NO.  The model was placed on a magnetic hot plate to 
keep the aqueous phase at 37
o
C, under constant stirring. 
 
 
Magnetic hot plate 
1 
2 
3 
4 5 
6 
7 
8 
Aqueous phase: HCl 
(pH 1.5), ASC (1mM), 
EDTA (1mM), NaSCN 
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(100µM).  Total volume 
50 mL 
 
 Waterbath: 
Temp 37
o
C 
 
Magnetic stirrer 
 
Silastic tubing: PBS (pH 
7.4), 25mM MOR, 
compartmentalised into eight 
sections 
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Figure 6.3: Model 3 consisted of two glass beakers of 50 ml total volume.  In 
beaker 1 there was HCl (pH 1.5) with NaSCN (1 mM), EDTA (1 mM) 
and NaNO2 (1 mM).  Beaker 2 had the same contents as beaker 1 but 
with ascorbic acid.  Two sections of silastic tubing were then placed 
into each of the beakers, while four others lay out with.  The lumen of 
the tubing contained PBS (pH 7.4), EDTA (1 mM) and in one section of 
tubing per beaker a thin lining of concentrated >96% α-tocopherol (α-
TP).  In each beaker, exposed to the aqueous phase, a control length of 
tubing had no α-tocopherol present.  The model was placed on a 
magnetic hot plate to keep the aqueous phase at 37
o
C and to allow 
stirring of the beaker contents through a magnetic stirrer. 
 
Magnetic hot plate 
Waterbath 
37
o
C 
Magnetic stirrer 
BEAKER 2 
Aqueous phase (50 
mL): pH 1.5HCl, 
1mM NaSCN, 
1mM EDTA, 1mM 
NaNO2, 5mM 
ascorbic acid 
BEAKER 1: Aqueous phase: 
pH 1.5HCl, 1mM NaSCN, 
1mM EDTA, 1mM NaNO2 
Silastic tubing: pH 7.4 PBS, 1mM 
EDTA ± α-tocopherol on the INSIDE  
or OUTSIDE of the lumen (yellow) 
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Figure 6.4: In model 4 silastic tubing was coated with concentrated α-tocopherol on 
the outside while in others the silastic tubing was unaltered.  Silastic 
tube luminal pH was one of 0.6, 1.5, 2.5 or 4.5 adjusted by using HCl 
and PBS.  NaSCN (1 mM) was either absent or present in the silastic 
tubing.  The tube was placed into a glass beaker containing an acidic 
aqueous phase.  The aqueous phase was made up of HCl (pH 1.5), 
EDTA (1mM), NaSCN (1 mM) and NaNO2 (1mM) was added to 
initiate the reaction.  In all experiments using this model there was no 
ascorbic acid present. 
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Silastic tubing: Range 
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o
C 
Magnetic stirrer 
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6.3 Results 
 
6.3.1 Experiments using silastic tubing in model 1 
 
6.3.1.1 NO concentrations within the aqueous phase  
 
NO was generated in the aqueous phase of model 1, at a peak concentration of 
89 (± 4) µM at time 30 seconds, and continued to be produced in high concentrations 
throughout the time course of the experiments, when the 100 µM nitrite was the 
concentration added to the experimentantal model (figure 6.5).  The relationship of 
NO produced was linear to the concentration of nitrite added (r
2
=0.96) (figure 6.5). 
 
6.3.1.2 Silastic Tubing Nitrite Concentration 
 
The mean silastic tubing nitrite concentration at 15 minutes when 100µM 
nitrite was added into the aqueous phase of the bench top model was 705 (±25) µM.  
When other concentrations of nitrite were added to the aqueous environment the 
silastic tubing mean nitrite concentration showed a linear relationship (r
2
=0.92) to 
the concentration of nitrite added as shown in figure 6.6.   
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Figure 6.5: Mean NO concentrations within the aqueous phase of the model 1 are 
shown in relation to time (minutes).  Concentrations of NO are shown 
for four different concentrations of nitrite (10, 25, 50 and 100µM) which 
were added to the acidic aqueous phase containing 1mM ascorbic acid.  
Data labels show the mean concentration at 1 minute (maximal 
concentration) and 15 minutes. Error bars represent 1 standard 
deviation.  n=12 
  
0
46
40.2
89
82
0
10
20
30
40
50
60
70
80
90
100
µM 
NO
time (minutes)
10µM
25µM
50µM
100µM23 18
8.59
176 
 
 
 
 
 
 
 
Figure 6.6: Mean silastic tubing concentrations are shown at the end of a 15 minute 
experiment, where silastic tubing with a neutral luminal compartment 
was exposed to an acidic phase containing ascorbic acid, to which was 
added one of four nitrite concentrations (10, 25, 50 and 100µM) at time 
0 minutes. Data labels show the mean nitrite concentration within the 
lumen.  Error bars represent 1 standard deviation from the mean value.  
n=12 
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6.3.1.3  Silastic tubing NMOR concentrations with different silastic tubing 
morpholine concentrations 
 
Model 1 was used but on this occasion varying concentrations of morpholine 
were placed within the silastic tubing (5 mM, 10 mM, 25 mM, 33 mM, 50 mM and 
100 mM).  Keeping all other experimental conditions the same, there was an 
increase in the mean NMOR concentration formed as the morpholine concentration 
was increased (figure 6.7).  However, this relationship was not linear (r
2
=0.69).  
When 100 µM nitrite was added to the aqueous phase surrounding the silastic 
tubing, the mean concentration of NMOR at 15 minutes, when 5 mM morpholine 
was present within the tubing, was 8.24 (± 3.11) µM.  The mean silastic tubing 
NMOR concentrations at 15 minutes was 49.0 (±13.9) µM, when 25 mM 
morpholine was present within the tubing at the start of the experiment.  This 
represents a nitrite to NMOR ratio of 1:14. 
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Figure 6.7: NMOR concentrations (µM) in the silastic tubing at the end of a 15 
minute incubation, according to the concentration of secondary amine 
present (5, 10, 25, 33, 50, 100 mM).  The tube was exposed to an acidic 
aqueous phase in the presence of ascorbic acid, with 100 µM sodium 
nitrite added to initiate the experiment.  Data labels show the mean 
NMOR concentration within the tube.  Error bars represent 1 standard 
deviation from the mean. n=12 
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6.3.2 Compartmentalisation of silastic tubing using Model 2 
 
Two separate experiments were performed to assess for compartmentalisation.  
The first of these experiments looks at physical compartmentalisation in the aqueous 
phase, while the second experiment determines the effectiveness of 
compartmentalisation as regards the diffusion of gaseous NO. 
 
6.3.2.1 pH Studies to determine successful compartmentalisation of 
silastic tubing in Model 2 
 
This experiment was performed to assess for liquid compartmentalisation of 
the silastic tubing into sections.  Into one open end of the silastic tube was 
introduced a solution of HCl (pH 1.5) using a Thomson injector needle, while into 
the other end was added PBS (pH 7.4).  The pH was recorded at the start of the 
experiment, and also at the end of twelve hours to allow for any diffusion.  This 
experiment was repeated six times.  There was no recordable-statistical difference 
between the starting pH and the final pH in any of the experiments, indicating that 
there was no liquid diffusion contamination (table 6.1). 
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Table 6.1: Starting and finishing pH in 12 hour aqueous diffusion experiment to 
assess compartmentalisation of silastic tubing 
 
 Starting pH 
(average of 6 
experiments) 
Finishing pH 
(average of 6 
experiments) 
Acid  
Compartment 
 
1.5 ± 0 
 
1.51 ± 0.01 
Neutral 
Compartment 
 
7.4 ± 0 
 
7.38 ± 0.03 
 
 
6.3.2.2 Studies to Assess Gaseous Contamination of Neighbouring 
Sections of Tubing 
 
Given that NO can diffuse through the membrane, these studies were 
undertaken to determine whether NO could diffuse through the length of the wall of 
the tubing and contaminate neighbouring sections.  Model 2 allows us to assess for 
nitrosation, by measuring nitrite and NMOR from sections deliberately exposed to 
NO, as opposed to neighbouring sections deliberately not exposed to NO.  In this 
model 100 µM nitrite was added to the aqueous phase containing ascorbic acid.  
Results from this model show that only those compartments exposed to NO had 
significant concentrations of nitrite and NMOR (table 6.2).  The concentration of 
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nitrite in those compartments not exposed to NO was 5 (±2) µM, while the average 
concentration in the compartments exposed to NO was 689 (±36) µM.  The mean 
NMOR in the compartments exposed to NO was 50.13 (±11.5) µM while no 
detectable NMOR was found in any of the compartments not subjected to NO. 
 
Table 6.2: Luminal NMOR (μM) and NO2 (mM) ± SD according to the section of 
silastic tube analysed at 15 minutes 
 
Compartment Submerged in 
NO containing 
aqueous phase 
Mean nitrite 
µM (±SD) 
Mean NMOR 
µM (±SD) 
1 No 3 (±2.5) N.D. 
2 No 8 (±3.0) N.D. 
3 Yes 705 (±35) 53.8 (±9.5) 
4 Yes 657 (±28) 48.1(±10.6) 
5 Yes 721 (±42) 46.3 (±11.0) 
6 Yes 676 (±39) 52.3 (±14.7) 
7 No 7 (±1.5) N.D. 
8 No 5 (±0.5) N.D. 
 
This series of results demonstrates appropriate compartmentalisation such that 
there is no aqueous diffusion through the twists and no diffusion of NO along the 
length of the silastic tubing. 
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6.3.3  Studies using model 3 with α-tocopherol on the outside and inside of the   
tube with luminal pH 1.5 
 
Comparison between tubing smeared with α-tocopherol on the inside and the 
tubing not so treated showed that, in the presence of ascorbic acid, when the tube 
was exposed to 1 mM acidified nitrite, there was a significant reduction in the nitrite 
concentration where α-tocopherol was present (p=0.0000002) (figure 6.8).  The 
mean nitrite concentration in the tubing without α-tocopherol was 1831 (± 60.5) µM 
whereas the mean nitrite concentration was 1172 (± 65.6) µM when α-tocopherol 
(1mM) was present.  In the absence of ascorbic acid there was a doubling in the 
mean nitrite concentration when α-tocopherol was present inside the tubing 
(p=0.000006).  In experiments where there was no ascorbic acid there was a mean 
nitrite concentration of 229 (± 32.7) µM in tubing without α-tocopherol compared to 
478 (± 20.1) µM when α-tocopherol was present inside the tubing.  For experiments 
with α-tocopherol smeared on the outside of the tube, in the absence of ascorbic 
acid, the mean nitrite concentration from the inside of the tubing was 838 (± 45) µM.  
This reflects a four fold increase in nitrite concentration as compared to studies 
where there was no ascorbic acid and no α-tocopherol (p=0.0000004), and is double 
the concentration compared to when α-tocopherol is on the inside of the tubing.  
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Figure 6.8: The mean silastic tubing nitrite under different experimental 
conditions after the addition of 1mM sodium nitrite into an acidic 
aqueous phase surrounding silastic tubing.  The different experimental 
conditions are in the absence of ascorbic acid (asc) and α-tocopherol 
(α-TP) (dark blue column), absence of ascorbic acid with concentrated 
α-tocopherol smeared on the inside of the tubing (red column), in the 
absence of ascorbic acid with concentrated α-tocopherol smeared on 
the outside of the tubing (green column), 5mM ascorbic acid present in 
the aqueous phase with concentrated α-tocopherol smeared on the 
inside of the tubing (purple column), 5mM ascorbic acid present 
within the aqueous phase with no α-tocopherol present (light blue 
column).  Data labels show mean values.  Error bars represent 1 
standard deviation. 
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6.3.4  Model 4 with Α-tocopherol on the outside of silastic tubing with varying 
pH of the luminal silastic tube compartment and no ascorbic acid in the 
aqueous phase 
 
At pH 4.5 no nitrite was found within the tubing whether thiocyanate was 
present or not.  In experiments with reduced pH, there was increased nitrite 
formation within the tubing in the presence of α-tocopherol, with six times the nitrite 
concentration present at pH 0.6 compared to pH 2.5 (p<0.001) (figure 6.9).  
Thiocyanate made the greatest percentage increase in silastic tube nitrite, in the 
presence of α-tocopherol when the pH was 1.5, as it led to over a doubling of nitrite 
concentration compared to when α-tocopherol was present alone (326 μM to 823 
μM).  At a pH of less than 4.5 the acidity of the solution made no difference to the 
effect of thiocyanate on silastic tube mean nitrite concentrations, in the absence of α-
tocopherol (p>0.2).  There was also no difference in silastic tube mean nitrite across 
the range of pH’s less than 4.5 in the absence of both thiocyanate and α-tocopherol 
(p>0.05).    
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Figure 6.9: The mean nitrite concentration within silastic tubing with different pH 
of the silastic tubing compartment.  Within the silastic tubing there was 
one of four experimental conditions.  There was a combination of the 
presence or absence of α-tocopherol (αTP) and thiocyanate (SCN).  The 
tubing was bathed in an acidic aqueous phase which always contained 
EDTA (1 mM), NaSCN (1 mM) and ascorbic acid (5 mM), and to 
which was added NaNO2 (1 mM) to initiate the generation of NO. Data 
labels show the mean nitrite concentration.  Error bars represent 1 
standard deviation. n=12 
 
 
1852
823
319
0
213 198 173
0
1263
326
237
0
208 190 198
0
0
500
1000
1500
2000
2500
pH 0.6 pH 1.5 pH 2.5 pH 4.5
µM 
nitrite
pH of silastic tube lumen
αAT + SCN
SCN only
αAT only
neither 
p<0.001
p<0.001
186 
 
6.4 Discussion 
 
This chapter describes the design of a useful model for nitrosative stress in 
vitro which can be transferred to the in vivo setting.  Silastic membranes have been 
known to behave in a similar way to epithelial lipid membranes, in terms of NO and 
O2 diffusion, for some time, and have been successfully used in several different 
experimental models (44,273-277).  In previous studies, silastic tubing had been 
used to show nitrosative stress in bench top models of the chemistry occurring in the 
upper gastrointestinal tract, where salivary nitrite meets acidic gastric juice (44).  We 
have taken this model and made adjustments to provide a potentially useful tool for 
in vivo studies.  This model has had to be developed in stages to show robustness, 
allowing its use in vivo, while still demonstrating nitrosative stress.  The model has 
been adapted further still, to create a more physiologically representative situation 
where lipid antioxidants are also present.  The use of lipid antioxidants in this setting 
has provided information relating to the chemistry of nitrosative stress, secondary to 
the generation of NO from nitrite.  
 
In model 1, after the addition of nitrite to the acidic aqueous phase in the 
presence of ascorbic acid, NO is generated.  NO will rapidly diffuse into and through 
the silastic membrane (120,251).  As NO passes through the silastic tubing, it reacts 
with O2 to form N2O3, (273).  N2O3 can then nitrosate secondary amines such as 
morpholine (120,278).  N2O3 also reacts with water in the neutral pH of the lumen of 
the tubing, to form nitrite (279).  The nitrite formed in this way is trapped within the 
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lumen and is indicative of the flux of NO into the tubing.  The exact NO 
concentrations generated within the lumen of the human upper gastrointestinal tract, 
at any one time, depend mainly on the delivery of nitrite from saliva.  There is 
evidence that after a nitrate rich meal there, high concentrations of NO in excess of 
100µM are produced (43,45,280).  This study, showed that across a range of NO 
concentrations from 10-100µM detectable levels of nitrite are generated within the 
neutral lumen of silastic tubing.  This is particularly useful information, as the 
thickness of the wall of tubing used in these experiments was considerably greater 
than those used in a previous model developed by Iijima et al (44).  It may have been 
that with the increased thickness, there was not sufficient passage of NO to generate 
nitrosative stress, at the concentrations of NO we expect to find in vivo.  The 
thickness of the tubing was increased to facilitate passing it nasogastrically, without 
coiling in the oropharynx.  This also allowed us to use a tube with a greater internal 
capacity, and thus provide us with more volume for subsequent nitrite and NMOR 
analysis.  The silastic tubing nitrite concentrations increased linearly with the 
increase in aqueous phase NO concentrations used in these experiments making the 
tubing a useful tool for measuring the amount of nitrosative stress produced over the 
range of NO concentrations we would expect to encounter at and around the 
gastroesophageal junction. 
 
There was an increase in the NMOR concentration generated as the 
concentration of morpholine was increased within the silastic tubing, although this 
relationship was not linear.  At the concentrations of NO we may expect to find in 
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vivo after a nitrate meal, the most suitable morpholine concentration was 25mM as 
this provided a NMOR concentration which was within the range of concentrations 
which were easily measurable, using the same nitrosamine analysis and calculations 
as were already in place for previous experiments.   The simultaneous increase in 
NMOR and nitrite suggests this is largely mediated by NO produced by the reaction 
of nitrite with ascorbic acid, in the acidic aqueous phase of model 1.  Previous work 
has shown that in the absence of ascorbic acid in the aqueous phase, there was 
accumulation of nitrite within the luminal compartment of silastic tubing, although 
the concentration found was not as high as when ascorbic acid was present.  
However, only very low concentrations of silastic tubing N-nitrosamine were formed 
when there was no ascorbic acid present.  The accumulation of some nitrite can be 
partly explained by nitrous acid passing through the membrane, and also by 
chemical species such as N2O3 passing through the membrane in small 
concentrations into the lumen of the tubing, where they can then be oxidised to 
nitrite (44).   
 
In order to be useful for defining anatomical areas of increased nitrosative 
stress there had to be compartmentalisation of the silastic tubing into small sections.  
To provide enough volume from the lumen, the tubing was divided into individual 
sections every 1.5 cm.  This section length was also the smallest, technically 
feasible, with the diameter of tubing and the tying required.  Several different 
methods of forming suitable compartments were attempted before the method 
described above was proven to be successful.  The compartmentalisation had to be 
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intact, so that there was no aqueous diffusion between neighbouring sections.  pH 
studies confirmed that there was little if any diffusion of aqueous contents of the 
tubing between sections.  As NO is very lipophilic (251), we also had to ensure that 
there was no diffusion of NO along the length of the tubing, into neighbouring 
sections.  The results presented confirm that there is minimal, if any, NO diffusion 
along the length of the tubing.  Therefore, if a section of the tube is situated within a 
certain anatomical region, then the nitrite and NMOR concentrations from that 
section represent the nitrosative stress arising at that anatomical location. 
 
The last part of this chapter looks at the presence of α-tocopherol inside and 
outside the silastic tubing.  The intention in using α-tocopherol, had been to build up 
a physiologically relevant model, which was more representative of the conditions in 
vivo.  There were limitations using models 3 and 4.  The most important is that 
controlling the exact concentration of α-tocopherol smeared along the tubing was not 
possible.  It may also be that where α-tocopherol was smeared on the outside of the 
tubing there was some of the lipid antioxidant distributed into the aqueous phase as 
small particles.  There were, however, some interesting results from these studies.  
When ascorbic acid was present in an aqueous phase, α-tocopherol within the tubing 
resulted in a reduction in silastic tube nitrite of approximately 35% compared to 
when there was no α-tocopherol.  However, in the absence of ascorbic acid in the 
aqueous phase α-tocopherol inside the tubing led to more than a doubling of the 
silastic tube nitrite concentration compared to when there was neither ascorbic acid 
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or α-tocopherol.  The silastic tube nitrite concentration was higher still when α-
tocopherol was smeared on the outside of the tubing, in the absence of ascorbic acid.   
 
The reaction of α-tocopherol with NO was an area of much controversy in the 
mid 1990s.  Reports of a direct oxidant effect of NO with α-tocopherol generating α-
tocopheroxyl radical were suggested by several researchers (153-155).  Other groups 
found that α-tocopherol was stable in the presence of NO (157,281).  It appears that 
NO does not directly react with α-tocopherol, but rather α-tocopherol oxidation is 
due to oxidised metabolites of NO such as N2O3.  The oxidised products of α-
tocopherol include α-tocopheroxyl radical and α-tocopheryl quinine (158).  It has 
been suggested that, in this way, α-tocopherol acts as an antioxidant to an even 
greater extent than aqueous antioxidants.  Other studies have gone on to suggest a 
complex and as yet undefined oxidation process between α-tocopherol and NO, 
resulting in compounds such as the nitrite ester of α-tocopherol (282).  It is known 
that when nitrite reacts with tocopherol NO is generated (283,284).  This chemistry 
has relevance to the findings in our studies.  In the presence of ascorbic acid in the 
aqueous phase, NO is generated, and diffuses across the silastic membrane, where it 
reacts with O2 to form N2O3.  In the absence of α-tocopherol, nitrite will accumulate 
from the reaction of this N2O3 with water.  When α-tocopherol is present inside the 
tubing it will compete for the reaction with N2O3, resulting in less nitrite 
accumulating within the tubing.  In an acidic aqueous environment, but in the 
absence of ascorbic acid, and with no α-tocopherol associated with the silastic 
tubing, there is still a small accumulation of nitrite within the tubing.  This can be 
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explained by the fact that the pKa of nitrous acid is 3.23 and that in acidic 
environments nitrous acid is produced.  This nitrous acid will diffuse across the 
silastic membrane, although the rate of diffusion of this molecule will be 
considerably slower than the highly lipophilic NO molecule.   
 
When α-tocopherol was smeared on the outside of the silastic tubing nitrite, and 
nitrous acid, will react with α-tocopherol in the aqueous phase of the model, 
producing NO which then diffuses across the silastic membrane into the aerobic 
neutral environment, producing nitrite within the lumen of the tubing.  This can 
explain the high nitrite concentrations in silastic tubing when α-tocopherol was 
smeared on the outside of the tubing in the absence of aqueous ascorbic acid.  That 
proposed mechanism of the production of α-tocopherol derived NO facilitates its 
diffusion from aqueous phase to silastic tubing is supported by results showing an 
altered intraluminal silastic tubing pH and the presence or absence of thiocyanate.  A 
silastic tubing pH of 4.5 is above the pKa of nitrite (pKa 3.23).  This explains why 
there was no accumulation of nitrite in any of the experimental conditions where α-
tocopherol was smeared on the outside of the tubing.  As the pH within silastic 
tubing became more acidic there was a proportional rise in silastic tubing nitrite 
concentrations when α-tocopherol was present on the outside of the tubing.  There 
was no change in the silastic tubing nitrite concentrations with thiocyanate in the 
absence of α-tocopherol as the pH was more acidic.  The presence of thiocyanate 
does however lead to higher nitrite concentrations in the presence of α-tocopherol.  
These findings suggest that the increase in epithelial nitrite, when α-tocopherol was 
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smeared on the outside of the tubing in the absence of aqueous ascorbic acid, was 
influenced by the presence of nitrosating species and therefore largely NO mediated. 
 
 It was also found that, even when α-tocopherol was smeared on the inside of 
the silastic tubing, in the absence of aqueous ascorbic acid, there was an increase in 
nitrite accumulation.  In these experiments however, the concentration of nitrite 
within the tubing was only half that seen when α-tocopherol was smeared on the 
outside of the tubing.  This is a more difficult observation to explain but may be due 
to α-tocopherol incorporating its structure into the silastic membrane and thus 
presenting its polar antioxidant head into the aqueous nitrite rich environment where 
NO can be formed and subsequently diffuse over the membrane. 
 
The studies with α-tocopherol show the versatility of the silastic tubing model 
and how it could be manipulated to answer questions in vivo.  However, given that 
the concentrations of α-tocopherol cannot be accurately determined, and that some 
of the mechanisms behind the NO α-tocopherol interaction are yet to be defined, it 
would be premature to use this model in vivo at present. 
 
There is good evidence from the studies presented within this Chapter that the 
adapted silastic tubing with compartmentalisation into 1.5 cm segments, will 
potentially be able to provide accurate information on nitrosative stress at different 
sites in the upper gastrointestinal tract. 
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Chapter 7  In vivo studies to determine sites of nitrosative stress at and around 
the gastroesophageal junction in subjects with a healthy acid 
secreting stomach. 
 
The work presented within this Chapter was carried out in collaboration with Dr J 
Winter. 
 
7.1  Introduction 
 
This thesis has, so far, concentrated on bench top models to evaluate the 
chemistry occurring at and around the gastroesophageal junction, in relation to 
dietary nitrate.  It is however recognised that these models do not necessarily fully 
represent in vivo conditions. Thus far, it has not been possible to determine the 
dynamic effects of changing the luminal environment from normal to being rich in 
nitrite on human tissue.  It has been established that increased dietary nitrate leads to 
increased NO levels at the gastroesophageal junction (45).  It is proposed that the 
high concentrations of NO generated, at and around the gastroesophageal junction, 
will lead to nitrosative stress in those individuals with a healthy acid secreting 
stomach.  The compartmentalised silastic tubing, designed in Chapter 6, provides a 
tool for measuring nitrosative stress along the length of the oesophagus and stomach, 
and in particular around the gastroesophageal junction in human subjects.  The 
following studies were therefore performed to assess any nitrosative stress in the 
upper gastrointestinal tract in vivo in healthy volunteers.    
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7.2 Materials and Methods 
 
7.2.1 Silastic tubing  
 
Compartmentalised silastic tubing similar to Model 2 described in Chapter 6 
was created.  This tubing was filled with 25mM morpholine, which was buffered at 
intracellular pH 7.4 using 2mM phosphate buffer solution. Compartmentalisation of 
the tube into 21 compartments was performed as outlined previously (Chapter 6.2.2).  
In order to simultaneously monitor luminal pH, a customised four channel pH 
catheter was attached to the silastic tubing by tying with Vicryl sutures and securing 
with Sleek waterproof tape.  To assist passage of the tubing, a 5 cm length of 10F 
gastric tubing containing a radio-opaque marker was secured to the distal end of the 
pH catheter.   The radio-opaque marker was also used to locate the end of the tubing 
and ensure the tubing was sitting in the appropriate place in the stomach by 
radiography (Figure 7.1). 
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Figure 7.1:  Silastic tubing used in in vivo studies.  The sections shown represent the 
region that traversed the gastroesophageal junction.  The pH probe 1 
was in line with section 10.  This was the probe that was used to 
determine if there was significant reflux of acidic stomach contents into 
the oesophagus. The pH probes 2 and 3 were tied beside sections 13 and 
14.  These probes were used to determine the pH step up point where 
the acidic stomach contents met the neutral pH environment of the 
oesophagus, and thus helped to define the gastroesophageal junction in 
these healthy volunteers.  The individual sections were 15mm in length 
each containing approx 80-100 µL of PBS (pH 7.4) with 25 mM 
morpholine.  
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7.2.2 Healthy human subjects and protocol 
 
Six male volunteers were recruited, with a median age of 42 years.  Ethical 
approval for the studies was granted by the West Glasgow’s University NHS Trust 
Ethical Approval Committee.  The subjects were healthy volunteers with no history 
of reflux disease and were Helicobacter pylori negative on carbon urea breath 
testing.  These subjects attended, fasting, on two separate days.  On each day, they 
had the silastic tubing passed nasogastrically, such that sections 1-13 lay within the 
oesophagus and sections 14-21 lay within the stomach.  This was achieved using the 
pH sensors and confirmed radiologically (figure 7.2).  The tip of the tube lay 12 cm 
within the stomach.  Thirty minutes after the insertion of the tube, the subjects were 
administered one of the two study drinks.  On Day 1, the volunteer was given a 
control drink of 60 mL of water.  On Day 2, the volunteer was given 60 mL of water 
containing potassium nitrate (2 mmole).  This amount of KNO3 equates to the total 
in a standard meal of fish and chips 
 
The tube remained in situ for two hours after the drink had been ingested.  
During this time, the pH was monitored, using the four channel pH catheter, at each 
site every four seconds, giving a detailed assessment of the acidity around the 
gastroesophageal junction, and at points within the oesophagus and stomach.  
Immediately before the drink and at 15 minute intervals after it, a 1 mL saliva 
sample and a 10 mL blood sample were collected for measurement of serum nitrate 
and salivary nitrate concentrations.   
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Figure 7.2: Radiograph of the lower chest and upper abdomen, and 4 channel 
continuous pH study of a healthy volunteer with silastic tube in situ.  
The pH channel probes are radio-opaque and are shown together with a 
radio-opaque marker secured at the most distal end of the pH catheter.  
Sections 13 and 14 lay either side of the gastroesophageal junction, as 
recognised by the pH step up point between probes 2 (green) and 3 
(purple).  Probe 1 (red), adjacent to section 10, lay in the neutral pH 
oesophagus.  Probe 4 (blue), adjacent to section 19, lay within the more 
distal acidic stomach. 
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7.2.3 Serum nitrate analysis 
 
Blood samples (10 mL) were taken from a 20G i.v cannula sited in the 
antecubital fossa at times 0, 15, 30, 45, 60, 75, 90, 105 and 120 minutes.  The first 5 
mL of this sample were discarded to allow for dead space within the cannula.  The 
serum sample (2 mL) was stored at –20°C prior to analysis. On thawing, 400 µL of 
sample was centrifuged through a 10-kilodalton ultrafilter to remove high-
molecular-weight proteins. Samples were then mixed with a nitrate reductase in 
reaction buffer and analysed as described in Chapter 2.1.5.  
 
7.2.4 Salivary nitrite analysis 
 
Salivary samples of 1 mL were obtained, passively without stimulation of 
salivation, at times 0, 15, 30, 45, 60, 75, 90, 105 and 120 minutes.  Samples were 
mixed with 10 µL of 5.0 M NaOH. This rendered the samples alkaline and 
prevented loss of nitrite. Samples were stored at 4°C, then centrifuged and analyzed 
the same day, on 96-well microplates using the modified Griess reaction described 
in Chapter 2.1.4. 
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7.2.5 Silastic tube nitrite and NMOR concentrations  
 
Immediately after removal of the tube after 2 hours, each section of tubing was 
carefully aspirated using a 100 µL glass syringe.  A total of 10 µL of sample 
removed from each section of tubing was used for measurement of the silastic tube 
nitrite concentration, while 40 µL was used for analysis of NMOR.  Analysis for 
concentrations of nitrite and NMOR were carried out as described in Chapter 2.1.10. 
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7.3 Results 
 
7.3.1 pH studies  
 
During the study, only small pH variations at the electrodes lying either side of 
the gastroesophageal junction were recorded.  There were changes in pH at these 
sites mainly related to movement with respiration and on swallowing.  There was 
excursion of the tubing at the gastroesophageal junction of 3-4 cm with normal 
respiration as detected by fluoroscopic screening.  Actual reflux was recorded as a 
pH of less than 4 in the electrode placed 5 cm above the gastroesophageal junction 
(see figure 7.1 – probe 1 lying beside section 10 of the silastic tubing).  There was 
only one volunteer in whom reflux was observed and this was for a very short period 
of time.  It occurred only on the day that the control drink was given.  Overall, reflux 
was seen for a median of only 0.1% of the total time (interquartile range 0%-1.0%).  
The pH of section 13 which was primarily on the oesophageal side of the 
gastroesophageal junction had a pH of less than 2 for only 7% of the time, while 
section 14, which was mainly on the gastric side of the gastroesophageal junction, 
had a pH of less than 2 for 63% of the time.  Section 19 was always exposed to an 
acidic environment.  
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7.3.2 Serum nitrate 
 
The median serum nitrate concentration prior to the administration of the 
control drink was 16.9 (interquartile range, 7.9 - 20.3) µM.  45 minutes after the 
administration of the control drink, the serum nitrate concentration did not 
significantly change (p>0.05) from the basal reading, with a median concentration of 
14.1 (interquartile range, 7.2-17.7) µM and this continued to the case up to the end 
of the experiment at 120 minutes.  However, after ingestion of a 2 mmole potassium 
nitrate drink, a significant increase (p<0.005) in the median serum nitrate 
concentration was observed, from 12.7 (interquartile range, 6.9-16.1) µM on 
sampling prior to administration of the drink to a peak of 47.1 (interquartile range, 
23.2-57.9) µM 45 minutes after the drink was given.  The serum nitrate 
concentration remained at this higher level concentration for the duration of the 
study (figure 7.3). 
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Figure 7.3: Median serum nitrate concentration (µM) in healthy volunteers at the 
given time intervals (minutes) during the 2 hours of the experiment after 
either a control drink or 2 mmole KNO3
-
 drink has been ingested at time 
0 minutes.  Interquartile ranges are shown by the error bars. 
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7.3.3 Salivary nitrite 
 
For volunteers, on the day they consumed the control drink, the median salivary 
nitrite concentration prior to the administration of the control was 63.7 (interquartile 
range, 43.5 – 89.4) µM.  75 minutes after the administration of the control drink, the 
salivary nitrite concentration did not significantly change (p>0.05) from the basal 
reading, with a median concentration of 57.3 (interquartile range, 38.6 – 87.5) µM.  
However, on the day the volunteers were given a 2 mmole potassium nitrate drink 
there was a significant increase (p<0.0005) in the median salivary nitrite 
concentration from 30.5 (interquartile range, 21.6 - 38.3) µM on sampling prior to 
administration of the drink to a peak of 330.9 (interquartile range, 250.2 – 398.5) 
µM 75 minutes after the drink was ingested.  The salivary nitrite concentration 
reached peak concentrations at 45 minutes (311.1 μM), and remained significantly 
elevated for the remainder of the study (figure 7.4). 
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Figure 7.4: Median salivary nitrite concentrations (µM) in healthy volunteers taken 
at the given time intervals over the 120 minute time course of the 
experiment.  Red columns represent the mean concentrations on the day 
the KNO3 drink was ingested, while the blue columns represent the 
control day.  The concentration on the day a control drink was given is 
compared to a day on which a 2mmole nitrate drink was given.  Error 
bars represent the interquartile range. (n=6) 
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7.3.4 Silastic tube nitrite 
 
Nitrite was not detected within the tube sections lying within the oesophagus, 
whereas, nitrite was present in tube sections exposed to gastric acid, on both control 
and KNO3 administered days.  In the tubing from the control day the median total 
nitrite formed within the tube was 13.1 (interquartile range, 6.9-22.2) nmoles 
whereas there was significantly more (p=0.001) nitrite formed within the tubing of 
volunteers when they were administered the KNO3 drink with the median value of 
42.1 (interquartile range, 27.8 - 60.3) nmoles.  The concentration profile of the 
sections of tubing was similar on both study days, with the highest concentration 
being detected in sections 15 and 16 (figure 7.5).  These sections are the first 
sections to be exposed constantly to intragastric acidity.  Peak median concentrations 
of nitrite were detected in section 15, being 54.6 (interquartile range, 35.0-65.2) µM 
after the control drink and increasing to 128.9 (interquartile range, 46.1-148.7) µM 
after nitrite.  The peak median concentration of tubing nitrite was found in section 
16 on the day the nitrate drink was given, with a concentration of 180.8 (interquartile 
range, 95.0-229.7) µM.  This compares to a median concentration of 53.0 
(interquartile range, 35.6-67.1) µM for the same section on the day a control drink 
was given.  This is therefore over a three fold increase in nitrite concentration 
between the control drink group and those administered the nitrate drink (figure 7.5). 
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Figure 7.5: Median silastic tubing nitrite concentrations for individual sections of 
tubing at the end of the 2 hour experiment.  The gastroesophageal (GO) 
junction is represented by the vertical line between sections 13 and 14.  
Results are shown after administration of either the control drink or 
nitrate drink. The data values shown below the graph are median values 
for each section after both control and KNO3. Median concentrations are 
shown with interquartile range indicated for each section by the error 
bars. 
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7.3.5 Silastic tube NMOR 
 
Throughout the sections of silastic tubing lying within the oesophagus, there 
was no NMOR detected.  However, NMOR was detected in the sections of tubing 
exposed to gastric acid in volunteers after administration of both control and nitrate 
drinks.  There was a significant difference in the NMOR formed in the tubing after 
administration of potassium nitrate (2 mmole) compared to the control, with a near 
doubling in the median concentration of NMOR (p=0.008) (Figure 7.6).  The median 
NMOR formed within the tube was 2.1 (interquartile range, 0.8-2.9) nmols on the 
control day and 4.3 (interquartile range, 2.3-6.6) nmols on the day the potassium 
nitrate drink was given.  In the control experiments, the peak NMOR concentration 
was 8.2 (interquartile range, 1.9-9.8) µM, measured in section 15 of the tubing.  
However, the concentration profile was different on the day the volunteers were 
given the potassium nitrate drink.  There was a plateau of increased concentrations 
in the gastric lying sections of the tubing, rather than a peak concentration.  The 
peak NMOR concentration after nitrate drink was measured in section 19, where the 
concentration of 9.3 (interquartile range, 4.0-15.7) µM was almost four times the 2.3 
(interquartile range, 0-4.1) µM detected in section 19 on the day of the control drink.  
In fact, the most striking differences between the control day and nitrate drink 
NMOR concentrations occurred in the most distal section of gastric tubing.  Even in 
section 21, the most distal section of gastric tubing, there was 3.5 (interquartile 
range, 0 – 7.3) µM NMOR formed on the day the volunteers had a nitrate drink 
compared to 1.0 (interquartile range 0 -2.1) µM on the control day 
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Figure 7.6: Median silastic tube NMOR concentrations at the end of a 2 hour 
experiment. The gastroesophageal (GO) junction is represented by the 
vertical line between sections 13 and 14.  Results are shown after 
administration of either the control drink or nitrate drink. The data 
values shown below the graph are median values for each section after 
both control and KNO3.  Median concentrations are shown with 
interquartile range indicated for each section by the error bars. 
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7.3.6 Correlation of silastic tube nitrite with NMOR 
 
There was a near four fold increase in the peak silastic tube nitrite 
concentration after the administration of nitrate.  However, there was only a 
doubling in the peak NMOR concentration.  The ratio of NMOR to nitrite was 
therefore calculated for each gastric tube section.  The median of all ratios of 
NMOR:nitrite concentration was 0.1258 (interquartile range, 0.0903-0.1691) µM 
after the control drink.  There was a significantly lower ratio of 0.0580 (interquartile 
range, 0.0445-0.0711) µM after the nitrate drink (p=0.0047).  For oesophageal tube 
sections there were small concentrations of nitrite found in the lower two 
oesophageal sections in one of the subjects.  This subject was the same volunteer in 
whom there was a small degree of reflux recorded on the day the control drink was 
given.  There was no recordable NMOR found within these sections and therefore no 
ratios have been calculated. 
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7.4  Discussion 
 
A novel mechanism whereby dietary nitrate can produce nitrosative stress at 
and around the gastroesophageal junction has been proposed.  This has been 
supported by the results of in vitro experiments using bench top models, described in 
this thesis, and by others working within this area of research (43,44,144,285,286).  
In this hypothetical model, NO is generated in extremely high concentrations where 
salivary nitrite, generated from dietary nitrate, meets acidic gastric juice in the 
presence of ascorbic acid, as has been shown to be the case in human subjects after a 
nitrate meal (44,280).   The model suggests that NO then diffuses into the 
surrounding epithelial compartments or lipid where it can form nitrosating species 
such as dinitrogen trioxide through the reaction of NO with O2.     
 
This study indicates that the hypothetical model for N-nitrosation proposed 
above has relevance in an in vivo situation in subjects with a healthy acid secreting 
stomach.  Overall, healthy volunteers showed an increase in nitrosative stress in the 
upper gastrointestinal tract after a nitrate rich drink was given.  This was indicated 
by an increase in the total silastic tube nitrite and NMOR concentrations.  The site of 
all of the nitrosative stress was within the stomach with the exception of one 
volunteer who had a short lived period of proven acidic reflux into the oesophagus.   
 
The highest concentrations of nitrite were seen within the sections of tubing 
that lay in the proximal stomach.  This was seen on both the control day and on the 
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day a nitrate rich drink was given.  These findings would be in keeping with the 
anatomical site where high concentrations of salivary nitrite are first meeting with 
acidic gastric juice containing ascorbic acid (221).  Nitrite can enter into the lumen 
of the silastic tubing by one of two routes (44).  The first, and in these experiments 
the one likely to be more important, is the generation of NO from the reaction of 
nitrosating species with ascorbic acid.  The NO can then diffuse through the wall of 
the silastic tubing and both within the wall and within the lumen of the tubing, react 
with O2 to form N2O3.  N2O3 can then either react with nitrosatable species such as 
the amine present in the lumen or it can react with water to form nitrite as shown in 
the reaction: 
 
N2O3 + H2O  2NO2
-
 + 2H
+
 
 
In an acidic environment nitrite will largely form nitrous acid as shown by the 
reaction: 
 
HNO2 H
+
 + NO2
- 
 
The second mechanism through which nitrite can accumulate within the lumen of 
the tube depends on the pKa of nitrous acid being 3.34.  At the acidic pH found in 
subjects with a healthy acid secreting stomach nitrous acid is in the relatively non 
polar form HNO2.  This HNO2 can then slowly diffuse through the wall of the 
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silastic tube.  Once within the neutral environment of the tube lumen HNO2 will 
quickly form nitrite. 
 
One of the more surprising results from this study was the plateau effect of 
the distribution of NMOR within the sections of tubing extending into the more 
distal regions of the stomach.  The tubing extended into the stomach some 12.5cm.  
It had been expected that the nitrosative stress in this region would be less than at the 
gastroesophageal junction and cardia region of the stomach.  These results can, 
however, be explained by the availability of chemical reactants within the lumen of 
the healthy acid secreting stomach.  We found that the peak nitrite concentration was 
in the sections that lay within the proximal stomach, while the NMOR 
concentrations appeared in the proximal stomach and concentrations began to 
plateau in the more distal sections in the stomach.  The peak concentration of 
NMOR was seen several centimetres below the gastroesophageal junction in section 
19.  Therefore, there was a tendency for the ratio of nitrite to NMOR to be lower in 
the proximal stomach after the nitrate drink. The ratio of NMOR:nitrite within the 
silastic tube is an expression of NO:nitrite in the lumen of the gastrointestinal tract.  
NMOR only can be formed, within the epithelial compartment, by the diffusion of 
NO, whereas nitrite can be formed via the diffusion of either NO or nitrous acid, as 
discussed above.  The administration of nitrate resulted in a 230% increase in peak 
silastic tube nitrite concentrations, but only a 45% increase in peak NMOR 
concentrations.  Therefore, the nitrate meal actually reduced the ratio of 
NMOR:nitrite, although not the amount of NMOR produced.  This suggests that the 
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entire increased amount of swallowed salivary nitrite was not being converted to NO 
in the proximal stomach, but rather some of it remained in the form of nitrous acid 
and nitrosating species in the lumen of the stomach itself.  This could occur if the 
high proximal stomach nitrite concentrations have exhausted the ascorbic acid 
concentration.  This would then allow nitrite to enter the tubing as nitrous acid rather 
than NO.  There was intragastric variation in concentrations of ascorbic acid, with 
the concentrations being lower in the cardia region of the stomach than the more 
distal region (221).  The reason for ascorbic acid concentrations varying within 
different regions of the stomach is not clear, although it is known that in the fasting 
state vitamin C is actively secreted into the stomach (96,134).  It has previously been 
observed that the ratio of nitrite to ascorbic acid is highest in the most proximal 
stomach, with the authors proposing that this was potentially the maximal site within 
the stomach for the well recognised acid-catalysed nitrosation (221).  The current 
studies would support this argument, and would suggest that there are two 
mechanisms for nitrosation due to salivary nitrite in the human subject.  The first of 
these is the well established and analysed acid-catalysed nitrosation, the second 
being NO production in the presence of an antioxidant and a lipid phase.  The factor 
determining which mechanism of nitrosative stress is dominant in the human subject 
is the availability of ascorbic acid.    
 
Further studies using this silastic tube in vivo model have been performed by 
one of my colleagues (Winter J), with whom the initial studies were performed.  
Data from these studies are now published (286).  A further 12 ‘healthy’ volunteers 
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were studied by the same methods described in this chapter.  The results for silastic 
tubing nitrite, NMOR and the correlation between them are reassuringly similar to 
the results presented within this thesis.  There was good correlation between the 
studies in terms of the sections of tubing identified with peak concentrations of 
nitrite and NMOR, and the median values for each section of tubing are remarkably 
consistent.  The additional 12 patients did however provide an interesting 
observation that helps support the argument for acid-catalysed nitrosation and NO 
mediated nitrosative stress.  One of the twelve volunteers was not included in the 
results of the studies, as they were found to be achlorhydric through recording from 
the pH probes in this study.  The silastic tube luminal contents from this volunteer 
did not contain any detectable nitrite or NMOR.  This is not to say that this person is 
at no risk of nitrosative stress.  There is another well recognised mechanism for 
nitrosation within the human stomach and that is through denitrifying bacteria 
generating nitrosating species and N-nitrosocompounds.  These bacteria can colonise 
an achlorhydric stomach mucosa.  This mechanism is thought to be relevant to 
patients who develop noncardia gastric cancer, secondary to atrophic gastritis 
(68,287). 
 
Further studies were also performed using the silastic tube model to examine 
patients who were known to have Barrett’s oesophagus (286).  This group of patients 
was chosen as they usually have severe acid reflux disease.  Within this group, 
nitrite and NMOR were found in the oesophageal sections of the silastic tube lumen 
as well as the gastric sections.  The extent to which the nitrite and NMOR were 
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detected was directly related to the degree of reflux as recorded on the pH probe 
lying within the oesophagus (286).   
 
Overall the studies in this chapter indicate that, in an in vivo setting, there are 
two mechanisms through which there is the potential for nitrosative stress within the 
upper gastrointestinal tract from dietary nitrate.  There is the well established 
luminal acid-catalysed N-nitrosation in the absence, or exhaustion, of ascorbic acid, 
and there is NO mediated stress in the healthy acid and ascorbic acid secreting 
stomach.  These studies have allowed us to determine where there are the different 
types of stresses, as the ratio of nitrite to nitrosamine allows us to determine whether 
the stress is from NO, where there is both nitrite and NMOR formed, or from acid-
catalysed nitrosation from nitrous acid, where there is accumulation of nitrite in the 
tubing but there is not the nitrosating potential of this to generate nitrosamine within 
the tubing.  It has previously been established that NO has mutagenic potential to a 
cell through DNA base deamination, inactivating DNA repair enzymes, inactivating 
DNA repair enzymes and through the generation of N-nitrosocompounds such as 
nitrosamines.  It is also known that within cells there is a range of compounds that 
could be nitrosated to potentially mutagenic products. These compounds that are 
potentially nitrosated include secondary amines, polyamines, amino acids, peptides 
and amides (200,288-290).  With particular relevance to the upper gastrointestinal 
tract are conjugated bile salts glycocholic acid and taurocholic acid.  These are 
amides that are potentially present within the refluxate of bile.  It is known that bile 
and acid reflux are irritants to the lower oesophagus causing oesophagitis.  With 
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oesophagitis as a background, there is then also the potential of nitrosated bile salts 
adding insult to the already exposed and damaged epithelium. 
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Chapter 8 Studies to determine intraepithelial nitrate and nitrite from human 
upper gastrointestinal tract tissue 
 
8.1  Introduction 
 
While in vitro studies suggest a potential mechanism for nitrosative stress from 
dietary nitrate, with the possible implication of this chemistry contributing to the 
increasing incidence in adenocarcinoma at and around the gastroesophageal 
junction, there had been no confirmation of this stress from human tissue studies.  
As has been discussed previously within this thesis, an influx of nitrite is a good 
marker of increased nitrosative stress.  Therefore, if increased nitrite and related 
chemistry, such as nitrate, could be measured in the intraepithelial compartment of 
cells from human tissue biopsies, this would be good evidence for nitrosative stress 
at an in vivo cellular level. 
 
The intraepithelial measurement of nitrite and nitrate from biopsies from the 
upper GI tract has not previously been described, therefore new techniques were 
attempted to obtain this information.  This chapter describes the process of obtaining 
human biopsy specimens from specific anatomical regions of the oesophagus and 
stomach, cleaning of these samples, lysis of the cells within these samples and 
specific analysis of nitrite and nitrate from the samples.  The subsequent Chapter, 
Chapter 9, will describe anatomical variation in nitrate and nitrite concentrations 
from biopsies. 
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Previous studies within this thesis have analysed nitrite from a simple medium 
in bench-top models.  Human tissue is more complex and therefore analysis of two 
different methods of determining nitrite concentration was undertaken.  These 
methods are the Greiss Reagent and the release of NO recorded using an NO probe, 
and are described in this chapter. 
 
As well as measuring nitrite from upper gastrointestinal tract biopsies, it is also 
important to measure nitrate in vivo.  This is because human tissue is more complex 
than previously used bench top models.  It has been shown that in biological tissue 
the most important metabolic reaction of NO is with iron in oxyhaemoglobin to 
produce methaemoglobin and nitrate (291), as shown in the following reaction:   
 
[HbFe(II)O2]2 + NO  [HbFe(III)]3
+ 
+ NO3
-
 
 
For example, the uptake of NO into the red blood cells with subsequent oxidation is 
the major metabolic pathway for endogenously formed NO (292).  Also, it is known 
that NO reacts with superoxide in aqueous solution to form peroxynitrite.  
Superoxide ion has been shown to be ubiquitous in mammalian cells (293).  The 
peroxynitrite/peroxynitrous acid system is known to be very labile, and the 
decomposition products from this are nitrate, nitrite and dioxygen (294), as shown 
by the following reactions: 
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O2
-
 + NO  OONO 
 
4OONO  2NO3
-
 + 2NO2
-
 + O2 
 
It has also previously been shown that in the presence of peroxynitrite, nitrite is 
converted to nitrate.  Therefore, in the following studies nitrate concentration is also 
measured.  
 
Upper gastrointestinal tract biopsies require a cleaning process, as surrounding 
mucus and the haem components of blood would interfere with subsequent analysis 
of intraepithelial nitrite/nitrate.  Within the lumen, oesophageal defences against acid 
include pre-epithelial compartments such as mucus and bicarbonate (295,296).  
Mucus itself is not an effective barrier to hydrogen ions (297,298) but provides 
mucosal protection by contributing to an area of low turbulence. Adjacent to the 
mucosa is the unstirred water layer (299).  This layer acts as a sink for bicarbonate 
ions, creating an alkaline environment close to the mucosal surface (298-300).  
Mucus, lining the epithelial surfaces, will be the first point of contact of the 
luminally generated NO.  Nitrite is formed from the reaction of NO with water at a 
more neutral pH, so therefore nitrite can be expected to be formed here when NO 
diffuses into the mucus. This would mean that unclean biopsies could record high 
nitrite concentrations from the mucus, without this being a reflection of 
intraepithelial nitrite content. 
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There are several mucolytic agents that are used in cleaning mucus from biopsy 
samples.  Mucolytic agents that were explored as possible cleaning agents for the 
studies presented in the chapter were N-Acetylcysteine (NAC) (301), pepsin, and 
pronase E.  Unfortunately, these cleaning agents are normally used in a setting 
where rupture or leak of the cell membranes would not be important.  For the 
proposed measurement of intraepithelial contents, it was thought that the ideal 
solution would be isotonic and non toxic to the cell membrane.  Pepsin works best at 
lower pH and from pH 6 and above is unstable.  Therefore, this wasn’t suitable for 
use in these studies where there is a neutral pH.  NAC is known to be a mucolytic 
agent that has been previously used to clean surrounding mucus from 
gastrointestinal biopsy specimens.  Solutions between 3 and 10% NAC have been 
used effectively to clean samples from the upper gastrointestinal tract (302,303).  A 
solution of NAC is acidic and the pH of a solution of 3.1% NAC is 3.  "Pronase E" 
is the name given to a group of proteolytic enzymes produced by Streptomyces 
griseus K-1.  At least 10 proteases are in the mixture, five serine-type proteases, two 
zinc endopeptidases, two zinc leucine aminopeptidases and one zinc 
carboxypeptidase.  Digestion with the product has been useful when extensive or 
complete degradation of protein is required.  It has previously been used to digest 
mucus from rat stomachs in experimental models (304-307).  In previous studies this 
has always been used as part of a harvesting of cells and has not been used simply to 
clean around biopsy specimens.  It has stable activity across a range of pH from 5.0-
9.0.   Cleaning methods are described in this chapter. 
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After cleaning of the surrounding mucus, lysis of the cell membranes within the 
biopsy sample had to be performed as the intracellular concentrations are the 
measurements that are expected to be important.  A suitable method of cell lysis, to 
release intracellular nitrite and nitrate into surrounding PBS, had to be developed 
and is discussed. 
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8.2 Materials and Methods 
 
8.2.1 Obtaining and storing upper gastrointestinal tract samples 
 
Epithelial biopsies from the oesophagus and stomach were obtained from 
volunteers undergoing upper gastrointestinal endoscopy in Gartnavel General 
Hospital.  Ethical approval for the studies was granted by the West Glasgow’s 
University NHS Trust Ethical Approval Committee.  All patients were confirmed 
Helicobacter pylori negative by urease CLO testing, and were not receiving antacid 
therapy.  Biopsies were taken using standard endoscopy forceps with large capacity.  
The gastroesophageal junction was identified as the top of the mucosal folds and 
coincided with the squamo-columnar junction in these healthy subjects.  
Oesophageal biopsies were taken 5 cm above the gastroesophageal junction.  
Proximal stomach biopsies were taken immediately below the gastroesophageal 
junction.  Distal stomach biopsies were taken from the distal body of the stomach.  
Immediately after removing the forceps from the scope portal, the sample was 
transferred from the forceps using tweezers, and placed into a 1 mL plastic 
Eppendorf test tube after undergoing a cleaning process.  PBS (80 µL) was added to 
the sample, which was placed in liquid nitrogen for transfer to a -70
o
C freezer.  All 
samples were analysed within four weeks. 
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8.2.2 Determining the optimal method for cleaning biopsy samples 
 
Cleaning Solutions assessed:  
 
NAC - In order to prevent osmotic and acidic lysis of our cells during the 
cleaning stage, it was important to clean samples at a neutral pH, with a 
physiological osmolarity.  Therefore, sodium bicarbonate (200 mM) was added to 
3.1% NAC to give a final pH of 7.2 and osmolarity of 320 mM.  Biopsy samples 
were left in this solution for 30 minutes.  After 30 minutes the sample was taken out 
and placed on benchguard paper, and any obvious surrounding mucus removed. 
 
Pronase E – 1% pronase was added to PBS (pH 7.4).  The biopsy samples were 
placed in a plastic Eppendorf test tube containing 2 mL of this solution for 30 
minutes.  Thereafter, the samples were placed on benchguard paper and any obvious 
surrounding mucus was cleaned. 
 
In experiments used to assess the efficacy of cleaning using these solutions, 
twelve biopsy samples were placed in an Eppendorf test tube containing 2 mL 
KNO3
-
 (5mM) enriched with 
15
N.  These were compared to control samples exposed 
to the same contaminant but which had no cleaning.  
15
N content of samples was 
then analysed.  
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8.2.3 Protein concentration as a measure for weight of biopsy samples 
 
Upper gastrointestinal tract biopsy samples vary largely in size.  Multiple 
biopsy samples were taken and analysed for wet and dry weight after heating in an 
incubator overnight.  It is particularly important to do this given that oesophageal 
biopsies are more difficult to obtain and generally are smaller.  This revealed that 
wet weight could vary by up to five times between the biopsy sample weights.  The 
dry weight was approximately 10-15% of the wet weight.  The protein content may 
be used as a standard against size for each sample.  This would allow standardisation 
of the nitrite and nitrate content of each sample, according to concentration per unit 
of protein.  
 
8.2.4 Releasing intraepithelial contents by cell membrane lysis 
 
A comparison of four different methods of cell lysis was made by measuring 
total nitrite and protein concentrations from each biopsy sample.  Each method was 
performed on each sample from each of the three areas of interest in the upper 
gastrointestinal tract.  There were thirty-six times samples taken to obtain mean 
values (± 1 standard deviation).   
 
Snap freezing:  Immediately after the cleaning process the biopsy sample was 
placed in 80 µL PBS in a 1 mL plastic Eppendorf test tube.   It was then immediately 
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placed into liquid nitrogen to snap freeze the sample, thus bursting the cell 
membranes. 
Homogenisation:  After snap freezing the samples were homogenised in a 
glass, 1 mL, hand held homogeniser for 120 seconds. 
Sonication:  After snap freezing, the samples were defrosted and sonicated at 
6 microns amplitude for three minutes before being centrifuged for three minutes at 
13000 rpm in a microcentaur.  The supernatant was thereafter analysed. 
Homogenisation and Sonication combined: samples were snap frozen then 
homogenised, sonicated and centrifuged as in the above descriptions. 
 
8.2.5 Biopsy nitrite concentration analysis  
 
Within the laboratory we had access to, and experience of using, several 
methodologies for nitrite concentration measurement.  Previous assessment of the 
HPLC method suggested it did not provide any more accurate measurement 
compared to the relatively simple Greiss reagent. For the studies in this chapter the 
Greiss reagent was compared to measurement using a NO probe. 
 
a. NO probe 
b. One step Greiss reagent 
 
a. NO assessment is based on using NO production in an acidic environment 
and measuring NO with a WPI NO probe.  The method used was based on 
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the same principles, and used the same probe, as discussed in Chapter 2.1.1.  
There was however several differences from the basic methodology and 
these will be described here.  These differences arise mainly due to the 
small volumes and small concentrations of nitrite expected to be found.  
 
The NO probe was calibrated at room temperature using known 
standards. As the sample was diluted by surrounding PBS, the expected 
concentration of nitrite, and therefore NO generated was low.  The 
standards used to calibrate the probe were therefore, 10 nM, 50 nM, 100 
nM, 500 nM and 1 µM nitrite.  To the standards, an acidic reaction solution 
(Solution A) was added to generate NO.  Solution A was made up of 30mls 
dH2O, 0.55 g of potassium iodide (KI) and 200 µL of concentrated H2SO4.  
This had to be stored in the dark until it is used to prevent the KI reacting 
with light.  80 µL of each standard was added to 80 µL of solution A to 
obtain a graph of standard concentrations against the pA reading of each 
and to provide a y value from which we were able to calculate the NO 
concentration produced from the samples with unknown nitrite content.  As 
with the standards, we added 80 µL of sample to solution A to liberate the 
nitrite as NO and took a pA reading which was converted into a 
concentration of NO released.  In this experiment there was gross excess of 
KI in acid this reflects the nitrite concentrations as all nitrite will be 
converted to NO. 
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Given that the approximate intracellular volume of the samples was 
only 3 µL, the total volume of acidic solution that could be used to initiate 
the release of NO was very small, and this led to several technical 
difficulties.  There has to be sufficient volume to cover the membrane of the 
probe.  Also, due to the fact that the reading was based on a current, when 
the NO probe was touched the baseline amplitude of electrical current 
changed.  Although the amplitude changes due to this interference were 
only a matter of tens of pA they were still significant because the samples 
being analysed were very dilute and the readings we expected to see were 
very small.   
 
b.  One step Greiss Reagent – Nitrate and nitrite have previously been 
measured within human biological material by the simple Greiss reaction 
(308-310). This method of measuring is outlined in Chapter 2.1.4. 
 
After deliberately exposing 12 biopsy samples to high concentrations of NO 
generated in the model shown in figure 8.1, nitrite concentrations were measured 
using both of the methods described above.  Of the total 80 µL volume half was used 
for analysis by the NO probe method, and half was used for the one step Greiss 
reagent method.   
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Figure 8.1: Schematic diagram of the model used to expose human upper 
gastrointestinal tract biopsy samples to NO.  A 20 mL glass vial was 
filled with HCl (pH 1.5), ascorbic cid (1 mM), NaSCN (1 mM) and 
NaNO2 (50 µM) to allow generation of approximately 50 µM of NO.  
The lid of this vial was cut in the middle to establish a small hole.  Into 
this hole were placed three biopsy samples, so that the samples were 
both in contact with, both the lower layer to form a seal, and also the air 
outside the vial.  Concentrations of NO were 45 µM and above in the 
aqueous phase of this model after 30 seconds, and were maintained at 
this high concentration for the 15 minutes that the biopsies remained 
inside.   
50µM NO 
generation within 20 
ml glass beaker 
 
pH 1.5 HCl 
1mM ascorbic acid 
1mM NaSCN 
50µM NaNO2 
 
Air surrounding 
beaker 
Biopsy 
samples being 
exposed to 
both NO from 
beaker and air 
from outside 
beaker 
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8.3 Results  
 
8.3.1 Cleaning with NAC and pronase E 
 
These experiments revealed that after cleaning with 3.1% NAC only 7% 
15
N 
remained while 25% 
15
N remained when Pronase E was used as the cleaning 
solution.  These experiments showed that while cleaning was not 100% effective 
with NAC, it was the best available solution and was more effective than Pronase E. 
 
8.3.2 Protein as standardisation for the weight of a sample 
 
There was a linear relationship between the weight of a biopsy and protein 
content (figure 8.2).  When these results were charted there was a direct correlation 
between protein content and sample weight, with the slope of best fit a linear line r
2
 
= 0.954: 
 
y (µg) = 3.7(mg) x X       (where y is the protein content in mg and X is the 
unknown weight of a sample in mg) 
 
This allowed use of the protein concentration as a standardising unit for nitrite 
and nitrate concentrations.  The units for nitrate and nitrite are then given against the 
protein concentration of a sample (µg).  
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Figure 8.2: This shows the linear relationship between the weight of a biopsy 
sample and the protein measurement between the weight and the protein 
measurement of a sample from the human upper gastrointestinal tract.  
Samples from the oesophagus are labelled , samples from the 
proximal stomach , and samples from the distal stomach . The 
protein concentration of a biopsy sample added to an Eppendorf test 
tube containing 80 µL PBS was plotted against the wet weight of the 
same sample.  The number of samples evaluated was twenty-one and 
these were taken in equal number from oesophagus, proximal stomach 
and distal stomach. 
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8.3.3 Releasing intraepithelial contents 
 
Perhaps not surprisingly, the combined method involving all three 
approaches gave results with the highest concentrations of protein and nitrite per 
biopsy specimen (figure 8.3).  The mean nitrite concentration of samples for each 
method was 12 (± 4.7) µM for snap freezing alone, 40 (± 7.3) µM for snap freezing 
and sonication, 46 (± 8.1) µM for snap freezing and homogenization and 66 (± 11.7) 
µM for a combination of all three methods.  The difference between a combination 
approach and each individual method was statistically significant (p = 0.0001)   The 
mean protein content for each method was 49 (± 10.2) µg for snap freezing alone, 87 
(± 16.0) µg for snap freezing and sonication, 92 (± 16.4) µg for snap freezing and 
homogenization and 110 (± 20.1) µg for a combination of all three methods (p = 
0.001).  Performing all three of these actions on the biopsy samples represented the 
most effective method, and was therefore employed for all subsequent analysis. 
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Figure 8.3: Mean nitrite (µM) (blue column) and protein (µg) (red column) 
concentrations in each sample when analysed by the different methods.  
Methods were snap freezing only, snap freezing and sonication, snap 
freezing and homogenization or a combination of all procedures.  Data 
labels show mean values.  Error bars represent 1 standard deviation.  
Statistical significance is shown. 
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8.3.4 Nitrite analysis 
 
8.3.4.1 Results to determine the better method of nitrite analysis in human  
studies 
 
The results for each sample when analysed by both the Greiss reagent method 
and NO probe method, are shown in figure 8.4. The average nitrite concentration 
from the NO probe method was 12.9 (± 2.1) µM, while the average from the greiss 
reagent was 18.0 (± 4.3) µM.  There was a statistically significant difference 
between the two methods (p=0.00004).  On all but two samples, the amount of 
nitrite detected was greater with the Greiss reagent.   
 
 
 
 
 
 
 
 
 
 
 
234 
 
 
 
Figure 8.4: This graph compares the µM nitrite concentration measured using both 
NO probe recording and Greiss reaction in human biopsy samples.  For 
each biopsy sample, both methods were performed and compared.  The 
line between points in the NO probe column and Greiss column is to 
display the measurements for one sample assessed by the different 
methods. 
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8.3.4.2 Assessment of interference with the Greiss reaction 
 
It has been established above that the one step Greiss reaction was the better of 
the methods for nitrite analysis from biopsy samples.  However, a previously 
published paper by Tsikas et al (308) had suggested that, in the presence of the thiol 
groups on glutathione and NAC, there would be interference with the Greiss 
reaction, since the reaction works on the basis of acidifying the solution to allow the 
reaction to occur.  It was suggested that this would result in nitrosothiols being 
formed from nitrite.  In an attempt to clarify this further, a series of experiments was 
set up using standard concentrations of nitrite, and subjecting them to the Greiss 
reagent in the presence of varying concentrations of glutathione and NAC.  Ascorbic 
acid was also assessed during these experiments, for any interference.  The 
concentration of nitrite standards used was 25 µM, 50 µM and 100 µM.  The 
percentage nitrite recorded after addition of ascorbic acid, glutathione and NAC was 
then measured by the one step Greiss reagent method.   
 
Across a range of concentrations from 10 µM to 500 µM there was no 
interference from glutathione, NAC or ascorbic acid (Table 8.1).  At glutathione and 
ascorbic acid concentrations of 1 mM and above there was interference with the 
Greiss reaction.  Only at NAC concentrations of 5 mM and 10 mM was there a 
recorded reduction in nitrite concentration and the reduction was only 2-3%.  
Assessment for synergy between glutathione and ascorbic was also made, at the 
concentrations shown to significantly interfere with the reaction (10 mM).  There did 
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not appear to be any synergy.  Instead the combined effect of these two antioxidants 
led to an 18% reduction in nitrite concentration.   
 
Within the samples that were being assessed the concentrations of the solutions 
would be considerably smaller than the concentrations required to interfere with the 
Greiss reaction.  The studies performed by Tsikas et al suggested that smaller 
concentrations of these antioxidants would lead to interference (308).  However, in 
their studies they did not use a one step Greiss reaction, but rather, they left the 
solution acidified for two hours prior to adding the dye component.  This could have 
allowed time for the thiol groups to cause more interference by forming nitrosothiols 
from acidified nitrite.   
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Table 8.1: Percentage of nitrite measured using the one step Greiss reaction, after a 
known concentration of nitrite standard was added to one of three 
antioxidants, ascorbic acid, NAC and glutathione, to assess for any 
interference with the Greiss reaction by these antioxidants. 
 
% of standard nitrite concentration  
measured by greiss reagent 
Antioxidant 
concentration 
Glutathione Ascorbic acid NAC 
10 µM 100 100 100 
50 µM 100 100 100 
75 µM 100 100 100 
100 µM 100 100 100 
250 µM 100 100 100 
500 µM 100 100 100 
1 mM 98 99 100 
5 mM 95 96 98 
10 mM 88 77 97 
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8.3.4.3 Comparison of nitrite to nitrosothiol content of biopsy samples  
 
It has previously been suggested that, in the acidic environment generated by 
the Greiss reaction, all the nitrite would react with intracellular thiol groups to form 
nitrosothiols (308).  Nitrosothiols will also be formed from nitrosation of thiol 
groups in vivo, although the percentage of the total nitrite ending up as nitrosothiols 
would be expected to be small. To assess this further, we measured both 
nitrosothiols and nitrite from twelve biopsies obtained from an equal mix of the 
oesophagus, proximal stomach and distal stomach.  We measured the nitrosothiols in 
the presence of an excess of glutathione, to both donate thiol groups, and act as a 
reducing agent.  Therefore, when we measured nitrosothiols the total intracellular 
nitrite would be measured.  Nitrosothiol measurement was through the NO probe 
method described in Chapter 8.2.5 and Chapter 2.1.7. 
 
The results show that there is no significant difference between the nitrosothiol 
concentration measured and the nitrite concentration measured by the Greiss reagent 
(p=0.60) (Figure 8.4).  The mean total nitrosothiol concentration was 12.1 (± 5.7) 
µM while the nitrite concentration was 13.8 (± 5.1) µM.  Therefore, the contribution 
of nitrosothiols to total biopsy nitrite was not detectable by the methods adopted in 
this study and therefore were not measured in further studies. 
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Figure 8.5: Human upper gastrointestinal tract biopsy specimens were analysed for 
nitrite concentration (µM), using the Greiss reagent method, and for 
nitrosothiol concentrations (µM), using a method whereby all nitrite 
would also be converted to nitrosothiol.  The concentration of 
nitrosothiol (µM) is therefore a reflection of sample nitrite + nitrosothiol 
concentrations.  Comparison is made between the sample concentration 
of nitrite, measured using the different methods, to assess any additional 
concentration recorded in the nitrosothiol samples which would reflect 
true nitrosothiol concentration. 
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8.4 Discussion 
 
The intention, in performing the studies in this chapter, was to develop a 
method of assessing human upper gastrointestinal tract intracellular nitrate and 
nitrite concentrations, to enable assessment of nitrosative stress.  Previous studies 
using silastic tubing as an epithelial compartment had shown that nitrite was a 
marker of nitrosative stress.   
 
It was possible to standardise sample nitrite and nitrate concentrations relative 
to the protein content of each biopsy sample.  This allowed for the varied sizes of 
biopsy that are taken from the upper gastrointestinal tract.  Although the biopsy 
samples would have protein contained within the mucus layer the cleaning effect, of 
over 90%, was consistent between samples from the three anatomical regions 
sampled and between samples from the same anatomical region.  This means that if 
the protein content was being overestimated it would be so constantly.  Protein 
content, therefore, is a useful standardising measurement for nitrite and nitrate.   
 
Processing of samples was effective in terms of releasing intracellular content 
into PBS by a combination of snap freezing, sonication and homogenisation.  
Although a combination of these techniques yielded the highest concentrations of 
nitrite and protein the actual degree of cell membrane destruction was not 
determined.  This could mean that the concentrations recorded are an underestimate 
of the true intracellular concentrations.   An independent control, such as electron 
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microscopy, could be employed to assess the degree of cell membrane lysis.  
Measurement of nitrite by the one step Greiss reaction was validated in our studies, 
which also show that the contribution of nitrosothiols from the samples was not 
relevant.    
 
To enable accurate assessment of intracellular contents it was apparent that the 
mucus barrier present in the upper gastrointestinal tract would have to be removed.  
Unfortunately, mucus in the upper gastrointestinal tract is relatively adherent to the 
epithelium.  This is particularly the case in the stomach.  The best mucolytic 
cleaning solution was found to be NAC.  This has been used previously to clean the 
upper gastrointestinal tract from mucus, but not in the context of measuring 
intracellular content concentrations.  In our studies, the cleaning achieved was 
removal of over 90% of the surrounding mucus from biopsy samples.   
 
NAC appeared to be the best cleaning solution.  However, acetylcysteine is the 
N-acetyl derivative of the amino acid L-cysteine and exhibits direct and indirect 
antioxidant properties. Its free thiol group is capable of interacting with the 
electrophilic groups of ROS (310,311). This interaction with ROS leads to 
intermediate formation of NAC thiol, with NAC disulphide as a major end product 
(312). In addition, NAC can exert an indirect antioxidant effect related to its role as 
a GSH precursor in vivo. It has been shown that thiols enhance NO generation from 
NO releasing agents (313,314).  This could, theoretically, result in the cleaning 
solution used in our experiments releasing NO from nitrite within the mucus layer.  
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NO would then be free to pass into the epithelial compartment and form nitrite and 
nitrosating species.  However, the reaction of nitrite with NAC will take place in the 
neutral environment of the mucus lining of the oesophagus.  The NAC produced for 
the studies was also made up in 200 mM sodium bicarbonate to neutralise the pH of 
the solution and to make it more isotonic.  This means that although NO would be 
produced from this reaction in an acidic environment its production in a neutral 
environment would be minimal.   
 
Overall, measurement of upper gastrointestinal tract biopsy nitrate and nitrite is 
possible using the methods described.  The major problem with these methods is 
cleaning of adherent mucus from the biopsy sample prior to subsequent analysis for 
nitrite and nitrate.  The mucus is likely to have a high concentration of nitrate and 
nitrite.  The cleaning methods do appear to be able to clean over 90% of the 
surrounding mucus and although it may not be possible to extrapolate data relevant 
to intraepithelial concentrations of nitrate and nitrite, the nitrosative stress within the 
biopsy sample of an anatomical region can be determined. 
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Chapter 9: Upper gastrointestinal tract biopsy sample nitrite and nitrate 
concentrations  
 
9.1 Introduction 
 
The hypothesis, that intraepithelial nitrite and nitrate reflect where NO 
generation is maximal, would mean that on analysis of samples from three areas of 
the upper gastrointestinal tract, oesophagus, proximal stomach and distal stomach, 
we would expect samples from the proximal stomach of healthy subjects to have the 
highest concentrations of nitrite and nitrate.  In previous studies it was not possible 
to remove all adherent mucus from biopsy samples.  This means that measuring 
intraepithelial nitrate and nitrite is not possible with the methods described.   
However, studies were performed to look for biopsy sample nitrite and nitrate 
concentrations.  While it is not possible to extrapolate from this series of 
experiments whether this increase is related to intracellular nitrate and nitrite, it 
could still provide information regarding nitrosative chemistry within the upper 
gastrointestinal tract. The working hypothesis was that biopsy sample nitrite and 
nirrate concentrations would be higher in proximal stomach biopsies, as compared to 
oesophageal and distal stomach biopsies, due to generation of NO from salivary 
nitrite meeting acidic gastric juice.  To show that the higher concentrations were 
related to ingested nitrate, the studies were performed before and after the ingestion 
of a nitrate drink. 
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9.2 Methods 
 
9.2.1 Healthy volunteers 
 
A total of 17 healthy volunteers were enrolled, 9 of whom were male.  The 
median age was 52 years.  All volunteers were Helicobacter pylori negative, as 
detected by urease CLO testing, and had no history of antacid ingestion.  Endoscopy 
with biopsy was performed on two separate days.  On day one, the volunteer had 60 
mL of control drink which was dH2O.  On the second day the volunteer was given a 
60 mL drink containing 2 mmole KNO3.  Endoscopy with biopsy sampling was 
performed 2 hours after either the control or nitrate drink was given. On each day six 
biopsies were taken from each of, the oesophagus (5cm above the GO junction), 
proximal stomach (just below the gastroesophageal junction) and the distal stomach.  
A 1 mL salivary sample was collected at times 0 and 120 minutes for nitrite analysis.  
At the same time intervals as salivary samples were taken, the volunteers had blood 
samples taken for analysis of serum nitrate from an i.v cannula, placed in the 
antecubital fossa prior to the start of the experiment. 
 
9.2.2 Processing of biopsy samples 
 
Biopsy samples were immediately placed in a 2 mL solution of 3.1% NAC in 
NaOH (pH 7.4) and left for 30 minutes before being subjected to the cleaning 
process and cell lysis described in sections 8.2.2 and 8.2.4.  Of the cleaned sample, 
245 
 
snap frozen, homogenised and sonicated in 80 µL PBS, 20 µL was then analysed for 
each of protein, nitrite and nitrate concentrations.   Biopsy nitrate and nitrite 
concentrations were recorded as concentration per µg protein. 
 
9.2.3 Serum nitrate analysis 
 
Blood samples (10 mL) were taken at times 0 and 120 minutes.  The first 5 mL 
of this sample was discarded to allow for dead space within the i.v cannula.  2 mL of 
serum sample was stored at –20°C until it was analysed. On thawing, 400 µL of 
sample was centrifuged through a 10-kilodalton ultrafilter to remove high-
molecular-weight proteins. Samples were then mixed with nitrate reductase in 
reaction buffer and analysed as described in Chapter 2.1.5.  
 
9.2.4 Salivary nitrite analysis 
 
Salivary samples (1 mL) were obtained at times 0 and 120 minutes.  This was 
mixed with 10 µL of 5.0 M NaOH.  This rendered the samples alkaline and 
prevented loss of nitrite. Samples were stored at 4°C, then centrifuged and analyzed 
the same day on 96-well microplates using the modified Griess reaction as described 
in Chapter 2.1.4. 
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9.3 Results 
 
9.3.1 Salivary nitrite 
 
For volunteers on the day they consumed the control drink, the median salivary 
nitrite concentration prior to the administration of the control was 42.5 (interquartile 
range, 28.5 – 97.3) µM.  120 minutes after the administration of the control drink, 
the salivary nitrite concentration did not significantly change (p=0.09) from the basal 
reading, with a median concentration of 52.0 (interquartile range, 35.8 – 86.2) µM.  
However, on the day the volunteers were given a 2 mmole potassium nitrate drink, 
there was a significant increase (p=0.0000003) in the median salivary nitrite 
concentration from 39.7 (interquartile range, 29.6 – 65.8) µM on sampling prior to 
administration of the drink to a concentration 264.8 (interquartile range, 160.1 – 
358.6) µM 120 minutes after the drink was given. 
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9.3.2 Serum nitrate  
 
On the day the volunteers consumed the control drink, the median serum nitrate 
concentration prior to the administration of the control was 11.6 (interquartile range, 
4.3 - 17.3) µM.  At 120 minutes after the administration of the control drink, the 
serum nitrate concentration did not significantly change (p=0.19) from the basal 
reading, with a median concentration of 12.2 (interquartile range, 7.2-15.7) µM.  
However, in those who were given a 2 mmole potassium nitrate drink, there was a 
significant increase (p=0.00004) in the median serum nitrate concentration from 13.5 
(interquartile range, 5.6-18.3) µM on sampling prior to administration of the drink to 
54.7 (interquartile range, 31.2-69.8) µM 120 minutes after the drink was given. 
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9.3.3 Nitrate and nitrite concentrations at different anatomical sites 
 
Samples from the proximal stomach had the highest concentrations of both 
nitrite and nitrate.  The median nitrite concentration from the proximal stomach was 
36.7 (interquartile range 19.5 – 48.2) µM per µg protein, which was a significantly 
higher concentration than the concentrations from the oesophagus (14.5 µM) 
(p=0.00001) and distal stomach (24.0 µM) (p=0.0003) (figure 9.1).  For all three 
regions of the upper GI tract from which biopsies were taken, there was a 
significantly higher nitrate than nitrite concentration.  The median nitrate 
concentration in the proximal stomach was 114.1 (interquartile range 64.5 - 222.1) 
µM per µg protein, which is significantly higher than the concentration in the 
oesophagus (65.2 µM) (p = 0.00004) and distal stomach (65.7 µM) (p=0.00002). 
 
After ingestion of a 2 mmole KNO3 drink, there was a significant increase in 
the median nitrite and nitrate concentrations for all anatomical sites sampled, 
compared to control drink ingestion samples.  The greatest percentage increase in 
concentrations was seen in the proximal stomach samples, where there was a three 
fold increase in nitrite concentration with a median nitrite concentration of 124 
(interquartile range 86.2 – 176.2) µM per 100 µg protein (p=0.000002), and 2.5 fold 
increase in nitrate concentrations with a median nitrate concentration of 285 
(interquartile range 167.2 – 341.9) µM per 100 µg protein (p=0.00007) (Figure 9.2). 
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 Figure 9.1: Median nitrite concentrations expressed as µM per µg protein are shown 
for three regions of the human upper gastrointestinal tract (oesophagus, 
proximal stomach and distal stomach) after a control drink (blue 
columns) and after a drink containing 2 mmole nitrate (red columns).  
Data labels show the median value.  The error bars represent the 1
st
 and 
3
rd
 interquartile range. 
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Figure 9.2:  Median nitrate concentrations expressed as µM per µg protein are 
shown for three regions of the human upper gastrointestinal tract 
(oesophagus, proximal stomach and distal stomach) after a control drink 
(blue columns) and after a drink containing 2 mmole nitrate (red 
columns).   Data labels show the median value.  The error bars represent 
the 1
st
 and 3
rd
 interquartile range. 
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9.4 Discussion 
 
This study suggests that, in vivo, there is an increase in nitrosative stress within 
the human upper gastrointestinal tract after nitrate ingestion.  The mechanism 
proposed for the increase in this stress is through the generation of NO where 
salivary nitrite, produced in greater concentrations after a nitrate meal due to 
bacterial conversion and enterosalivary recirculation, meets acidic gastric juice 
containing ascorbic acid.  NO can then rapidly cross the lipid cell membrane into the 
neutral epithelial compartment forming nitrosating species and nitrite.   
 
After the control drink was given, the proximal stomach was the site of the 
highest concentrations of nitrite and nitrate.   This is likely due to this region being 
the first point of contact of salivary nitrite with acidic gastric juice in the presence of 
ascorbic acid.  Even in the control group there will be carriage of nitrite in saliva as 
shown by the concentration of salivary nitrite being 40 – 50 µM (221).  It has 
previously been shown that the concentrations of nitrite along the length of the 
oesophagus are similar to the concentrations in saliva (221).  NO will therefore be 
generated in the proximal stomach, as nitrite meets ascorbic acid in acidic gastric 
juice.   
 
After ingestion of a nitrate drink the nitrite concentration of biopsy samples 
from all three regions of upper gastrointestinal tract was higher than concentrations 
found in the control samples.  The greatest increase in nitrite concentrations was 
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observed in samples from the proximal stomach where this was three fold.  There 
are two potential mechanisms for this.  There is the generation of NO as discussed 
for the control group.  The maximal point of NO production will be the proximal 
stomach, where salivary nitrite meets gastric juice containing ascorbic acid.  The 
second mechanism is through acid-catalysed nitrosation, where the ascorbic acid 
within the proximal stomach is exhausted after reaction with nitrite (221).  Nitrite 
will then form nitrous acid in the proximal stomach and this may diffuse into the 
neighbouring intraepithelial cellular compartments.   
 
In our study, the biopsy concentration of nitrate was higher than nitrite in the 
control samples and increased after a nitrate drink.  There are two possible 
mechanisms to explain the increase in nitrate from NO generation.  The first of these 
is the well recognised reaction of NO with the iron contained within 
oxyhaemoglobin to produce methaemoglobin and nitrate (117).  NO can also be 
expected, within a cell, to react with the superoxide to form peroxynitrite.   Nitrate is 
a decomposition product of peroxynitrite.  These chemical reactions are shown 
below: 
 
O-O- + N=O  OONO-   the reaction of superoxide with NO 
 
4OONO
-
  NO3
-
 + 2NO2
-
 + O2  the decomposition of peroxynitrite to 
nitrate, nitrite and oxygen 
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There are a few potential problems in concluding that the increases in biopsy 
sample nitrite and nitrate are all due to generation of NO.  The main problem relates 
to the cleaning of the biopsy specimens.  It had been the intention in this study that 
measurement of nitrite and nitrate concentrations would have been from the 
intracellular compartment.  Enrichment studies using 
15
N suggested that 93% of 
adherent mucus was cleaned from the biopsies using NAC.  While this suggests 
reasonable cleaning, it is not enough to provide confidence that the increases in 
biopsy sample nitrite and nitrate are all due to an increase in intracellular 
compartment concentrations of these compounds.  It is possible that the increases 
observed were mainly due to an increase in the adherent mucus concentrations of 
these compounds. The mucus overlying the epithelium of the upper gastrointestinal 
tract has a neutral pH and when NO meets this environment the NO can be expected 
to form nitrite.  Whether there is enough of a mucus barrier to prevent any of the 
very high concentrations of NO seen to be produced at the gastroesophageal junction 
and proximal stomach (43,45,280)
 
 is unknown.   
 
As well as nitrosative stress from NO, there is also the potential for acid-
catalysed nitrosation to be having an effect in these studies.  Previous work by 
Suzuki et al has shown that after a nitrate rich meal there is a change in the nitrite to 
ascorbic acid ratio such that acid-catalysed nitrosation is favoured (221).  This could 
be due to exhaustion of available gastric juice ascorbic acid such that nitrous acid is 
formed in acid from nitrite.  This can then pass into the epithelial compartment and 
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here be converted to nitrite.  Acid-catalysed nitrosation within the stomach is well 
recognised and discussed in the literature.   
 
This is, therefore, an interesting study in mapping potential nitrosative stress in 
the upper gastrointestinal tract.  The proximal stomach is the site of maximal nitrite 
and nitrate concentrations.  The study also shows that after a nitrate meal there is an 
increase in nitrosative stress, and this is most marked in the proximal stomach.  
While it is possible that some of the increased stress is not NO mediated, the fact 
that, in these healthy volunteers, the proximal stomach is the site of maximal 
concentration of nitrite and of the increase in nitrite after a nitrate meal, makes it 
likely that NO has a significant role to play in nitrosative stress after a nitrate meal.   
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Chapter 10: Rat model: Nitrite as a marker of nitrosative stress 
 
10.1 Introduction 
 
It has previously been found that nitrite is a marker of nitrosative stress in an 
in vitro model simulating the chemistry occurring at the gastroesophageal junction 
(44).  Nitrite is, therefore, an attractive candidate as a marker of nitrosative stress in 
biological tissue of the upper gastrointestinal tract.  Studies performed using rat 
stomach tissue were devised to evaluate the efficacy of the cleaning of biological 
tissue required prior to quantification of intracellular nitrite and nitrate, and later, to 
assess the effect of NO on epithelial samples to determine if nitrite was a 
measurable marker of NO in biological tissue. 
 
The availability of human tissue is dependent on biopsies taken at time of 
endoscopy.  Rat tissue is more freely available and can be obtained in large 
quantities, as the entire stomach can be removed for tissue analysis.  Although the 
rat stomach is not anatomically or physiologically identical to the human stomach, 
as it is more easily obtained, it allows multiple experiments to be perfomed to 
assess whether the measurement of biopsy nitrite and nitrate, related to NO, is 
possible.  There is a difference in the thickness of the mucus in the rat stomach 
compared to the human.  The mucus layer between the acidic gastric lumen and the 
epithelial surface is thicker in human samples than in rat (315).  As the whole rat 
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stomach can be dissected out, an appropriate sized piece of tissue can be placed in 
specifically designed experimental models.   
 
The rat stomach is divided into two parts, the forestomach and corpus (figure 
10.1 and 10.2):  Forestomach: thin-walled, non-glandular section that receives the 
oesophagus and serves as a holding chamber for food. Its walls are similar to those 
of the oesophagus.  Corpus: thick-walled, glandular section. Its walls have 
secretory glands that produce digestive enzymes and mucus. Digestion begins in the 
corpus. The pyloric sphincter controls the movement of food from the corpus to the 
intestines and specifically the duodenum. 
 
         The forestomach and the corpus are separated by a low fold of tissue called 
the limiting ridge (margo plicatus). The limiting ridge extends circumferentially 
from the large curvature of the stomach to the small curvature, just below the 
oesophagus. At the oesophagus, the course of the limiting ridge bends into a U-
shape and almost surrounds the oesophageal opening (316).  
 
In the following studies in this chapter, the rat forestomach was used to 
represent the human oesophageal tissue, while the rat stomach corpus tissue was 
used to represent the human stomach tissue. 
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Figure 10.1: A schematic diagram of the rat stomach, showing the forestomach, 
limiting ridge (margo plicatus) and corpus regions of the stomach.  The 
oesophagus empties into the forestomach.  The corpus empties into the 
duodenum through the pyloric sphincter.  The limiting ridge separates 
the forestomach from the corpus. 
 
                                           
Figure 10.2: The rat stomach can be seen to be divided into the forestomach and the 
corpus, by the limiting ridge which extends circumferentially from the 
large curvature of the stomach to the small curvature, just below the 
oesophagus. 
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10.2 Methods and materials 
 
10.2.1 Rats 
 
All rats used were female Wistar rats greater than 250g in weight.  The large 
weight was used to ensure that the size of the stomach was adequate for our 
experiments.  The rats were fasted for 24 hours prior to dissection. 
 
Dissection of the rats took place in the animal house after being sacrificed 
using 50% CO2 and O2 causing asphyxiation.  The dissection consisted of making a 
vertical incision the length of the rat, from vagina to sternum.  The incision went 
through to the abdominal cavity where the stomach was located underneath the 
liver.  The stomach was separated from the peritoneum and remainder of the 
gastrointestinal tract, by several small incisions.  
 
10.2.2 Storage and preparation of tissue 
 
The stomach was immediately placed in chilled Krebs solution and kept on ice 
after dissection.  The stomachs were then transferred to the laboratory, where the 
experiments were performed within 2 hours of the dissection. 
 
Once in the laboratory, the stomach was cut along the greater curvature to 
enable visualisation of the margo plicatus.  The whole stomach was then briefly 
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rinsed in dH2O to remove remaining food residue.  Tissue from both the corpus and 
forestomach was used in the experimental models.  It was technically difficult to 
obtain, solely, the epithelial layer.  In these experiments the mucosa was removed 
by injecting 1 mL saline solution to create a bleb into the submucosa, thereby 
lifting the mucosa from the underlying layers.  This area of mucosa was then 
carefully dissected from the rest of the tissue, using a 0.5mm scalpel blade.  Once 
tissue for analysis was obtained, it was cleaned anplaced in PBS (80 µL) before 
being snap frozen in liquid nitrogen before storage at -70
o
C. 
 
10.2.3 Processing of tissue  
 
After thawing the samples required a cleaning process to remove surrounding 
mucus from the rat tissue.  As discussed in Chapter 8.2.2, 3.1% NAC at neutral pH 
in PBS is a mucolytic agent with the capability of cleaning surrounding mucus from 
human tissue.  Where rat tissue has been cleaned, in the following experiments, 
3.1% NAC has been used. 
 
Samples were then snap frozen, homogenised and sonicated to release 
intracellular compartment constituents, as discussed in Chapter 8.2.4.  Initially there 
was difficulty homogenising rat stomach samples, both in a glass hand held 
homogenizer, and also in a larger steel shafted serrated head mortar and pestle.  
Therefore, softening of the samples by alkalisation was performed to aid the 
homogenisation process.  Alkalisation was achieved using sodium hydroxide, by 
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adding 50 μL of 5 M NaOH to 420 μL of PBS.  After this alkalisation the samples 
were homogenised using a glass hand held homogenizer (Anachem Ltd, 
Bedforshire, UK), with subsequent centrifugation of the sample at 13000g.   
 
10.2.4 Chemical analysis 
 
Measurement of NO and O2 was performed using WPI probes and sensors as 
described in Chapter 2.1.1 and 2.1.2.  Methods for protein, nitrite and 
15
N analysis 
were as for human samples and are described in Chapter 2.1.3, 2.1.4 and 2.1.6.   
 
The analysis of nitrate was performed with some adjustments from previous 
methods.   Nitrate reductase which converts nitrate to nitrite is a pH dependent 
enzyme working best at pH 7.5.  Samples in these experiments were strongly 
alkaline after a softening process prior to homogenisation.  Although the samples 
were placed in PBS, the volume of PBS used was small and did not cause the pH of 
the sample to reach neutrality.  It was found that, when the pH was not corrected to 
a neutral pH, we did not record any nitrate from our samples.  This problem was 
overcome by using a ‘super’ acidic buffer which was constituted as 0.1 M NaOH 
and half volume 0.3 M HCl.  When plating the samples, 30µL of sample was taken 
and 30 µL of the ‘super’ buffer was added to make the final pH neutral.  Samples 
were then analysed for nitrate concentrations as described in Chapter 2.1.5. 
 
 
261 
 
10.2.5 Contamination studies to assess cleaning of sample 
 
10.2.5.1 Immersion in 5 mM nitrate 
 
Dissected rat stomach mucosa from both the forestomach and corpus was 
removed, and subjected to one of the following conditions in a 1 mL plastic 
Eppendorf test tube: exposed to dH2O and left unclean, exposed to dH2O but 
cleaned in 3.1% NAC for 30 minutes, exposed to 5 mM KNO3 for 30 minutes then 
left unclean or exposed to 5 mM KNO3 for 30 minutes then cleaned in 3.1% NAC 
for a further 30 minutes. 
 
The stomach from six different rats was used for these experiments and six 
different samples from each rat were used for each condition to which the mucosa 
was exposed.  Samples were then analysed for protein, nitrate and nitrite. 
 
10.2.5.2 Three layer Delrin model contamination studies with 5 mM nitrite 
and nitrate 
 
A specially designed Delrin model was constructed as shown in Figure 10.3.   
The lower chamber in this model was filled with a solution of 5 mM KNO3 or 5 
mM KNO2 to contaminate the sample.  Contamination studies were performed in 
this model as it is similar to the model used to perform the studies subjecting rat 
tissue to NO.  Tissue from six rats, from both the corpus and forestomach, were 
placed between the upper and lower layers of this model.  In this experiment there 
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was a control sample, which was placed within the Delrin model containing only 
dH2O only before being either cleaned in 3.1% NAC or left unclean.  Of the tissue 
placed within the KNO3 Delrin model, half of the samples were left unclean, while 
the other half of the samples were subjected to the cleaning process in 3.1% NAC.  
For each experimental condition there were six samples in each arm of the 
experiment per rat stomach. 
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Funnel for 
adding contents
Rat stomach tissue 
placed between lower 
and upper chamber
Upper chamber of 
only 400μLof PBS 
pH 7.4
Altesil membrane 
seals x2 to act as 
seal and keep 
tissue 
Lower chamber 
containing 5mM 
KNO3 or KNO2.
 
Figure 10.3: Three-phase Delrin model used to subject the epithelial surface of rat 
stomach mucosa to high concentrations of contaminant KNO3 or 
KNO2.  In this three-phase model the rat tissue formed the middle 
layer.  The rat tissue was supported by a hydrophobic altesil 
membrane (thickness 0.8mm) through which NO and O2 are known 
to pass.  The tissue was placed between two layers of the membrane.  
The membrane had a hole cut, in the centre of where the tissue lay, to 
allow the rat tissue to be the only contact between the upper and 
lower layers of the model.  The lower chamber consisted of 5 mM 
KNO3
 
or KNO2.  The upper chamber was formed by 400 μL PBS at a 
neutral pH.   
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10.2.5.3 Three layer Delrin model contamination with 
15
N nitrite and 
nitrate 
 
To assess the extent of contamination after cleaning more closely,   
experiments were perfomed involving a labeled 
15
N preparation of nitrite and 
nitrate.  This allowed determination of whether nitrogen measured was 
contamination from the nitrate and nitrite used to spike the samples or whether it 
was nitrogen already present in the sample.  If 
15
N concentrations were high, then 
the cleaning was not as efficient as we required for assessing intraepithelial nitrite 
and nitrate. 
 
 The 
15
N nitrite and nitrate was used in the same Delrin experimental model as 
shown in figure 10.3.  The concentrations used as contaminant solutions were 5 
mM K
15
NO2 and 5 mM K
15
NO3.   After processing in the standard way described in 
10.2.3, samples were analysed for protein, nitrite, nitrate and 
15
N content.  Six 
samples, from each of six different rats, were taken and subjected to experimental 
conditions.  
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10.2.6 Model used to assess the effect of NO on rat epithelial cells 
 
Experiments were performed, within a three layer model, with rat stomach 
tissue being exposed to NO produced from the acidification of nitrite in the 
presence of ascorbic acid (figure 10.4). 
 
Rat mucosal tissue was obtained as described in 10.2.1.  Both the glandular 
corpus of the rat stomach and the forestomach were used.  Once the appropriate 
tissue was obtained, it was placed between two layers of altesil membrane which 
had been specially prepared.  The membrane was cut with a hole in the middle, this 
was to allow the rat tissue to be the only layer between the upper chamber and the 
lower chamber.  The tissue was then clamped in place in the Delrin model.  HCl 
(pH 1.5) with ascorbic acid (1 mM) to a volume of 17.9 mL was added to the lower 
chamber.  The experiments were initiated by adding 120 µM nitrite to the lower 
chamber, except in control experiments where nitrite was replaced with dH2O. 
 
Experiments were performed to ensure that this system was allowing rat tissue 
to be exposed to appropriate concentrations of NO.  NO levels were measured, 
using a WPI NO probe, from the upper chamber surface of the rat tissue to ensure 
that NO was passing through the tissue.  We found that it took between 60 and 90 
seconds for the NO to diffuse through the tissue, after the addition of the nitrite to 
the lower layer. After that time there was a steady rise in the NO level to a 
maximum of between 60 and 70 µM at the end of the twenty minute experiments 
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(figure 10.5).  At no point during the experiment was the upper layer deficient in O2 
as measured with a WPI O2 probe placed in the upper chamber on the rat surface.  
At the end of the 20 minute experiment the pH in the upper chamber was still 
neutral, showing the integrity of the rat stomach tissue to form a middle layer 
during the experiment.   
 
Thereafter, experiments were performed to determine if we could measure 
intracellular nitrite/nitrate in the rat stomach tissue by exposing the tissue to 
generated NO.  The experiments were set up as described above.  In addition, 
control experiments, with tissue from the same rat, were set up exactly as above, 
but on these occasions no nitrite was added to the lower chamber.  Instead, in these 
control experiments there was no generation of NO, as was confirmed by the 
absence of a rise when the NO level was measured using the NO probe and meter. 
 
A series of experiments to assess the effect of nitrous acid on the samples was 
also set up, by having the same experimental conditions as in the experiments 
generating NO except that the lower chamber had no ascorbic acid present.  In 
these experiments there was no recordable NO generation in the upper chamber.  
All samples were cleaned using 3.1% NAC as described in Chapter 8.2.2.  
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Funnel for adding 
contents
Rat stomach tissue placed 
between lower and upper 
layer
Upper layer of only 
400μL of PBS pH 
7.4
Altesil membrane 
seals x2 to act as seal 
and keep tissue 
Lower layer 
containing HCl, 
ascorbic acid with 
nitrite added to 
this to generate 
NO. pH 1.5.  Total 
Volume 17.9mls.
NO/O2 probe
 
Figure 10.4: Three layer Delrin model to expose rat stomach mucosa to NO 
generated from acidified nitrite in the presence of ascorbic acid.  Rat 
stomach tissue was placed between two layers of silicone altesil 
membrane (thickness 0.8mm), with a hole in the membranes so that 
there was an area of tissue that was not covered by the membrane.  
This was then clamped between the top of the Delrin lower base unit 
and the upper Delrin unit.  Into the lower unit was added HCl (pH 1.5) 
and ascorbic acid (1mM).  This is to represent the acidic environment 
of the stomach.  The upper layer had 400 µL PBS added to it (pH 7.4).  
The rat tissue used was the mucosa obtained after a submucosal bleb 
had lifted the mucosa from underlying tissue.  After the addition of 
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nitrite (120 µM) to the lower layer NO is generated in this layer and the 
rat tissue that is above is exposed to this NO.   
 
 
 
 
 
Figure 10.5: NO and O2 concentrations on the upper surface of rat stomach tissue 
after the addition of nitrite (120 µM) to an acid environment containing 
ascorbic acid in the lower chamber of a three-phase Delrin model.  
Data labels show the mean NO concentration at 15 minutes. n=12 
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10.3 Results 
 
10.3.1 Contamination studies  
 
10.3.1.1 Immersion studies in 5 mM KNO3 
 
 
The immersion form of contamination with 5 mM KNO3
 
led to a significant 
rise in mean nitrate concentration compared to samples which were not subjected to 
any nitrate (figure 10.6) (p<0.0001).  In forestomach samples, there was effective 
cleaning of samples with only 8% more nitrate present after contamination and 
cleaning as compared to samples that had not been exposed to contaminant.  The 
mean nitrate concentration of samples exposed to nitrate and cleaned was 24.8 
(±3.7) µM per µg protein compared to 22.9 (±2.0) µM per µg protein for samples 
which were not subjected to contaminant nitrate and cleaned (figure 10.6) (p=0.18).  
This represented cleaning of around 96% when compared to the contaminated 
unclean sample.  The rat stomach corpus samples appeared to be more difficult to 
clean, as the mean nitrate concentration  of samples subjected to nitrate and cleaned 
is 28.6 (±3.2) µM per µg protein compared to 24.5 (±4.1) µM per µg protein when 
samples were not subjected to nitrate and cleaned (p=0.03).  This means there was 
16% more nitrate on the contaminated samples than the control samples.  The 
cleaning efficiency when contaminated unclean samples were compared to 
contaminated clean samples was 92%.  There was no significant difference in mean 
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nitrite concentrations for samples subjected to contamination with nitrate (p=0.64).  
There was, however, a trend for the mean nitrite concentration to be lower in 
samples that were cleaned over those that were not cleaned, but this was not 
statistically significant (p=0.29).  
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Figure 10.6: The mean nitrate and nitrite concentrations (µM per µg protein) are 
shown for rat tissue contamination studies.  The tissue from either the 
forestomach (blue bars) or corpus (red bars) were either left unaltered 
or left immersed in a plastic Eppendorf test tube containing 5 mM 
KNO3
- 
for 30 minutes.  Samples were then either analysed without 
cleaning or subjected to cleaning in 3.1% NAC.  The mean 
concentrations are given to the left for nitrate concentrations and to the 
right for nitrite concentrations.  Data labels show mean values. Error 
bars represent 1 standard deviation.  n=36 
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10.3.1.2 Delrin model contamination with nitrate and nitrite to assess cleaning 
 
In studies with nitrate as the contaminant:  The mean nitrate and nitrite 
concentrations in the Delrin model contamination studies showed that the cleaning 
process was effective in cleaning what appeared to be 100% of contaminant KNO3
 
from the forestomach samples (figure 10.7).  As in the immersion studies, the 
cleaning process was not as efficient for the corpus samples, although the mean 
nitrate concentration from contaminated clean samples was only 8% more than 
uncontaminated cleaned samples (p=0.28).   
 
In studies with nitrite as the contaminant: The mean nitrate concentrations, 
when the contaminant was KNO2, did not significantly increase compared to 
control samples exposed to deionised water only (p=0.08).  There was however a 
trend for the nitrate concentration to be slightly increased after exposure to KNO2 
with subsequent cleaning, with a mean concentration of 28.0 (±2.7) µM per µg 
protein for forestomach samples (figure 10.8).  The highest concentration of nitrate, 
in any of the samples, from all four conditions, was found in the corpus samples 
exposed to KNO2 and subsequently cleaned, although the difference between this 
and the cleaned uncontaminated sample was not statistically significant (p=0.11).  
The mean nitrite concentrations were appropriately elevated after exposure and no 
cleaning.  There was however 20% and 27% more nitrite, in forestomach and 
corpus samples respectively, after contamination and cleaning compared to no 
contamination and cleaning (figure 10.8). 
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Figure 10.7: Mean nitrate and nitrite concentrations from KNO3 Delrin model 
contamination studies.  Rat tissue biopsies were either placed in a 
Delrin model as shown in figure 10.3 and exposed to 5 mM KNO3
 
for 
30 minutes or were left uncontaminated by placing them in a model 
containing deionised water only (H2O).  The mean nitrate and nitrite 
concentrations are shown after either being left unclean or cleaned 
using 3.1% NAC.  The blue columns represent the mean concentrations 
for tissue from the forestomach while the red column represents the 
corpus.  Mean nitrate concentrations are shown on the left hand side of 
the chart and mean nitrite concentrations on the right.  Data labels 
show mean values.  Error bars show 1 standard deviation. (n=18) 
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Figure 10.8: Mean nitrate and nitrite concentrations from KNO2 delrin model 
contamination rat studies.  Rat tissue biopsies were either placed in a 
Delrin model as shown in Figure 10.3 and exposed to 5 mM KNO2
 
for 
30 minutes or were left uncontaminated by placing them in a model 
containing deionised water only (H2O).  The mean nitrate and nitrite 
concentrations are shown after either being left unclean or cleaned using 
3.1% NAC.  The blue columns represent the mean concentrations for 
tissue from the forestomach while the red column represents the corpus.  
Mean nitrate concentrationsare shown on the left hand side of the chart 
and mean nitrite concentrations on the right.  Data labels show mean 
values.  Error bars represent 1 standard deviation. (n=18) 
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10.3.1.3  Delrin model with 
15
N 
 
With 
15
N Nitrate
 
 
The 
15
N measured after forestomach rat mucosal samples were exposed to 
contaminant K
15
NO3
 
in a Delrin model with subsequent NAC cleaning was no 
higher than the background 
15
N measured from samples not exposed to K
15
NO3 
(0.07 ng versus 0.08 ng) (p=0.7).  There was a slight increase of approximately 
20% in the corpus samples 
15
N content (p=0.05), although there appeared to be 
cleaning effectiveness of over 97% using 3.1% NAC (Figure 10.9). 
 
With 
15
N Nitrite
 
 
The 
15
N measured in forestomach and corpus cleaned samples exposed to 
K
15
NO2 was slightly elevated compared to samples exposed to dH2O (Figure 
10.10).  For forestomach samples this difference was not statistically significant 
(p=0.23).  However, the difference was statistically different for the more glandular 
rat corpus samples (p=0.004).  For both forestomach and corpus samples there was 
over 98% effective cleaning when the cleaned samples exposed to K
15
NO2
 
were 
compared to unclean K
15
NO2 against the control samples.   
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Figure 10.9: The mean 
15
N content (ng 
15
N per µg protein) from forestomach (blue 
column) and corpus (red column) rat stomach tissue samples exposed 
to either dH2O or 5mM K
15
NO3 in a delrin model.  The samples were 
then either cleaned in 3.1% NAC or left unclean.  Data labels show 
mean values.  Error bars represent 1 standard deviation. (n=18) 
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Figure 10.10: The mean 
15
N content (ng 
15
N per µg protein) from forestomach (blue 
column) and corpus (red column) rat stomach tissue samples exposed 
to either dH2O or 5mM K
15
NO2 in a delrin model.  The samples were 
then either cleaned in 3.1% NAC or left unclean.  Data labels show 
mean values.  Error bars represent 1 standard deviation. (n=18) 
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10.3.2 Studies in three-phase Delrin model to assess the effect of NO and nitrous 
acid on rat epithelial cell nitrate and nitrite  
 
There were significant differences in the mean nitrate and nitrite 
concentrations of both corpus and forestomach rat samples, when comparing tissue 
exposed to NO against tissue exposed to deionised water only.  There were 
increases of 50% (corpus) (p=0.0003) and 67% (forestomach) (p=0.00009) in 
measurable nitrite and approximately 30% (both corpus and forestomach) increase 
in mean nitrate concentrations after NO exposure for both forestomach (p=0.002) 
and corpus samples (p=0.001) (Figure 10.11).   
 
There was no statistical difference in mean nitrate and nitrite concentrations 
when samples exposed to nitrous acid were compared to samples exposed to water 
only for both forestomach (nitrite p=0.91, nitrate p=0.86) and corpus (nitrite 
p=0.96, nitrate p=0.79)) samples (Figure 10.11).  
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Figure 10.11: Mean concentrations of nitrite and nitrate for both corpus (red 
column) and forestomach (blue column) rat mucosal samples after 
exposure to NO or nitrous acid in a three-phase Delrin model.  
There were three different conditions within the Delrin model 
shown in figure 10.4 that the samples were exposed to: deionised 
water and cleaned, exposed to NO and then cleaned, exposed to 
nitrous acid and then cleaned.   Mean nitrate concentrations are 
shown on the right hand side of the chart and mean nitrite 
concentrations on the left.  Data labels show mean values.  Error 
bars represent 1 standard deviation. (n=18) 
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10.4 Discussion 
 
The studies described in this chapter had the primary aims of effectively 
cleaning rat stomach biopsy samples of adherent mucus, and to determine if 
changes in intracellular nitrite and nitrate were recordable after exposure of this 
tissue to high concentrations of NO.  Both of these primary aims have been 
achieved.   The ability to measure changes in intracellular nitrite and nitrate is 
important as we move towards determining a marker of nitrosative stress in human 
subjects.   
 
The samples from the upper gastrointestinal tract are known to have an 
adherent mucus lining on the surface (317).  The rat stomach is divided in two by 
the margo plicatus, into the more glandular corpus in the more distal portion of 
stomach, and the more proximal forestomach which in cell type more resembles the 
human oesophagus.  The glandular part of the stomach can be expected to have 
more adherent mucus and this is consistent with the findings in this study, that the 
corpus tissue was more difficult to clean when tissue samples were subjected to 
nitrate and nitrite contaminants.  Although the corpus was more difficult to clean, 
more than 97% of contaminant nitrate and nitrite was effectively washed from 
samples after being subjected to a cleaning process in NAC, as evidenced in 
15
N 
studies.  It is not surprising to find that rat mucosa is easier to clean with NAC than 
human tissue as it has been shown that the mucus layer is more adherent in human 
stomach tissue compared to rat tissue.  This, therefore, allows further work with rat 
stomach samples to determine intramucosal nitrite and nitrate concentrations. 
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However, it should be noted that there is no independent marker of cleaning of 
these biopsy samples and the effectiveness of the cleaning process cannot be 
considered perfect.  This is important as the concentrations of nitrite and nitrate 
measured were small and any contamination from the mucus could be significant 
when measuring intracellular concentrations.  An independent marker of cleaning is 
also important as nitrogen containing compounds may have been generated during 
the cleaning process, thus underestimating the effectiveness of the cleaning.  It may 
be possible in the future to use a protein marker from within the mucus layer as a 
means of determining the effectiveness of the cleaning process, although this was 
not performed within these studies. 
 
It was interesting to note that there was considerably more nitrate than nitrite 
within the biopsy sample.  It is likely that this was due to the conversion of nitrite to 
nitrate.  This occurs due to oxidation of nitrate in the presence of haemoglobin, as 
NO can react with oxyhaemoglobin to form methaemoglobin and nitrate directly 
(117).  This is the likely mechanism through which the nitrate concentrations were 
found to be increased in our studies where rat tissue was subjected to NO.  Nitrate 
concentrations were increased in samples that had been deliberately exposed to 
contaminant nitrite in very high concentrations.  The concentrations of nitrate found 
in these experiments with nitrite were higher than those found when the 
contaminant had been the same concentration of nitrate.  This may be explained by 
the generation of low concentrations of NO during the cleaning process with NAC.  
NAC is itself an antioxidant, similar to glutathione (310,311), and therefore in 
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reaction with nitrite NAC can be expected to form NO (313,314).  NO could then 
cross over into the cells and react with either oxyhaemoglobin (117) or superoxide, 
forming nitrate.  The reaction of NO with superoxide generates peroxynitrite which 
decomposes to nitrate, nitrite and O2 (294).  The reaction of nitrite with NAC is 
more likely to occur in an acidic environment, therefore in the neutral environment 
of the mucus layer (317) this reaction if likely to liberate only a small concentration 
of NO.  In contamination studies the concentrations of nitrate and nitrite used were 
deliberately excessive to ensure the subsequent cleaning process was adequate.  
This would explain why small concentrations could be found.  The effect of NAC 
on uncontaminated samples is unlikely to be having a significant artefactual effect 
on nitrite and nitrate concentrations, as evidenced by the fact that samples not 
contaminated but rather just cleaned in NAC showed no recordable difference in 
nitrate and nitrite concentrations.  Unfortunately, in our experiments we did not 
examine for the reaction of NAC with nitrite. 
 
It would appear that we are able to measure intramucosal nitrate and nitrite 
concentrations, and the change in these concentrations after exposure to NO.  In 
studies where rat tissue was exposed to nitrite in the absence of ascorbic acid, so 
that only nitrous acid rather than NO would be present, there was no increase in 
nitrate and nitrite concentrations.  This shows that it is the presence of acidified 
nitrite with ascorbic acid present generating NO that is important for the increased 
intramucosal concentrations of nitrite and nitrate.  This not only shows that a flux in 
intraepithelial nitrite and nitrate concentrations is measurable, but also that the NO 
283 
 
generated does have direct effects on the tissue in terms of nitrosative stress.  In 
these studies we have used nitrite as a marker of nitrosative stress.  The 
concentration of nitrite used in these experiments was not excessive, being 120µM, 
while the concentrations found in vivo have been 5-200µM after a nitrate rich meal 
(45,143).  This means that the concentrations found in vivo are significant enough 
to cause a measurable flux in tissue nitrate and nitrite concentrations, albeit in rat 
tissue. This would, therefore, allow for damage to occur either through the 
generation of N-nitrosocompounds or by NO directly affecting the cell.  The 
carcinogenic effects of N-nitrosocompounds and NO are well established, as 
discussed in the introduction to this thesis 
 
A recent study by Asanuma et al looked at a different marker of nitrosative 
stress due to NO in human upper gastrointestinal tract tissue.  This study made use 
of the high affinity of NO for Fe-S cluster proteins, and the fact that measurable 
DNIC (dinitrosyl dithiolato iron complex) is a biomarker for the interaction 
between Fe-S proteins and NO.  After the ingestion of nitrate drink, the appearance 
of DNIC was found in biopsies from the gastroesophageal junction in a significant 
number of human volunteers.  This, therefore, provides complimentary evidence of 
NO generated within the lumen of the upper gastrointestinal tract having a direct 
effect within the cells in the mucosa (285).  In another recent study by Clemons et 
al, acidification of salivary nitrite, resulting in the generation of NO, was shown to 
produce double strand DNA breaks in transformed and primary Barrett’s 
oesophageal cells, as well as adenocarcinoma cells (238).  These studies show that 
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cells of the upper gastrointestinal tract have determinable, detrimental changes 
related to NO generated from salivary nitrite, albeit in the setting of in vitro studies. 
 
This chapter adds to the current research on nitrosative stress in the upper 
gastrointestinal tract by showing that rat tissue can be adequately cleaned of mucus, 
and that NO flux into the cells is measurable as intramucosal nitrite and nitrate.  It 
would also appear that luminal nitrite requires the conversion to NO to be able to 
have significant effects, as without ascorbic acid there was no measurable 
difference in nitrite and nitrate concentrations in experiments where rat stomach 
tissue was exposed to nitrous acid in three layer model.  As well as nitrite being a 
marker for this nitrosative stress, we have shown that nitrate is also important to 
measure in the in vivo setting. 
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Chapter 11 Concluding discussion 
 
The studies described within this thesis add to the growing body of evidence in 
support of a novel mechanism of nitrosation within the upper gastrointestinal tract 
(43,45,144,221,222,280,285).  Nitrosation within the stomach is well described in 
the literature.  This is known to occur both from acid-catalysed nitrosation through 
decreased ascorbic acid production, and also from colonisation by denitrifying 
bacteria in those who are achlorhydric.  The potential for a third mechanism, but in 
this case occurring in the healthy acid secreting stomach, in the presence of ascorbic 
acid, has been explored within the work presented in the preceding chapters.  Bench 
top experiments have been performed and then transferred into in vivo conditions to 
show the importance of this mechanism of nitrosative stress in human subjects. 
 
 The major source of this nitrosative stress is dietary nitrate.  Through bacterial 
conversion of nitrate to nitrite, after enterosalivary recirculation of nitrate, 
swallowed saliva contains high concentrations of nitrite (45).  When this saliva 
meets acidic gastric juice, in the presence of ascorbic acid, NO is produced (44).  
Ascorbic acid is therefore acting as a luminal antioxidant and, in this compartment, 
is preventing nitrosative stress by limiting the production of nitrosating species such 
as NOSCN and N2O3 (240,267,318,319). 
 
 However, within the upper gastrointestinal tract there is not only a luminal but 
also a lipid compartment.  Lipid is found in two main forms in this region.   There is 
fat provided in the diet which floats within the more proximal stomach, and in 
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particular in the fundus, post prandially (244).  Perhaps providing the greatest 
surface area of lipid is the epithelial cell bilayer membranes.  The lipid bilayer forms 
a barrier between the luminal and epithelial compartments.  Within cells of intestinal 
metaplasia type there is particularly high lipid content (243).  Work presented in 
chapter 3 showed that when lipid is added to an aqueous phase the aqueous 
antioxidant (ascorbic acid) can change from being antioxidant to pro-oxidant.  This 
occurs due to the reaction product of nitrite with ascorbic being the highly lipophilic 
molecule NO.  NO then diffuses into the lipid, where it can rapidly react with O2 to 
form nitrosating species such as N2O3 (251).   In support of ascorbic acid being pro 
carcinogenic in certain situations, a previous study has shown that it can potentiate 
the growth inhibitory effects of NO in SK-N-MC human neuroblastoma (320).  
Ascorbic acid was not the first antioxidant to have been shown to have carcinogenic 
potential.  The synthetic antioxidant BHA was demonstrated, in rat forestomach 
epithelium, to be carcinogenic as early as 1983 (262).  One of the limitations of the 
studies in Chapter 3 was the measurement of lipid nitrosamine concentrations.  A 
robust lipid nitrosamine analysis has subsequently been developed, and results from 
these experiments confirm the results presented in this thesis, showing that 
nitrosamines are present within the lipid phase in high concentrations within our 
model (255). 
 
 The importance of lipid antioxidants has been recognised for many years.  Α-
tocopherol is the most abundant lipid antioxidant in living organisms.  Our studies 
have shown that this has an important inhibitory effect on nitrosation, in models of 
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the gastroesophageal junction.  The effect of α-tocopherol was greater than β-
carotene, which was in turn greater than the synthetic antioxidant BHT.  This is in 
keeping with in vitro experiments assessing the effectiveness of lipid chain breaking 
antioxidants (270), and also their biological activities in vivo (256).  Other studies 
have shown that β-carotene has the greatest inhibitory effect on bacterial 
mutagenicity from NO (125).  Nonetheless, all three antioxidants inhibited 
nitrosation within our model.  The surprising result from this set of experiments was 
the low concentration of α-tocopherol required to prevent nitrosation.  This is due to 
the in vitro recycling of α-tocopherol by ascorbic acid as shown by experiments in 
chapter 5.  Whether this process occurs in vivo is an area of controversy with some 
experiments suggesting such a process (162,321), while others have shown no 
recycling (174).   There have also been studies to show synergy between β-carotene 
and ascorbic acid (266).  Further experiments using different combinations of 
antioxidants could be undertaken in our models of the upper gastrointestinal tract.  
Within the studies presented in this thesis it would also have been worthwhile to 
determine the reaction products of the reaction between α-tocopherol and nitrite, NO 
and nitrosating species.  This may include measurement of reaction products such as 
α-tocopheroxyl radical and α-tocopherolquinone. 
 
 In order to transfer our understanding of gastroesophageal junction chemistry in 
vitro to the in vivo setting, a compartmentalised silastic tubing capable of measuring 
nitrosative stress was produced.  In subsequent studies using this tubing, in healthy 
volunteers, we showed nitrosative stress extending from the gastroesophageal 
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junction into the proximal stomach.  This was increased after a nitrate rich drink was 
ingested.  The proposed mechanism for this is that the increased nitrite swallowed in 
saliva, after a nitrate rich meal, causes both the generation of NO while ascorbic acid 
is present, and acid-catalysed nitrosation once gastric ascorbic acid has been 
overwhelmed in its initial reaction with nitrite with subsequent recycling of this 
nitrite through NO.  The tubing was further developed, in vitro, to include lipid 
antioxidant smeared either inside or outside.   Importantly, this showed the 
generation of NO from the reaction between nitrite and α-tocopherol, whether 
outside or inside the tube.  This modified tubing could be used in vivo in due course, 
although it would be best to standardise the concentrations of α-tocopherol inside the 
tubing before this is undertaken.   
 
 Our in vivo studies have not clearly shown whether nitrite is a good biomarker 
of nitrosative stress in human tissue.  This is mainly due to difficulties in cleaning 
adherent mucus from biopsy specimens.  Perhaps a more useful assessment of NO 
within the cells from the upper gastrointestinal tract would have come from analysis 
using diaminofluorescence and its diacetate (322).  Different markers have been 
assessed by other groups.  In a study by Asanuma et al, Fe-S cluster proteins affinity 
with NO has been used to assess for NO generation in the upper gastrointestinal tract 
after a nitrate rich meal.  A biomarker of the reaction between Fe-S cluster protein 
and NO was found in biopsies from the gastroesophageal junction in a significant 
number of subjects.  This, therefore, provides complementary evidence of NO 
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generated within the lumen of the upper gastrointestinal tract having a direct effect 
within the cells in the mucosa (285). 
 
It had been hoped that data regarding the measurement the DNA adduct O
6
-
carboxymethyl-2’-deoxyguanosine and O6-methyl deoxyguanosine as biomarkers of 
nitrosative stress would have been presented within this thesis.  DNA adducts can be 
useful markers of stress as they are more frequent abnormalities than cancer itself, 
they can be recognised early and they predict the onset of disease independently of 
exposure levels (323).  Previous work had shown the DNA adduct O
6
-
carboxymethyl-2’-deoxyguanosine present in human gastric biopsy tissue which had 
been exposed to endogenously nitrosated glycine (324).  In our studies, we had 
hoped to measure the DNA adduct O
6
-methyl deoxyguanosine and O
6
-
carboxymethyl-2’-deoxyguanosine before and after a nitrate meal.  These studies 
were performed on healthy volunteers.  Unfortunately, however, while waiting for 
refinement of the assay by collaborative colleagues in Greece, the samples were 
destroyed by a freezer failure within our department.  This is an area of research that 
could be explored again in the future.   
 
 Epidemiological studies do not provide a strong association when assessing the 
influence of nitrosamine, and related food intake, on oesophageal and gastric cancer 
(325).  However, recent studies carried out in humans have shown that endogenous 
N-nitrosocompounds could be up to 30 fold higher than exposure from dietary 
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sources, suggesting that only a small part of the human exposure to N-
nitrosocompounds has been measured (326-328). 
 
 The epidemiological evidence for an association between dietary nitrate intake 
and adenocarcinoma of the upper gastrointestinal tract is admittedly weak.  The only 
study to suggest a positive association was a large Swedish based one in 2001 (25),
 
while many others suggest a negative association with a high fruit and vegetable 
intake, likely to be due to the antioxidants present within these foodstuffs.  The 
reason for the lack of a positive association may be due to difficulty elucidating the 
finer details of a subgroup of people who are at risk from this nitrosative stress.   
 
 There are a few important considerations to take into account in interpreting the 
role of dietary nitrate in overall health.  It is clear throughout many aspects of 
biological systems that, while a compound may be protective in some contexts, it 
can be harmful in others.  It would be unreasonable to suggest that nitrate is entirely 
a harmful substance and should be eliminated from our diet.  There is evidence that 
dietary nitrate may indeed by protective.  There has been a recent hypothesis article 
suggesting a cardioprotective effect from NO derived from dietary nitrate (329).  
This stems from epidemiological studies suggesting the strongest protection against 
coronary heart disease was seen in individuals with a high intake of green leafy 
vegetables which are rich in nitrate (330,331).  There is also evidence that dietary 
vegetables reduce blood pressure (332).  As regards the upper gastrointestinal tract, 
there is some evidence that dietary nitrate has a protective effect.  This can be 
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through increased gastric blood flow, increased mucus thickness and 
decontamination of the human stomach (333-338).   
 
However, there does appear to be the potential for harmful effects of nitrate in 
the upper gastrointestinal tract.  The specific role has yet to be fully elucidated.  It is 
well recognised that there will be more than one insult required to promote 
carcinogenesis in the lower oesophagus and proximal stomach (339).  Nitrosative 
stress from dietary nitrate may be most harmful in subjects with acid and bile reflux.  
It has been shown that nitrosative stress is shifted into the lower oesophagus in 
subjects with Barrett’s oesophagus (286).  It is known that acidity has a deleterious 
effect on the mucosal protective barrier leading to caustic injury of the mucosa, as 
well as causing DNA damage within oesophageal cells (238).  Bile refluxate 
provides three conditions which would potentiate nitrosative stress within the lower 
oesophagus.  It contains bile acids such as glycocholic and taurocholic acid that are 
nitrosatable amides.  Spermidine, a nitrosatable polyamine, which is carcinogenic, is 
also present (340).  Bile also contains lecithin which is known to promote nitrosation 
reactions (341).  N-nitrosamides and related compounds are chemically active under 
physiological pH conditions and decompose to form the same alkyldiazohydroxide 
as nitrosamines.  Nitrosamides have been shown to produce both local as well as 
systemic tumours.  Conditions within the lower oesophagus, in those individuals 
with acid and bile reflux, are therefore such that nitrosative stress from nitrate may 
have an important role in adenocarcinoma development. 
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 The work presented within this thesis shows that dietary nitrate has the 
potential to generate nitrosative stress within the upper GI tract where salivary nitrite 
meets acidic gastric juice.  This may have relevance to the observed increased 
incidence of adenocarcinoma in the cardia region of the stomach and the 
gastroesophageal junction.  The combination of molecular tools with biochemistry is 
likely to provide useful information regarding nitrosative stress in the upper 
gastrointestinal tract, and in particular the role of dietary nitrate in carcinogenesis of 
the lower esophagus and proximal stomach, as we search for a mutagen responsible 
for the increased incidence of adenocarcinoma in this anatomical region.   
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